BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, Liu S, Zhao P, Liu H, Zhu L, Tai Y, Bai C, Gao T, Song J, Xia P, Dong J, Zhao J, Wang FS. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8:420-422. [PMID: 32085846 DOI: 10.1016/s2213-2600(20)30076-x] [Cited by in Crossref: 3918] [Cited by in F6Publishing: 2632] [Article Influence: 1959.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang S, Gan J, Chen BG, Zheng D, Zhang JG, Lin RH, Zhou YP, Yang WY, Lin A, Yan WH. Dynamics of peripheral immune cells and their HLA-G and receptor expressions in a patient suffering from critical COVID-19 pneumonia to convalescence. Clin Transl Immunology 2020;9:e1128. [PMID: 32399213 DOI: 10.1002/cti2.1128] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
2 Parra Gordo M, Buitrago Weiland G, Grau García M, Arenaza Choperena G. Radiologic aspects of COVID-19 pneumonia: Outcomes and thoracic complications. Radiología (English Edition) 2021;63:74-88. [DOI: 10.1016/j.rxeng.2020.11.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
4 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
5 Perico L, Benigni A, Casiraghi F, Ng LFP, Renia L, Remuzzi G. Immunity, endothelial injury and complement-induced coagulopathy in COVID-19. Nat Rev Nephrol. 2021;17:46-64. [PMID: 33077917 DOI: 10.1038/s41581-020-00357-4] [Cited by in Crossref: 85] [Cited by in F6Publishing: 81] [Article Influence: 42.5] [Reference Citation Analysis]
6 Furci F, Caminati M, Senna G, Gangemi S. The potential protective role of corticosteroid therapy in patients with asthma and COPD against COVID-19. Clin Mol Allergy 2021;19:19. [PMID: 34719394 DOI: 10.1186/s12948-021-00159-4] [Reference Citation Analysis]
7 Meng L, Xu J, Zhang J, Zhang K, Shang P, Li Q, Li Y, Wang L, Cai B. Monitoring peripheral neutrophil and T-lymphocyte subsets could assist in differentiating the severity and disease progression of coronavirus disease 2019. Aging (Albany NY) 2021;13:7723-32. [PMID: 33741750 DOI: 10.18632/aging.202701] [Reference Citation Analysis]
8 Han NR, Moon PD, Nam SY, Ko SG, Park HJ, Kim HM, Jeong HJ. TSLP up-regulates inflammatory responses through induction of autophagy in T cells. FASEB J 2022;36:e22148. [PMID: 34997949 DOI: 10.1096/fj.202101447R] [Reference Citation Analysis]
9 Keyhanian K, Umeton RP, Mohit B, Davoudi V, Hajighasemi F, Ghasemi M. SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation. J Neuroimmunol 2020;350:577436. [PMID: 33212316 DOI: 10.1016/j.jneuroim.2020.577436] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
10 Derruau S, Bouchet J, Nassif A, Baudet A, Yasukawa K, Lorimier S, Prêcheur I, Bloch-Zupan A, Pellat B, Chardin H, Jung S, On Behalf Of Task Force Covid-Collège National des EnseignantS En Biologie Orale Cnesbo-France. COVID-19 and Dentistry in 72 Questions: An Overview of the Literature. J Clin Med 2021;10:779. [PMID: 33669185 DOI: 10.3390/jcm10040779] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Ucciferri C, Vecchiet J, Falasca K. Role of monoclonal antibody drugs in the treatment of COVID-19. World J Clin Cases 2020; 8(19): 4280-4285 [PMID: 33083387 DOI: 10.12998/wjcc.v8.i19.4280] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]
12 Sun R, Liu H, Wang X. Mediastinal Emphysema, Giant Bulla, and Pneumothorax Developed during the Course of COVID-19 Pneumonia. Korean J Radiol. 2020;21:541-544. [PMID: 32207255 DOI: 10.3348/kjr.2020.0180] [Cited by in Crossref: 136] [Cited by in F6Publishing: 109] [Article Influence: 68.0] [Reference Citation Analysis]
13 van Dam LF, Kroft LJM, van der Wal LI, Cannegieter SC, Eikenboom J, de Jonge E, Huisman MV, Klok FA. Clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism: A different phenotype of thrombotic disease? Thromb Res 2020;193:86-9. [PMID: 32531548 DOI: 10.1016/j.thromres.2020.06.010] [Cited by in Crossref: 71] [Cited by in F6Publishing: 64] [Article Influence: 35.5] [Reference Citation Analysis]
14 Ji X, Tan W, Zhang C, Zhai Y, Hsueh Y, Zhang Z, Zhang C, Lu Y, Duan B, Tan G, Na R, Deng G, Niu G. TWIRLS, a knowledge-mining technology, suggests a possible mechanism for the pathological changes in the human host after coronavirus infection via ACE2. Drug Dev Res 2020. [PMID: 32657473 DOI: 10.1002/ddr.21717] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
15 Wang LL, Yang JW, Xu JF. Coronavirus (SARS-CoV-2) causes lung inflammation and injury. Clin Microbiol Infect 2021:S1198-743X(21)00674-1. [PMID: 34861410 DOI: 10.1016/j.cmi.2021.11.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Nigro E, Perrotta F, Polito R, D'Agnano V, Scialò F, Bianco A, Daniele A. Metabolic Perturbations and Severe COVID-19 Disease: Implication of Molecular Pathways. Int J Endocrinol 2020;2020:8896536. [PMID: 33312199 DOI: 10.1155/2020/8896536] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
17 Lu S, Zhao Y, Yu W, Yang Y, Gao J, Wang J, Kuang D, Yang M, Yang J, Ma C, Xu J, Qian X, Li H, Zhao S, Li J, Wang H, Long H, Zhou J, Luo F, Ding K, Wu D, Zhang Y, Dong Y, Liu Y, Zheng Y, Lin X, Jiao L, Zheng H, Dai Q, Sun Q, Hu Y, Ke C, Liu H, Peng X. Comparison of nonhuman primates identified the suitable model for COVID-19. Signal Transduct Target Ther 2020;5:157. [PMID: 32814760 DOI: 10.1038/s41392-020-00269-6] [Cited by in Crossref: 62] [Cited by in F6Publishing: 69] [Article Influence: 31.0] [Reference Citation Analysis]
18 Mishra KP, Singh M, Saraswat D, Ganju L, Varshney R. Dysfunctional State of T Cells or Exhaustion During Chronic Viral Infections and COVID-19: A Review. Viral Immunol 2022. [PMID: 35325564 DOI: 10.1089/vim.2022.0002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Saburi A, Schoepf UJ, Ulversoy KA, Jafari R, Eghbal F, Ghanei M. From Radiological Manifestations to Pulmonary Pathogenesis of COVID-19: A Bench to Bedside Review. Radiol Res Pract. 2020;2020:8825761. [PMID: 33294226 DOI: 10.1155/2020/8825761] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
20 Deng Q, Hu B, Zhang Y, Wang H, Zhou X, Hu W, Cheng Y, Yan J, Ping H, Zhou Q. Suspected myocardial injury in patients with COVID-19: Evidence from front-line clinical observation in Wuhan, China.Int J Cardiol. 2020;311:116-121. [PMID: 32291207 DOI: 10.1016/j.ijcard.2020.03.087] [Cited by in Crossref: 195] [Cited by in F6Publishing: 162] [Article Influence: 97.5] [Reference Citation Analysis]
21 Tang L, Yin Z, Hu Y, Mei H. Controlling Cytokine Storm Is Vital in COVID-19. Front Immunol 2020;11:570993. [PMID: 33329533 DOI: 10.3389/fimmu.2020.570993] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
22 Raina R, Chakraborty R, Mawby I, Agarwal N, Sethi S, Forbes M. Critical analysis of acute kidney injury in pediatric COVID-19 patients in the intensive care unit. Pediatr Nephrol 2021;36:2627-38. [PMID: 33928439 DOI: 10.1007/s00467-021-05084-x] [Reference Citation Analysis]
23 Taha R, Abureesh S, Alghamdi S, Hassan RY, Cheikh MM, Bagabir RA, Almoallim H, Abdulkhaliq A. The Relationship Between Vitamin D and Infections Including COVID-19: Any Hopes? Int J Gen Med 2021;14:3849-70. [PMID: 34335050 DOI: 10.2147/IJGM.S317421] [Reference Citation Analysis]
24 Girum T, Lentiro K, Geremew M, Migora B, Shewamare S. Global strategies and effectiveness for COVID-19 prevention through contact tracing, screening, quarantine, and isolation: a systematic review. Trop Med Health 2020;48:91. [PMID: 33292755 DOI: 10.1186/s41182-020-00285-w] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
25 Huang L, Zhao P, Tang D, Zhu T, Han R, Zhan C, Liu W, Zeng H, Tao Q, Xia L. Cardiac Involvement in Patients Recovered From COVID-2019 Identified Using Magnetic Resonance Imaging. JACC Cardiovasc Imaging. 2020;13:2330-2339. [PMID: 32763118 DOI: 10.1016/j.jcmg.2020.05.004] [Cited by in Crossref: 144] [Cited by in F6Publishing: 144] [Article Influence: 72.0] [Reference Citation Analysis]
26 Li Q, Ding X, Xia G, Chen HG, Chen F, Geng Z, Xu L, Lei S, Pan A, Wang L, Wang Z. Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: A retrospective case-control study. EClinicalMedicine 2020;23:100375. [PMID: 32368728 DOI: 10.1016/j.eclinm.2020.100375] [Cited by in Crossref: 64] [Cited by in F6Publishing: 53] [Article Influence: 32.0] [Reference Citation Analysis]
27 Schlick T, Zhu Q, Jain S, Yan S. Structure-altering mutations of the SARS-CoV-2 frameshifting RNA element. Biophys J 2021;120:1040-53. [PMID: 33096082 DOI: 10.1016/j.bpj.2020.10.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
28 Solarino B, Ferorelli D, Dell'Erba A. Post-mortem routine practice in the era of the COVID-19 pandemic. J Forensic Leg Med 2020;74:102010. [PMID: 32658768 DOI: 10.1016/j.jflm.2020.102010] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Costa KTDS, Morais TNB, Justino DCP, Andrade FB. Evaluation of the epidemiological behavior of mortality due to COVID-19 in Brazil: A time series study. PLoS One 2021;16:e0256169. [PMID: 34383857 DOI: 10.1371/journal.pone.0256169] [Reference Citation Analysis]
30 Patel SK, Singh R, Rana J, Tiwari R, Natesan S, Harapan H, Arteaga-Livias K, Bonilla-Aldana DK, Rodríguez-Morales AJ, Dhama K. The kidney and COVID-19 patients - Important considerations. Travel Med Infect Dis 2020;37:101831. [PMID: 32750416 DOI: 10.1016/j.tmaid.2020.101831] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
31 Adu-Amankwaah J, Mprah R, Adekunle AO, Ndzie Noah ML, Adzika GK, Machuki JO, Sun H. The cardiovascular aspect of COVID-19. Ann Med 2021;53:227-36. [PMID: 33345626 DOI: 10.1080/07853890.2020.1861644] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
32 Sayed AA, Allam AA, Sayed AI, Alraey MA, Joseph MV. The use of neutrophil-to-lymphocyte ratio (NLR) as a marker for COVID-19 infection in Saudi Arabia: A case-control retrospective multicenter study. Saudi Med J 2021;42:370-6. [PMID: 33795491 DOI: 10.15537/smj.2021.42.4.20200818] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Dai J, Xiong Y, Li H, Qian Y, Xu Y, Xu Q, Yan X, Tang J. Corticosteroid treatment in severe COVID-19 pneumonia: two cases and literature review. Clin Rheumatol 2020;39:2031-7. [PMID: 32451729 DOI: 10.1007/s10067-020-05172-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
34 Zhao Z, Chen A, Hou W, Graham JM, Li H, Richman PS, Thode HC, Singer AJ, Duong TQ. Prediction model and risk scores of ICU admission and mortality in COVID-19. PLoS One 2020;15:e0236618. [PMID: 32730358 DOI: 10.1371/journal.pone.0236618] [Cited by in Crossref: 63] [Cited by in F6Publishing: 56] [Article Influence: 31.5] [Reference Citation Analysis]
35 Alvarez MM, González-González E, Trujillo-de Santiago G. Modeling COVID-19 epidemics in an Excel spreadsheet to enable first-hand accurate predictions of the pandemic evolution in urban areas. Sci Rep 2021;11:4327. [PMID: 33619337 DOI: 10.1038/s41598-021-83697-w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
36 Moghadam VD, Shafiee H, Ghorbani M, Heidarifar R. [Prone positioning in management of COVID-19 hospitalized patients]. Braz J Anesthesiol 2020;70:188-90. [PMID: 32419704 DOI: 10.1016/j.bjan.2020.05.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
37 Agrawal D, Saigal S. Utilization of SARS-COV-2 positive donors and recipients for Liver transplantation in the pandemic era – An evidence-based review. Journal of Liver Transplantation 2022. [DOI: 10.1016/j.liver.2022.100081] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Lai W, Xie C, Pan H, Fan M, Liu J. Computed tomography of the lungs in novel corona virus (COVID-19) infection. Pediatr Radiol 2020;50:1016-7. [PMID: 32358678 DOI: 10.1007/s00247-020-04664-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Miró Ò, Llorens P, Jiménez S, Piñera P, Burillo-Putze G, Martín A, Martín-Sánchez FJ, González Del Castillo J; Spanish Investigators on Emergency Situations TeAm (SIESTA) network. Frequency of five cardiovascular/hemostatic entities as primary manifestations of SARS-CoV-2 infection: Results of the UMC-19-S2. Int J Cardiol 2021;330:268-72. [PMID: 33529670 DOI: 10.1016/j.ijcard.2021.01.051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Zhang Z, Zheng Y, Niu Z, Zhang B, Wang C, Yao X, Peng H, Franca DN, Wang Y, Zhu Y, Su Y, Tang M, Jiang X, Ren H, He M, Wang Y, Gao L, Zhao P, Shi H, Chen Z, Wang X, Piacentini M, Bian X, Melino G, Liu L, Huang H, Sun Q. SARS-CoV-2 spike protein dictates syncytium-mediated lymphocyte elimination. Cell Death Differ 2021. [PMID: 33879858 DOI: 10.1038/s41418-021-00782-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
41 Alam I, Kamau AA, Kulmanov M, Jaremko Ł, Arold ST, Pain A, Gojobori T, Duarte CM. Functional Pangenome Analysis Shows Key Features of E Protein Are Preserved in SARS and SARS-CoV-2. Front Cell Infect Microbiol 2020;10:405. [PMID: 32850499 DOI: 10.3389/fcimb.2020.00405] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
42 Rossi M, Piagnerelli M, Van Meerhaeghe A, Zouaoui Boudjeltia K. Heme oxygenase-1 (HO-1) cytoprotective pathway: A potential treatment strategy against coronavirus disease 2019 (COVID-19)-induced cytokine storm syndrome. Med Hypotheses. 2020;144:110242. [PMID: 33254548 DOI: 10.1016/j.mehy.2020.110242] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
43 Ufuk F, Savaş R. Chest CT features of the novel coronavirus disease (COVID-19). Turk J Med Sci 2020;50:664-78. [PMID: 32394687 DOI: 10.3906/sag-2004-331] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 7.5] [Reference Citation Analysis]
44 Counoupas C, Johansen MD, Stella AO, Nguyen DH, Ferguson AL, Aggarwal A, Bhattacharyya ND, Grey A, Hutchings O, Patel K, Siddiquee R, Stewart EL, Feng CG, Hansbro NG, Palendira U, Steain MC, Saunders BM, Low JKK, Mackay JP, Kelleher AD, Britton WJ, Turville SG, Hansbro PM, Triccas JA. A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilising immunity against SARS-CoV-2 infection. NPJ Vaccines 2021;6:143. [PMID: 34848711 DOI: 10.1038/s41541-021-00406-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Chowdhury MR, Mas-ud MA, Ali MR, Fatamatuzzohora M, Shimu AS, Haq MA, Islam MA, Hossain MF, Hosenuzzaman M, Islam MM, Hasan MF, Matin MN. Harmful Effects of COVID-19 on Major Human Body Organs: A Review. J Pure Appl Microbiol 2021;15:500-11. [DOI: 10.22207/jpam.15.2.14] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
46 Rathi H, Burman V, Datta SK, Rana SV, Mirza AA, Saha S, Kumar R, Naithani M. Review on COVID-19 Etiopathogenesis, Clinical Presentation and Treatment Available with Emphasis on ACE2.Indian J Clin Biochem. 2021;1-20. [PMID: 33424145 DOI: 10.1007/s12291-020-00953-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
47 Tsyganova EV, Glukhoedova NV, Zhilenkova AS, Fedoseeva TI, Iushchuk EN, Smetneva NS. COVID-19 and features of cardiovascular involvement. Terapevticheskii arkhiv 2021;93:1091-9. [DOI: 10.26442/00403660.2021.09.201036] [Reference Citation Analysis]
48 Yekelchyk M, Madan E, Wilhelm J, Short KR, Palma AM, Liao L, Camacho D, Nkadori E, Winters MT, Rice ES, Rolim I, Cruz-Duarte R, Pelham CJ, Nagane M, Gupta K, Chaudhary S, Braun T, Pillappa R, Parker MS, Menter T, Matter M, Haslbauer JD, Tolnay M, Galior KD, Matkwoskyj KA, McGregor SM, Muller LK, Rakha EA, Lopez-Beltran A, Drapkin R, Ackermann M, Fisher PB, Grossman SR, Godwin AK, Kulasinghe A, Martinez I, Marsh CB, Tang B, Wicha MS, Won KJ, Tzankov A, Moreno E, Gogna R. Flower lose, a cell fitness marker, predicts COVID-19 prognosis. EMBO Mol Med 2021;13:e13714. [PMID: 34661368 DOI: 10.15252/emmm.202013714] [Reference Citation Analysis]
49 Kircheis R, Planz O. Could a Lower Toll-like Receptor (TLR) and NF-κB Activation Due to a Changed Charge Distribution in the Spike Protein Be the Reason for the Lower Pathogenicity of Omicron? Int J Mol Sci 2022;23:5966. [PMID: 35682644 DOI: 10.3390/ijms23115966] [Reference Citation Analysis]
50 Moga E, Lynton-pons E, Domingo P. The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection. Front Immunol 2022;13:904686. [DOI: 10.3389/fimmu.2022.904686] [Reference Citation Analysis]
51 Daher A, Balfanz P, Cornelissen C, Müller A, Bergs I, Marx N, Müller-Wieland D, Hartmann B, Dreher M, Müller T. Follow up of patients with severe coronavirus disease 2019 (COVID-19): Pulmonary and extrapulmonary disease sequelae. Respir Med 2020;174:106197. [PMID: 33120193 DOI: 10.1016/j.rmed.2020.106197] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 22.0] [Reference Citation Analysis]
52 Beitzke D, Salgado R, Francone M, Kreitner KF, Natale L, Bremerich J, Gutberlet M, Mousseaux E, Nikolaou K, Peebles C, Velthuis B, Vliegenthart R, Loewe C, Emrich T;  Executive Committee of the European Society of Cardiovascular Radiology (ESCR):; Luigi N, Matthias G, Rozemarijn V, Konstantin N, Marco F, Christian L, Brigitta V, Rodrigo S, Charles P, Ellie M. Cardiac imaging procedures and the COVID-19 pandemic: recommendations of the European Society of Cardiovascular Radiology (ESCR). Int J Cardiovasc Imaging. 2020;36:1801-1810. [PMID: 32451877 DOI: 10.1007/s10554-020-01892-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
53 Cafiero C, Re A, Micera A, Palmirotta R, Monaco D, Romano F, Fabrizio C, Di Francia R, Cacciamani A, Surico PL, D'Amato G, Pisconti S. Pharmacogenomics and Pharmacogenetics: In Silico Prediction of Drug Effects in Treatments for Novel Coronavirus SARS-CoV2 Disease. Pharmgenomics Pers Med 2020;13:463-84. [PMID: 33116761 DOI: 10.2147/PGPM.S270069] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Deinhardt-Emmer S, Wittschieber D, Sanft J, Kleemann S, Elschner S, Haupt KF, Vau V, Häring C, Rödel J, Henke A, Ehrhardt C, Bauer M, Philipp M, Gaßler N, Nietzsche S, Löffler B, Mall G. Early postmortem mapping of SARS-CoV-2 RNA in patients with COVID-19 and the correlation with tissue damage. Elife 2021;10:e60361. [PMID: 33781385 DOI: 10.7554/eLife.60361] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
55 Pasha SB, Swi A, Hammoud GM. Gastrointestinal and hepatic manifestations of COVID-19 infection: Lessons for practitioners. World J Meta-Anal 2020; 8(5): 348-374 [DOI: 10.13105/wjma.v8.i5.348] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Croccolo F, Roman HE. Spreading of infections on random graphs: A percolation-type model for COVID-19. Chaos Solitons Fractals 2020;139:110077. [PMID: 32834619 DOI: 10.1016/j.chaos.2020.110077] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
57 Jiang S, Wang R, Li L, Hong D, Ru R, Rao Y, Miao J, Chen N, Wu X, Ye Z, Hu Y, Xie M, Zuo M, Lu X, Qiu Y, Liang T. Liver Injury in Critically Ill and Non-critically Ill COVID-19 Patients: A Multicenter, Retrospective, Observational Study. Front Med (Lausanne). 2020;7:347. [PMID: 32656222 DOI: 10.3389/fmed.2020.00347] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
58 Mohapatra PR, Mishra B, Behera B. BCG vaccination induced protection from COVID-19. Indian J Tuberc 2021;68:119-24. [PMID: 33641831 DOI: 10.1016/j.ijtb.2020.08.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
59 Belen-Apak FB, Sarialioglu F. The old but new: Can unfractioned heparin and low molecular weight heparins inhibit proteolytic activation and cellular internalization of SARS-CoV2 by inhibition of host cell proteases? Med Hypotheses 2020;142:109743. [PMID: 32335456 DOI: 10.1016/j.mehy.2020.109743] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 12.0] [Reference Citation Analysis]
60 Duggan NM, Liteplo AS, Shokoohi H, Goldsmith AJ. Using Lung Point-of-care Ultrasound in Suspected COVID-19: Case Series and Proposed Triage Algorithm. Clin Pract Cases Emerg Med 2020;4:289-94. [PMID: 32926669 DOI: 10.5811/cpcem.2020.7.47912] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
61 Horenstein AL, Faini AC, Malavasi F. CD38 in the age of COVID-19: a medical perspective. Physiol Rev 2021;101:1457-86. [PMID: 33787351 DOI: 10.1152/physrev.00046.2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
62 Khan M, Shah N, Mushtaq H, Jehanzeb V. Profiling Laboratory Biomarkers Associated with COVID-19 Disease Progression: A Single-Center Experience. Int J Microbiol 2021;2021:6643333. [PMID: 33628256 DOI: 10.1155/2021/6643333] [Reference Citation Analysis]
63 Talukdar J, Dasgupta S, Nagle V, Bhadra B. COVID-19: Potential of Microalgae Derived Natural Astaxanthin As Adjunctive Supplement in Alleviating Cytokine Storm. SSRN Journal. [DOI: 10.2139/ssrn.3579738] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
64 Huang Y, Guo L, Chen J, Wu M, Zhang C, Liu Z, Li J, Li K, Xiong Z, Wu Q, Li Z, Luo K, Yuan W, Wu X. Serum Lactate Dehydrogenase Level as a Prognostic Factor for COVID-19: A Retrospective Study Based on a Large Sample Size. Front Med (Lausanne) 2021;8:671667. [PMID: 35059407 DOI: 10.3389/fmed.2021.671667] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
65 Jiang Y, Wei X, Guan J, Qin S, Wang Z, Lu H, Qian J, Wu L, Chen Y, Chen Y, Lin X. COVID-19 pneumonia: CD8+ T and NK cells are decreased in number but compensatory increased in cytotoxic potential. Clin Immunol 2020;218:108516. [PMID: 32574709 DOI: 10.1016/j.clim.2020.108516] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 23.0] [Reference Citation Analysis]
66 Adebayo A, Varzideh F, Wilson S, Gambardella J, Eacobacci M, Jankauskas SS, Donkor K, Kansakar U, Trimarco V, Mone P, Lombardi A, Santulli G. l-Arginine and COVID-19: An Update. Nutrients 2021;13:3951. [PMID: 34836206 DOI: 10.3390/nu13113951] [Reference Citation Analysis]
67 Polverino F, Kheradmand F. COVID-19, COPD, and AECOPD: Immunological, Epidemiological, and Clinical Aspects. Front Med (Lausanne) 2020;7:627278. [PMID: 33537336 DOI: 10.3389/fmed.2020.627278] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
68 Apostolopoulos ID, Mpesiana TA. Covid-19: automatic detection from X-ray images utilizing transfer learning with convolutional neural networks. Phys Eng Sci Med. 2020;43:635-640. [PMID: 32524445 DOI: 10.1007/s13246-020-00865-4] [Cited by in Crossref: 452] [Cited by in F6Publishing: 275] [Article Influence: 226.0] [Reference Citation Analysis]
69 Karn V, Ahmed S, Tsai LW, Dubey R, Ojha S, Singh HN, Kumar M, Gupta PK, Sadhu S, Jha NK, Kumar A, Pandit S, Kumar S. Extracellular Vesicle-Based Therapy for COVID-19: Promises, Challenges and Future Prospects. Biomedicines 2021;9:1373. [PMID: 34680490 DOI: 10.3390/biomedicines9101373] [Reference Citation Analysis]
70 Al-Dalahmah O, Thakur KT, Nordvig AS, Prust ML, Roth W, Lignelli A, Uhlemann AC, Miller EH, Kunnath-Velayudhan S, Del Portillo A, Liu Y, Hargus G, Teich AF, Hickman RA, Tanji K, Goldman JE, Faust PL, Canoll P. Neuronophagia and microglial nodules in a SARS-CoV-2 patient with cerebellar hemorrhage. Acta Neuropathol Commun 2020;8:147. [PMID: 32847628 DOI: 10.1186/s40478-020-01024-2] [Cited by in Crossref: 60] [Cited by in F6Publishing: 46] [Article Influence: 30.0] [Reference Citation Analysis]
71 Afewerky HK. Pathology and pathogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Exp Biol Med (Maywood) 2020;245:1299-307. [PMID: 32635753 DOI: 10.1177/1535370220942126] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
72 Szcześniak D, Gładka A, Misiak B, Cyran A, Rymaszewska J. The SARS-CoV-2 and mental health: From biological mechanisms to social consequences. Prog Neuropsychopharmacol Biol Psychiatry 2021;104:110046. [PMID: 32730915 DOI: 10.1016/j.pnpbp.2020.110046] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
73 Fraser M, Agdamag ACC, Maharaj VR, Mutschler M, Charpentier V, Chowdhury M, Alexy T. COVID-19-Associated Myocarditis: An Evolving Concern in Cardiology and Beyond. Biology (Basel) 2022;11:520. [PMID: 35453718 DOI: 10.3390/biology11040520] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Keshinro SO, Awolola NA, Adebayo LA, Mutiu WB, Saka BA, Abdus-Salam IA. Full autopsy in a confirmed COVID-19 patient in Lagos, Nigeria - A case report. Hum Pathol (N Y) 2021;24:200524. [PMID: 34026549 DOI: 10.1016/j.ehpc.2021.200524] [Reference Citation Analysis]
75 Brailovskaia J, Margraf J. Predicting adaptive and maladaptive responses to the Coronavirus (COVID-19) outbreak: A prospective longitudinal study. Int J Clin Health Psychol 2020;20:183-91. [PMID: 32837518 DOI: 10.1016/j.ijchp.2020.06.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
76 Pasquarelli-do-Nascimento G, Braz-de-Melo HA, Faria SS, Santos IO, Kobinger GP, Magalhães KG. Hypercoagulopathy and Adipose Tissue Exacerbated Inflammation May Explain Higher Mortality in COVID-19 Patients With Obesity. Front Endocrinol (Lausanne) 2020;11:530. [PMID: 32849309 DOI: 10.3389/fendo.2020.00530] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
77 Mondello C, Roccuzzo S, Malfa O, Sapienza D, Gualniera P, Ventura Spagnolo E, Di Nunno N, Salerno M, Pomara C, Asmundo A. Pathological Findings in COVID-19 as a Tool to Define SARS-CoV-2 Pathogenesis. A Systematic Review. Front Pharmacol 2021;12:614586. [PMID: 33867981 DOI: 10.3389/fphar.2021.614586] [Reference Citation Analysis]
78 Duraisamy S, Santhosh A, Anushkannan N, Saisadan D. Severe acute respiratory syndrome Coronavirus-2 – A surge of CoronaVirus Disease-2019: An epidemiological study in Coimbatore District. J Pharm Bioall Sci 2022;14:360. [DOI: 10.4103/jpbs.jpbs_124_22] [Reference Citation Analysis]
79 Zahedi M, Yousefi M, Abounoori M, Malekan M, Tajik F, Heydari K, Mortazavi P, Ghahramani S, Ghazaeian M, Sheydaee F, Nasirzadeh A, Alizadeh-Navaei R. The Interrelationship between Liver Function Test and the Coronavirus Disease 2019: A Systematic Review and Meta-Analysis. Iran J Med Sci 2021;46:237-55. [PMID: 34305236 DOI: 10.30476/ijms.2021.87555.1793] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
80 Chen F, Liu Q. Demystifying phytoconstituent-derived nanomedicines in their immunoregulatory and therapeutic roles in inflammatory diseases. Adv Drug Deliv Rev 2022;186:114317. [PMID: 35533788 DOI: 10.1016/j.addr.2022.114317] [Reference Citation Analysis]
81 Liu Y, Wang J, Tang Y, Su R, Yang Q. Surgical Management Strategy for Breast Cancer Patients During the COVID-19 Outbreak. Cancer Manag Res 2020;12:6053-8. [PMID: 32801857 DOI: 10.2147/CMAR.S258121] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
82 Gutierrez Amezcua JM, Jain R, Kleinman G, Muh CR, Guzzetta M, Folkerth R, Snuderl M, Placantonakis DG, Galetta SL, Hochman S, Zagzag D. COVID-19-Induced Neurovascular Injury: a Case Series with Emphasis on Pathophysiological Mechanisms. SN Compr Clin Med 2020;2:2109-25. [PMID: 33106782 DOI: 10.1007/s42399-020-00598-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
83 Li L, Wu Y, Wang J, Yan H, Lu J, Wan Y, Zhang B, Zhang J, Yang J, Wang X, Zhang M, Li Y, Miao L, Zhang H. Potential treatment of COVID-19 with traditional chinese medicine: What herbs can help win the battle with SARS-CoV-2? Engineering (Beijing) 2021. [PMID: 34729244 DOI: 10.1016/j.eng.2021.08.020] [Reference Citation Analysis]
84 Colon CM, Barrios JG, Chiles JW, Brown TM, Pogwizd SM, McElwee SK, Gandotra S, Russell DW, McElderry HT, Maddox WR. Atrial arrhythmia related outcomes in critically ill COVID-19 patients. Pacing Clin Electrophysiol 2021;44:814-23. [PMID: 33738812 DOI: 10.1111/pace.14221] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
85 Cheng Y, Luo R, Wang X, Wang K, Zhang N, Zhang M, Wang Z, Dong L, Li J, Zeng R, Yao Y, Ge S, Xu G. The Incidence, Risk Factors, and Prognosis of Acute Kidney Injury in Adult Patients with Coronavirus Disease 2019. Clin J Am Soc Nephrol 2020;15:1394-402. [PMID: 32963018 DOI: 10.2215/CJN.04650420] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 12.5] [Reference Citation Analysis]
86 Dwivedi S, Choudhary P, Gupta A, Singh S. The cross-talk between mucormycosis, steroids and diabetes mellitus amidst the global contagion of COVID-19. Crit Rev Microbiol 2022;:1-16. [PMID: 35324372 DOI: 10.1080/1040841X.2022.2052795] [Reference Citation Analysis]
87 Alinia C, Yaghmaei S, Abdullah FZ, Ahmadi A, Samadi N, Pourteimour S, Safari H, Mahmoodi H, Moradi G, Piroozi B. The health-related quality of life in Iranian patients with COVID-19. BMC Infect Dis 2021;21:459. [PMID: 34016041 DOI: 10.1186/s12879-021-06170-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
88 De Virgiliis F, Di Giovanni S. Lung innervation in the eye of a cytokine storm: neuroimmune interactions and COVID-19. Nat Rev Neurol 2020;16:645-52. [PMID: 32843733 DOI: 10.1038/s41582-020-0402-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
89 Felsenstein S, Herbert JA, McNamara PS, Hedrich CM. COVID-19: Immunology and treatment options. Clin Immunol. 2020;215:108448. [PMID: 32353634 DOI: 10.1016/j.clim.2020.108448] [Cited by in Crossref: 254] [Cited by in F6Publishing: 222] [Article Influence: 127.0] [Reference Citation Analysis]
90 Dang D, Wang L, Zhang C, Li Z, Wu H. Potential effects of SARS-CoV-2 infection during pregnancy on fetuses and newborns are worthy of attention. J Obstet Gynaecol Res 2020;46:1951-7. [PMID: 32779309 DOI: 10.1111/jog.14406] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
91 Han S, Zhao G, Wei Z, Chen Y, Zhao J, He Y, He YJ, Gao J, Chen S, Du C, Wang T, Sun W, Huang Y, Wang C, Wang J. An angiotensin-converting enzyme-2-derived heptapeptide GK-7 for SARS-CoV-2 spike blockade. Peptides 2021;145:170638. [PMID: 34419496 DOI: 10.1016/j.peptides.2021.170638] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 Ip A, Berry DA, Hansen E, Goy AH, Pecora AL, Sinclaire BA, Bednarz U, Marafelias M, Berry SM, Berry NS, Mathura S, Sawczuk IS, Biran N, Go RC, Sperber S, Piwoz JA, Balani B, Cicogna C, Sebti R, Zuckerman J, Rose KM, Tank L, Jacobs LG, Korcak J, Timmapuri SL, Underwood JP, Sugalski G, Barsky C, Varga DW, Asif A, Landolfi JC, Goldberg SL. Hydroxychloroquine and tocilizumab therapy in COVID-19 patients-An observational study. PLoS One 2020;15:e0237693. [PMID: 32790733 DOI: 10.1371/journal.pone.0237693] [Cited by in Crossref: 53] [Cited by in F6Publishing: 61] [Article Influence: 26.5] [Reference Citation Analysis]
93 Li Y, Zhao W, Liu J, Chen Z, Lv Q, Zhang Z. Immunotherapy Summary for Cytokine Storm in COVID-19. Front Pharmacol 2021;12:731847. [PMID: 34603047 DOI: 10.3389/fphar.2021.731847] [Reference Citation Analysis]
94 Simon TP, Stoppe C, Breuer T, Stiehler L, Dreher M, Kersten A, Kluge S, Karakas M, Zechendorf E, Marx G, Martin L. Prognostic Value of Bioactive Adrenomedullin in Critically Ill Patients with COVID-19 in Germany: An Observational Cohort Study. J Clin Med 2021;10:1667. [PMID: 33924637 DOI: 10.3390/jcm10081667] [Reference Citation Analysis]
95 Vallée A, Lecarpentier Y, Vallée JN. Interplay of Opposing Effects of the WNT/β-Catenin Pathway and PPARγ and Implications for SARS-CoV2 Treatment. Front Immunol 2021;12:666693. [PMID: 33927728 DOI: 10.3389/fimmu.2021.666693] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
96 Deng L, Li C, Zeng Q, Liu X, Li X, Zhang H, Hong Z, Xia J. Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study. J Infect 2020;81:e1-5. [PMID: 32171872 DOI: 10.1016/j.jinf.2020.03.002] [Cited by in Crossref: 249] [Cited by in F6Publishing: 235] [Article Influence: 124.5] [Reference Citation Analysis]
97 Rhodes RE, Liu S, Lithopoulos A, Zhang CQ, Garcia-Barrera MA. Correlates of Perceived Physical Activity Transitions during the COVID-19 Pandemic among Canadian Adults. Appl Psychol Health Well Being 2020;12:1157-82. [PMID: 33006279 DOI: 10.1111/aphw.12236] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 11.5] [Reference Citation Analysis]
98 Bossù P, Toppi E, Sterbini V, Spalletta G. Implication of Aging Related Chronic Neuroinflammation on COVID-19 Pandemic. J Pers Med 2020;10:E102. [PMID: 32858874 DOI: 10.3390/jpm10030102] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
99 Liu Q, Xu K, Wang X, Wang W. From SARS to COVID-19: What lessons have we learned? J Infect Public Health 2020;13:1611-8. [PMID: 32888871 DOI: 10.1016/j.jiph.2020.08.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
100 Müller J, Oberhoffer R, Brudy L, Ewert AP. COVID-19 and paediatric patient involvement (cardiovascular aspects). Eur Heart J Suppl 2020;22:P19-24. [PMID: 33390865 DOI: 10.1093/eurheartj/suaa168] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
101 Tan G, Lian X, Zhu Z, Wang Z, Huang F, Zhang Y, Zhao Y, He S, Wang X, Shen H, Lyu G. Use of Lung Ultrasound to Differentiate Coronavirus Disease 2019 (COVID-19) Pneumonia From Community-Acquired Pneumonia. Ultrasound Med Biol. 2020;46:2651-2658. [PMID: 32622684 DOI: 10.1016/j.ultrasmedbio.2020.05.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
102 Przekop D, Gruszewska E, Chrostek L. Liver function in COVID-19 infection . World J Hepatol 2021; 13(12): 1909-1918 [DOI: 10.4254/wjh.v13.i12.1909] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
103 Shen J. A recursive bifurcation model for early forecasting of COVID-19 virus spread in South Korea and Germany. Sci Rep 2020;10:20776. [PMID: 33247187 DOI: 10.1038/s41598-020-77457-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
104 Oyelade T, Alqahtani J, Canciani G. Prognosis of COVID-19 in Patients with Liver and Kidney Diseases: An Early Systematic Review and Meta-Analysis. Trop Med Infect Dis. 2020;5. [PMID: 32429038 DOI: 10.3390/tropicalmed5020080] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 26.0] [Reference Citation Analysis]
105 Adesunkanmi AO, Ubom AE, Olasehinde O, Wuraola FO, Ijarotimi OA, Okon NE, Ikimalo JI, Fasubaa OB, Adesunkanmi ARK. Impact of the COVID-19 Pandemic on Surgical Residency Training: Perspective from a Low-Middle Income Country. World J Surg 2021;45:10-7. [PMID: 33118075 DOI: 10.1007/s00268-020-05826-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
106 Miró Ò, Llorens P, Jiménez S, Piñera P, Burillo-Putze G, Martín A, Martín-Sánchez FJ, García-Lamberetchs EJ, Jacob J, Alquézar-Arbé A, Mòdol JM, López-Díez MP, Guardiola JM, Cardozo C, Lucas Imbernón FJ, Aguirre Tejedo A, García García Á, Ruiz Grinspan M, Llopis Roca F, González Del Castillo J; Spanish Investigators on Emergency Situations Team (SIESTA) Network. Frequency, Risk Factors, Clinical Characteristics, and Outcomes of Spontaneous Pneumothorax in Patients With Coronavirus Disease 2019: A Case-Control, Emergency Medicine-Based Multicenter Study. Chest 2021;159:1241-55. [PMID: 33227276 DOI: 10.1016/j.chest.2020.11.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
107 Lazar V, Ancuta P. SARS-CoV-2 - SYNOPTIC CHART OF THE MAIN CHARACTERISTICS OF VIRUS, PATHOGENESIS, IMMUNE RESPONSE, IMMUNOPROPHYLAXIS. Roum Arch Microbiol Immunol 2021;80:51-80. [DOI: 10.54044/rami.2021.01.07] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
108 Pezeshki PS, Rezaei N. Immune checkpoint inhibition in COVID-19: risks and benefits. Expert Opin Biol Ther 2021;:1-7. [PMID: 33543652 DOI: 10.1080/14712598.2021.1887131] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
109 Durmaz A, Yilmaz M. Long-Covid: What Awaits Us After Corona Infection? Journal of Basic and Clinical Health Sciences. [DOI: 10.30621/jbachs.1021549] [Reference Citation Analysis]
110 Wang L, Zhang Y, Zhang S. Cardiovascular Impairment in COVID-19: Learning From Current Options for Cardiovascular Anti-Inflammatory Therapy. Front Cardiovasc Med 2020;7:78. [PMID: 32426374 DOI: 10.3389/fcvm.2020.00078] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
111 Ratre YK, Kahar N, Bhaskar LVKS, Bhattacharya A, Verma HK. Molecular mechanism, diagnosis, and potential treatment for novel coronavirus (COVID-19): a current literature review and perspective. 3 Biotech 2021;11:94. [PMID: 33520580 DOI: 10.1007/s13205-021-02657-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
112 Metawea MI, Yousif WI, Moheb I. COVID 19 and liver: An A-Z literature review. Dig Liver Dis. 2021;53:146-152. [PMID: 32988758 DOI: 10.1016/j.dld.2020.09.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 11.0] [Reference Citation Analysis]
113 Chen J, He Z, Wang F. Evaluation of ferritin level in COVID-19 patients and its inflammatory response. Appl Nanosci. [DOI: 10.1007/s13204-021-02115-9] [Reference Citation Analysis]
114 Nakatsutsumi K, Sekiya K, Urushibata N, Hosoi M, Arai H, Nagaoka E, Fujiwara T, Morishita K, Aiboshi J, Otomo Y. A successful case of extracorporeal membrane oxygenation treatment for intractable pneumothorax in a patient with COVID-19. Acute Med Surg 2020;7:e612. [PMID: 33318806 DOI: 10.1002/ams2.612] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
115 Latifi-pupovci H. Molecular mechanisms involved in pathogenicity of SARS-CoV-2: Immune evasion and implications for therapeutic strategies. Biomedicine & Pharmacotherapy 2022;153:113368. [DOI: 10.1016/j.biopha.2022.113368] [Reference Citation Analysis]
116 Yao Y, Cao J, Wang Q, Shi Q, Liu K, Luo Z, Chen X, Chen S, Yu K, Huang Z, Hu B. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study. J Intensive Care 2020;8:49. [PMID: 32665858 DOI: 10.1186/s40560-020-00466-z] [Cited by in F6Publishing: 105] [Reference Citation Analysis]
117 Navarro Conde P, Alemany Monraval P, Medina Medina C, Jiménez Sánchez A, Andrés Teruel JC, Ferrando Marco J, Puglia Santos V, Mayordomo Aranda E. Autopsy findings from the first known death from Severe Acute Respiratory Syndrome SARS-CoV-2 in Spain. Rev Esp Patol 2020;53:188-92. [PMID: 32650970 DOI: 10.1016/j.patol.2020.04.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
118 Gluckman TJ, Bhave NM, Allen LA, Chung EH, Spatz ES, Ammirati E, Baggish AL, Bozkurt B, Cornwell WK, Harmon KG, Kim JH, Lala A, Levine BD, Martinez MW, Onuma O, Phelan D, Puntmann VO, Rajpal S, Taub PR, Verma AK. 2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play. Journal of the American College of Cardiology 2022. [DOI: 10.1016/j.jacc.2022.02.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 12] [Article Influence: 26.0] [Reference Citation Analysis]
119 Shao G, Huang S, Cui Y, Yang D. Maxingshigan decoction for treating COVID-19: A protocol for systematic review and meta analysis. Medicine (Baltimore) 2020;99:e23224. [PMID: 33235080 DOI: 10.1097/MD.0000000000023224] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
120 Zheng X, Tian L, Liu Q, Li S, Zeng F, Zeng F. The treatment and rehabilitation of a critical COVID-19 case in China. Clin Case Rep 2021;9:990-4. [PMID: 33598285 DOI: 10.1002/ccr3.3725] [Reference Citation Analysis]
121 Zhang Y, Gao Y, Qiao L, Wang W, Chen D. Inflammatory Response Cells During Acute Respiratory Distress Syndrome in Patients With Coronavirus Disease 2019 (COVID-19). Ann Intern Med 2020;173:402-4. [PMID: 32282871 DOI: 10.7326/L20-0227] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 12.5] [Reference Citation Analysis]
122 Jamal W, Sharif M, Sayeed A, Ur Rehman S, Nashwan AJ. Post-COVID-19 pneumonia pneumatoceles: a case report. European Clinical Respiratory Journal 2022;9:2028423. [DOI: 10.1080/20018525.2022.2028423] [Reference Citation Analysis]
123 Prasad A, Prasad M. Single Virus Targeting Multiple Organs: What We Know and Where We Are Heading? Front Med (Lausanne) 2020;7:370. [PMID: 32850890 DOI: 10.3389/fmed.2020.00370] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
124 Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054-62. [PMID: 32171076 DOI: 10.1016/S0140-6736(20)30566-3] [Reference Citation Analysis]
125 Zhang C, Wu Z, Li JW, Zhao H, Wang GQ. Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int J Antimicrob Agents. 2020;55:105954. [PMID: 32234467 DOI: 10.1016/j.ijantimicag.2020.105954] [Cited by in Crossref: 854] [Cited by in F6Publishing: 779] [Article Influence: 427.0] [Reference Citation Analysis]
126 Yang F, Yue R, Luo X, Liu R, Huang X. Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients. Front Pharmacol 2020;11:543718. [PMID: 33178011 DOI: 10.3389/fphar.2020.543718] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
127 Kimura T, Flynn CT, Whitton JL. Hepatocytes trap and silence coxsackieviruses, protecting against systemic disease in mice. Commun Biol 2020;3:580. [PMID: 33067530 DOI: 10.1038/s42003-020-01303-7] [Reference Citation Analysis]
128 Bonam SR, Kaveri SV, Sakuntabhai A, Gilardin L, Bayry J. Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients. Cell Rep Med. 2020;1:100016. [PMID: 32562483 DOI: 10.1016/j.xcrm.2020.100016] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 27.0] [Reference Citation Analysis]
129 Gupta A, Banerjee S, Das S. Significance of geographical factors to the COVID-19 outbreak in India. Model Earth Syst Environ 2020;:1-9. [PMID: 32838021 DOI: 10.1007/s40808-020-00838-2] [Cited by in Crossref: 43] [Cited by in F6Publishing: 24] [Article Influence: 21.5] [Reference Citation Analysis]
130 Khalil BA, Elemam NM, Maghazachi AA. Chemokines and chemokine receptors during COVID-19 infection. Comput Struct Biotechnol J 2021;19:976-88. [PMID: 33558827 DOI: 10.1016/j.csbj.2021.01.034] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
131 Jamal M, Bangash HI, Habiba M, Lei Y, Xie T, Sun J, Wei Z, Hong Z, Shao L, Zhang Q. Immune dysregulation and system pathology in COVID-19. Virulence 2021;12:918-36. [PMID: 33757410 DOI: 10.1080/21505594.2021.1898790] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
132 Emadi-Baygi M, Ehsanifard M, Afrashtehpour N, Norouzi M, Joz-Abbasalian Z. Corona Virus Disease 2019 (COVID-19) as a System-Level Infectious Disease With Distinct Sex Disparities. Front Immunol 2021;12:778913. [PMID: 34912345 DOI: 10.3389/fimmu.2021.778913] [Reference Citation Analysis]
133 Bergantini L, Mainardi A, d’Alessandro M, Cameli P, Bennett D, Bargagli E, Sestini P. Common Molecular Pathways Between Post-COVID19 Syndrome and Lung Fibrosis: A Scoping Review. Front Pharmacol 2022;13:748931. [DOI: 10.3389/fphar.2022.748931] [Reference Citation Analysis]
134 Ghannoum MA, Ford M, Bonomo RA, Gamal A, McCormick TS. A Microbiome-Driven Approach to Combating Depression During the COVID-19 Pandemic. Front Nutr 2021;8:672390. [PMID: 34504858 DOI: 10.3389/fnut.2021.672390] [Reference Citation Analysis]
135 Drak Alsibai K. Detection of Hemosiderin-Laden Macrophages in Bronchoalveolar Lavage Fluid of COVID-19 Patients: Is Perls Stain a Potential Indicator of Oxidative Alveolar Damage? Acta Cytol 2020;64:617-9. [PMID: 32506059 DOI: 10.1159/000508020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
136 Santana MF, Guerra MT, Hundt MA, Ciarleglio MM, Pinto RAA, Dutra BG, Xavier MS, Lacerda MVG, Ferreira AJ, Wanderley DC, Borges do Nascimento IJ, Araújo RFA, Pinheiro SVB, Araújo SA, Leite MF, Ferreira LCL, Nathanson MH, Vieira Teixeira Vidigal P. Correlation Between Clinical and Pathological Findings of Liver Injury in 27 Patients With Lethal COVID-19 Infections in Brazil. Hepatol Commun 2021. [PMID: 34520633 DOI: 10.1002/hep4.1820] [Reference Citation Analysis]
137 SanJuan-Reyes S, Gómez-Oliván LM, Islas-Flores H. COVID-19 in the environment. Chemosphere 2021;263:127973. [PMID: 32829224 DOI: 10.1016/j.chemosphere.2020.127973] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 12.5] [Reference Citation Analysis]
138 Sethi SK, Rana A, Adnani H, McCulloch M, Alhasan K, Sultana A, Safadi R, Agrawal N, Raina R. Kidney involvement in multisystem inflammatory syndrome in children: a pediatric nephrologist's perspective. Clin Kidney J 2021;14:2000-11. [PMID: 34471522 DOI: 10.1093/ckj/sfab073] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
139 Vagapova ER, Lebedev TD, Prassolov VS. Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis. Sci Rep 2021;11:11234. [PMID: 34045585 DOI: 10.1038/s41598-021-90701-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
140 Lozahic C, Maddock H, Sandhu H. Anti-cancer Therapy Leads to Increased Cardiovascular Susceptibility to COVID-19. Front Cardiovasc Med 2021;8:634291. [PMID: 33969006 DOI: 10.3389/fcvm.2021.634291] [Reference Citation Analysis]
141 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
142 Wang Y, Zheng Y, Tong Q, Wang L, Lv G, Xi Z, Liu W. Cardiac Injury and Clinical Course of Patients With Coronavirus Disease 2019. Front Cardiovasc Med 2020;7:147. [PMID: 33195443 DOI: 10.3389/fcvm.2020.00147] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
143 Liaudet L, Szabo C. Blocking mineralocorticoid receptor with spironolactone may have a wide range of therapeutic actions in severe COVID-19 disease. Crit Care 2020;24:318. [PMID: 32513242 DOI: 10.1186/s13054-020-03055-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
144 Abdulla S, Hussain A, Azim D, Abduallah EH, Elawamy H, Nasim S, Kumar S, Naveed H. COVID-19-Induced Hepatic Injury: A Systematic Review and Meta-Analysis. Cureus 2020;12:e10923. [PMID: 33194489 DOI: 10.7759/cureus.10923] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
145 Leroy H, Han M, Woottum M, Bracq L, Bouchet J, Xie M, Benichou S. Virus-Mediated Cell-Cell Fusion. Int J Mol Sci 2020;21:E9644. [PMID: 33348900 DOI: 10.3390/ijms21249644] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
146 Fischer JC, Zänker K, van Griensven M, Schneider M, Kindgen-Milles D, Knoefel WT, Lichtenberg A, Tamaskovics B, Djiepmo-Njanang FJ, Budach W, Corradini S, Ganswindt U, Häussinger D, Feldt T, Schelzig H, Bojar H, Peiper M, Bölke E, Haussmann J, Matuschek C. The role of passive immunization in the age of SARS-CoV-2: an update. Eur J Med Res 2020;25:16. [PMID: 32404189 DOI: 10.1186/s40001-020-00414-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
147 Vohora D, Jain S, Tripathi M, Potschka H. COVID-19 and seizures: Is there a link? Epilepsia 2020;61:1840-53. [PMID: 32944929 DOI: 10.1111/epi.16656] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
148 Mustafa MI, Abdelmoneim AH, Mahmoud EM, Makhawi AM. Cytokine Storm in COVID-19 Patients, Its Impact on Organs and Potential Treatment by QTY Code-Designed Detergent-Free Chemokine Receptors. Mediators Inflamm. 2020;2020:8198963. [PMID: 33029105 DOI: 10.1155/2020/8198963] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
149 Singh V, Upadhyay P, Reddy J, Granger J. SARS-CoV-2 respiratory co-infections: Incidence of viral and bacterial co-pathogens. Int J Infect Dis 2021;105:617-20. [PMID: 33640570 DOI: 10.1016/j.ijid.2021.02.087] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
150 Botta C, Indrieri A, Garofalo E, Biamonte F, Bruni A, Pasqua P, Cesario F, Costanzo FS, Longhini F, Mendicino F. COVID-19: High-JAKing of the Inflammatory "Flight" by Ruxolitinib to Avoid the Cytokine Storm. Front Oncol 2020;10:599502. [PMID: 33489899 DOI: 10.3389/fonc.2020.599502] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
151 Ruiz Mamani PG, Morales-García WC, White M, Marquez-Ruiz MS. [Properties of a scale of concern for COVID-19: Exploratory analysis in a Peruvian sample]. Med Clin (Barc) 2020;155:535-7. [PMID: 32718717 DOI: 10.1016/j.medcli.2020.06.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
152 Zhu A, Chen Z, Wang Y, Zeng Q, Sun J, Zhuang Z, Li F, Zhao J, Zhao J, Zhong N. Immune responses to SARS-CoV-2 infection in Humans and ACE2 humanized mice. Fundamental Research 2021;1:124-30. [DOI: 10.1016/j.fmre.2021.03.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
153 Tang L, Wang Y, Zhang Y, Zhang XY, Zeng XC, Song B. COVID-19: A review of what radiologists need to know. World J Clin Cases 2020; 8(22): 5501-5512 [PMID: 33344540 DOI: 10.12998/wjcc.v8.i22.5501] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
154 Novacescu AN, Duma G, Buzzi B, Baditoiu LM, Bedreag O, Papurica M, Sandesc D, Sorescu T, Vlad D, Licker M. Therapeutic plasma exchange followed by convalescent plasma transfusion in severe and critically ill COVID-19 patients: A single centre non-randomized controlled trial. Exp Ther Med 2022;23:76. [PMID: 34934447 DOI: 10.3892/etm.2021.10999] [Reference Citation Analysis]
155 Xiang C, Wu G. SARS-CoV-2 pneumonia with subcutaneous emphysema, mediastinal emphysema, and pneumothorax: A case report. Medicine (Baltimore) 2020;99:e20208. [PMID: 32443345 DOI: 10.1097/MD.0000000000020208] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
156 Grosse C, Grosse A, Salzer HJF, Dünser MW, Motz R, Langer R. Analysis of cardiopulmonary findings in COVID-19 fatalities: High incidence of pulmonary artery thrombi and acute suppurative bronchopneumonia. Cardiovasc Pathol 2020;49:107263. [PMID: 32784110 DOI: 10.1016/j.carpath.2020.107263] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 22.0] [Reference Citation Analysis]
157 Koneru G, Batiha GE, Algammal AM, Mabrok M, Magdy S, Sayed S, AbuElmagd ME, Elnemr R, Saad MM, Abd Ellah NH, Hosni A, Muhammad K, Hetta HF. BCG Vaccine-Induced Trained Immunity and COVID-19: Protective or Bystander? Infect Drug Resist 2021;14:1169-84. [PMID: 33790587 DOI: 10.2147/IDR.S300162] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
158 Hanchard J, Capó-Vélez CM, Deusch K, Lidington D, Bolz SS. Stabilizing Cellular Barriers: Raising the Shields Against COVID-19. Front Endocrinol (Lausanne) 2020;11:583006. [PMID: 33101215 DOI: 10.3389/fendo.2020.583006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
159 Chen MY, Xiao FP, Kuai L, Zhou HB, Jia ZQ, Liu M, He H, Hong M. Outcomes of atrial fibrillation in patients with COVID-19 pneumonia: A systematic review and meta-analysis. Am J Emerg Med 2021;50:661-9. [PMID: 34879483 DOI: 10.1016/j.ajem.2021.09.050] [Reference Citation Analysis]
160 Chetioui Y, Lebdaoui H. COVID-19 cause-related campaigns and consumers’ purchase intention: does religiosity matter? JIMA 2021. [DOI: 10.1108/jima-09-2020-0305] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
161 Yang L, Han Y, Jaffré F, Nilsson-Payant BE, Bram Y, Wang P, Zhu J, Zhang T, Redmond D, Houghton S, Uhl S, Borczuk A, Huang Y, Richardson C, Chandar V, Acklin JA, Lim JK, Chen Z, Xiang J, Ho DD, tenOever BR, Schwartz RE, Evans T, Chen S. An Immuno-Cardiac Model for Macrophage-Mediated Inflammation in COVID-19 Hearts. Circ Res 2021;129:33-46. [PMID: 33853355 DOI: 10.1161/CIRCRESAHA.121.319060] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
162 Lin F, Reid PF, Qin ZH. Cobrotoxin could be an effective therapeutic for COVID-19. Acta Pharmacol Sin 2020;41:1258-60. [PMID: 32843715 DOI: 10.1038/s41401-020-00501-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
163 Chen JM, Wang ZY, Chen YJ, Ni J. The Application of Eight-Segment Pulmonary Rehabilitation Exercise in People With Coronavirus Disease 2019. Front Physiol 2020;11:646. [PMID: 32574241 DOI: 10.3389/fphys.2020.00646] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
164 Zhu H, Rhee JW, Cheng P, Waliany S, Chang A, Witteles RM, Maecker H, Davis MM, Nguyen PK, Wu SM. Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response. Curr Cardiol Rep 2020;22:32. [PMID: 32318865 DOI: 10.1007/s11886-020-01292-3] [Cited by in Crossref: 79] [Cited by in F6Publishing: 82] [Article Influence: 39.5] [Reference Citation Analysis]
165 Chen B, Li QX, Zhang H, Zhu JY, Yang X, Wu YH, Xiong J, Li F, Wang H, Chen ZT. The psychological impact of COVID-19 outbreak on medical staff and the general public. Curr Psychol 2020;:1-9. [PMID: 33046955 DOI: 10.1007/s12144-020-01109-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 18] [Article Influence: 5.5] [Reference Citation Analysis]
166 Pawar A, Pal A. Molecular and functional resemblance of dexamethasone and quercetin: A paradigm worth exploring in dexamethasone-nonresponsive COVID-19 patients. Phytother Res 2020;34:3085-8. [PMID: 33000510 DOI: 10.1002/ptr.6886] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
167 Sujarwoto S, Maharani A. Sociodemographic characteristics and health access associated with COVID-19 infection and death: a cross-sectional study in Malang District, Indonesia. BMJ Open 2022;12:e052042. [PMID: 35613769 DOI: 10.1136/bmjopen-2021-052042] [Reference Citation Analysis]
168 Colafrancesco S, Scrivo R, Barbati C, Conti F, Priori R. Targeting the Immune System for Pulmonary Inflammation and Cardiovascular Complications in COVID-19 Patients. Front Immunol 2020;11:1439. [PMID: 32655577 DOI: 10.3389/fimmu.2020.01439] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
169 Thomas N, Gurvich C, Kulkarni J. Sex Differences and COVID-19. Adv Exp Med Biol 2021;1327:79-91. [PMID: 34279830 DOI: 10.1007/978-3-030-71697-4_6] [Reference Citation Analysis]
170 Hussain I, Cher GLY, Abid MA, Abid MB. Role of Gut Microbiome in COVID-19: An Insight Into Pathogenesis and Therapeutic Potential. Front Immunol 2021;12:765965. [PMID: 34721437 DOI: 10.3389/fimmu.2021.765965] [Reference Citation Analysis]
171 Mikhaleva LM, Cherniaev AL, Samsonova MV, Zayratyants OV, Kakturskiy LV, Vasyukova OA, Birukov AE, Kontorshchikov AS, Sorokina AV, Sinelnikov MY. Pathological Features in 100 Deceased Patients With COVID-19 in Correlation With Clinical and Laboratory Data. Pathol Oncol Res 2021;27:1609900. [PMID: 34421396 DOI: 10.3389/pore.2021.1609900] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
172 Wang W, Li SS, Xu XF, Yang C, Niu XG, Yin SX, Pan XY, Xu W, Hu GD, Wang C, Liu SW. Danshensu alleviates pseudo-typed SARS-CoV-2 induced mouse acute lung inflammation. Acta Pharmacol Sin 2022;43:771-80. [PMID: 34267343 DOI: 10.1038/s41401-021-00714-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
173 González-Gay MA, Castañeda S, Ancochea J. Biologic Therapy in COVID-19. Arch Bronconeumol 2021;57 Suppl 1:1-2. [PMID: 32654852 DOI: 10.1016/j.arbres.2020.06.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
174 Kanorskii SG. COVID-19 and the heart: direct and indirect impact. Kuban nauсh med vestnik 2021;28:16-31. [DOI: 10.25207/1608-6228-2021-28-1-16-31] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
175 Chakraborty S, Gonzalez JC, Sievers BL, Mallajosyula V, Chakraborty S, Dubey M, Ashraf U, Cheng BY, Kathale N, Tran KQT, Scallan C, Sinnott A, Cassidy A, Chen ST, Gelbart T, Gao F, Golan Y, Ji X, Kim-Schulze S, Prahl M, Gaw SL, Gnjatic S, Marron TU, Merad M, Arunachalam PS, Boyd SD, Davis MM, Holubar M, Khosla C, Maecker HT, Maldonado Y, Mellins ED, Nadeau KC, Pulendran B, Singh U, Subramanian A, Utz PJ, Sherwood R, Zhang S, Jagannathan P, Tan GS, Wang TT. Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity. Sci Transl Med 2022;:eabm7853. [PMID: 35040666 DOI: 10.1126/scitranslmed.abm7853] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 17.0] [Reference Citation Analysis]
176 Pourbagheri-Sigaroodi A, Bashash D, Fateh F, Abolghasemi H. Laboratory findings in COVID-19 diagnosis and prognosis. Clin Chim Acta 2020;510:475-82. [PMID: 32798514 DOI: 10.1016/j.cca.2020.08.019] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 15.5] [Reference Citation Analysis]
177 Satış H, Özger HS, Aysert Yıldız P, Hızel K, Gulbahar Ö, Erbaş G, Aygencel G, Guzel Tunccan O, Öztürk MA, Dizbay M, Tufan A. Prognostic value of interleukin-18 and its association with other inflammatory markers and disease severity in COVID-19. Cytokine 2021;137:155302. [PMID: 33002740 DOI: 10.1016/j.cyto.2020.155302] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
178 Fischer L, Barop H, Ludin SM, Schaible HG. Regulation of acute reflectory hyperinflammation in viral and other diseases by means of stellate ganglion block. A conceptual view with a focus on Covid-19. Auton Neurosci 2022;237:102903. [PMID: 34894589 DOI: 10.1016/j.autneu.2021.102903] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
179 Limanaqi F, Busceti CL, Biagioni F, Lazzeri G, Forte M, Schiavon S, Sciarretta S, Frati G, Fornai F. Cell Clearing Systems as Targets of Polyphenols in Viral Infections: Potential Implications for COVID-19 Pathogenesis.Antioxidants (Basel). 2020;9:1105. [PMID: 33182802 DOI: 10.3390/antiox9111105] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
180 Zha L, Li S, Pan L, Tefsen B, Li Y, French N, Chen L, Yang G, Villanueva EV. Corticosteroid treatment of patients with coronavirus disease 2019 (COVID-19). Med J Aust 2020;212:416-20. [PMID: 32266987 DOI: 10.5694/mja2.50577] [Cited by in Crossref: 171] [Cited by in F6Publishing: 145] [Article Influence: 85.5] [Reference Citation Analysis]
181 Cui Y, Chen F, Gao J, Lei M, Wang D, Jin X, Guo Y, Shan L, Chen X. Comprehensive landscape of the renin-angiotensin system in Pan-cancer: a potential downstream mediated mechanism of SARS-CoV-2. Int J Biol Sci 2021;17:3795-817. [PMID: 34671200 DOI: 10.7150/ijbs.53312] [Reference Citation Analysis]
182 Xiao L, Sakagami H, Miwa N. ACE2: The key Molecule for Understanding the Pathophysiology of Severe and Critical Conditions of COVID-19: Demon or Angel? Viruses 2020;12:E491. [PMID: 32354022 DOI: 10.3390/v12050491] [Cited by in Crossref: 64] [Cited by in F6Publishing: 55] [Article Influence: 32.0] [Reference Citation Analysis]
183 Ali Kazem T, Zeylabi F, Filayih Hassan A, Paridar P, Pezeshki SP, Pezeshki SMS. Diabetes mellitus and COVID-19: review of a lethal interaction from the cellular and molecular level to the bedside. Expert Rev Endocrinol Metab 2021;:1-19. [PMID: 34781797 DOI: 10.1080/17446651.2022.2002145] [Reference Citation Analysis]
184 Jin S, Hu W. Severity of COVID-19 and Treatment Strategy for Patient With Diabetes. Front Endocrinol (Lausanne) 2021;12:602735. [PMID: 33995267 DOI: 10.3389/fendo.2021.602735] [Reference Citation Analysis]
185 Zerbib Y, Guilain N, Eymieux S, Uzbekov R, Castelain S, Blanchard E, François C, Chatelain D, Brault C, Maizel J, Roingeard P, Slama M. Pathology Assessments of Multiple Organs in Fatal COVID-19 in Intensive Care Unit vs. Non-intensive Care Unit Patients. Front Med (Lausanne) 2022;9:837258. [PMID: 35547201 DOI: 10.3389/fmed.2022.837258] [Reference Citation Analysis]
186 Zhang J, Rao X, Li Y, Zhu Y, Liu F, Guo G, Luo G, Meng Z, De Backer D, Xiang H, Peng Z. Pilot trial of high-dose vitamin C in critically ill COVID-19 patients. Ann Intensive Care 2021;11:5. [PMID: 33420963 DOI: 10.1186/s13613-020-00792-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 28.0] [Reference Citation Analysis]
187 Khoshkam Z, Aftabi Y, Stenvinkel P, Paige Lawrence B, Rezaei MH, Ichihara G, Fereidouni S. Recovery scenario and immunity in COVID-19 disease: A new strategy to predict the potential of reinfection. J Adv Res 2021;31:49-60. [PMID: 33520309 DOI: 10.1016/j.jare.2020.12.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
188 Zhao C, Xu Y, Zhang X, Zhong Y, Long L, Zhan W, Xu T, Zhan C, Chen Y, Zhu J, Xiao W, He M. Public health initiatives from hospitalized patients with COVID-19, China. J Infect Public Health 2020;13:1229-36. [PMID: 32591163 DOI: 10.1016/j.jiph.2020.06.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
189 Yuan C, Wang H, Li K, Tang A, Dai Y, Wu B, Zhang H, Chen J, Liu J, Wu W, Gu S, Wang H, Xu H, Wu M, Yu M, Wang Y, Yu X, He J, Liu S, Zhang Y, Tong Z, Yan J. SARS-CoV-2 viral shedding characteristics and potential evidence for the priority for faecal specimen testing in diagnosis. PLoS One 2021;16:e0247367. [PMID: 33617590 DOI: 10.1371/journal.pone.0247367] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
190 Lee YH, Kim CH, Lee J. Coronavirus disease 2019 pneumonia may present as an acute exacerbation of idiopathic pulmonary fibrosis. J Thorac Dis 2020;12:3902-4. [PMID: 32802476 DOI: 10.21037/jtd-20-1658] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
191 Farjami A, Montazersaheb S, Soofiyani S, Akbarzadehlaleh P, Salatin S. Biopharmaceuticals for prevention of COVID-19: A scoping review. Asian Pac J Trop Med 2022;15:245. [DOI: 10.4103/1995-7645.348158] [Reference Citation Analysis]
192 Angelopoulou A, Alexandris N, Konstantinou E, Mesiakaris K, Zanidis C, Farsalinos K, Poulas K. Imiquimod - A toll like receptor 7 agonist - Is an ideal option for management of COVID 19. Environ Res. 2020;188:109858. [PMID: 32846644 DOI: 10.1016/j.envres.2020.109858] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
193 Fan S, Zhen Q, Chen C, Wang W, Wu Q, Ma H, Zhang C, Zhang L, Lu B, Ge H, Yong L, Li B, Yu Y, Chen W, Mao Y, Qu G, Su L, Wang A, Ding Z, Li H, Zhang J, Wang Y, Gao Y, Xu X, Zhu Z, Chen J, Zhang L, Liang H, Wu S, Huang M, Xia Q, Li P, Sun Y, Liang C, Wei W, Liu Q, Sun L. Clinical efficacy of low-dose emetine for patients with COVID-19: a real-world study. J BioX Res 2021;4:53-9. [PMID: 34254034 DOI: 10.1097/JBR.0000000000000076] [Reference Citation Analysis]
194 Zhong P, Xu J, Yang D, Shen Y, Wang L, Feng Y, Du C, Song Y, Wu C, Hu X, Sun Y. COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms. Signal Transduct Target Ther 2020;5:256. [PMID: 33139693 DOI: 10.1038/s41392-020-00373-7] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 17.5] [Reference Citation Analysis]
195 Ma Q, Qiu M, Zhou H, Chen J, Yang X, Deng Z, Chen L, Zhou J, Liao Y, Chen Q, Zheng Q, Cai L, Shen L, Yang Z. The study on the treatment of Xuebijing injection (XBJ) in adults with severe or critical Corona Virus Disease 2019 and the inhibitory effect of XBJ against SARS-CoV-2. Pharmacol Res 2020;160:105073. [PMID: 32653650 DOI: 10.1016/j.phrs.2020.105073] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
196 Koba H, Yoneda T, Kaneda T, Ueda T, Kimura H, Kasahara K. Severe coronavirus disease 2019 (COVID-19) pneumonia patients treated successfully with a combination of lopinavir/ritonavir plus favipiravir: Case series. Clin Case Rep 2020. [PMID: 33042544 DOI: 10.1002/ccr3.3358] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
197 Zheng L, Elhai JD, Miao M, Wang Y, Wang Y, Gan Y. Health-related fake news during the COVID-19 pandemic: perceived trust and information search. INTR 2022;ahead-of-print. [DOI: 10.1108/intr-11-2020-0624] [Reference Citation Analysis]
198 Parisi GF, Indolfi C, Decimo F, Leonardi S, Miraglia Del Giudice M. COVID-19 Pneumonia in Children: From Etiology to Management. Front Pediatr 2020;8:616622. [PMID: 33381482 DOI: 10.3389/fped.2020.616622] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
199 Bartoli A, Gabrielli F, Alicandro T, Nascimbeni F, Andreone P. COVID-19 treatment options: a difficult journey between failed attempts and experimental drugs. Intern Emerg Med 2021;16:281-308. [PMID: 33398609 DOI: 10.1007/s11739-020-02569-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
200 Cunha LL, Perazzio SF, Azzi J, Cravedi P, Riella LV. Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response. Front Immunol 2020;11:1748. [PMID: 32849623 DOI: 10.3389/fimmu.2020.01748] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 24.0] [Reference Citation Analysis]
201 Qiang W, Chunxiao L, Jiafeng W, Xiaolong L, Fengxin W, Hong G, Lei L. Association of T lymphocytes level and clinical severity in patients of COVID-19 in Shenzhen China. Eur J Inflamm 2021;19:205873922110144. [DOI: 10.1177/20587392211014409] [Reference Citation Analysis]
202 Luo P, Liu D, Li J. Epinephrine use in COVID-19: friend or foe? Eur J Hosp Pharm 2021;28:e1. [PMID: 32471815 DOI: 10.1136/ejhpharm-2020-002295] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
203 Alkhowailed M, Shariq A, Alqossayir F, Alzahrani OA, Rasheed Z, Al Abdulmonem W. Impact of meteorological parameters on COVID-19 pandemic: A comprehensive study from Saudi Arabia. Inform Med Unlocked 2020;20:100418. [PMID: 32875061 DOI: 10.1016/j.imu.2020.100418] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
204 Khorshidi M, Zarezadeh M, Emami M, Olang B, Moradi Moghaddam O. Promising impacts of mesenchymal stem cell therapy in treatment of SARS-CoV-2 (COVID-19). Heart Lung 2020;49:745-8. [PMID: 32911459 DOI: 10.1016/j.hrtlng.2020.08.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
205 Makarem J, Naghibi N, Beigmohammadi MT, Foroumandi M, Mehrpooya M. A Case Report of Progressive Liver Failure Inappropriate to Decompensated Heart Failure Following Infection With COVID-19. Cureus. 2020;12:e10142. [PMID: 33014641 DOI: 10.7759/cureus.10142] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
206 Arora S, Singh P, Dohare R, Jha R, Ali Syed M. Unravelling host-pathogen interactions: ceRNA network in SARS-CoV-2 infection (COVID-19). Gene 2020;762:145057. [PMID: 32805314 DOI: 10.1016/j.gene.2020.145057] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
207 Khodaei F, Ahsan A, Chamanifard M, Zamiri MJ, Ommati MM. Updated information on new coronavirus disease 2019 occurrence, drugs, and prediction of a potential receptor. J Biochem Mol Toxicol 2020;34:e22594. [PMID: 32770858 DOI: 10.1002/jbt.22594] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
208 Toyokuni S, Yanatori I, Kong Y, Zheng H, Motooka Y, Jiang L. Ferroptosis at the crossroads of infection, aging and cancer. Cancer Sci 2020;111:2665-71. [PMID: 32437084 DOI: 10.1111/cas.14496] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
209 Niu X, Li S, Li P, Pan W, Wang Q, Feng Y, Mo X, Yan Q, Ye X, Luo J, Qu L, Weber D, Byrne-Steele ML, Wang Z, Yu F, Li F, Myers RM, Lotze MT, Zhong N, Han J, Chen L. Longitudinal Analysis of T and B Cell Receptor Repertoire Transcripts Reveal Dynamic Immune Response in COVID-19 Patients. Front Immunol 2020;11:582010. [PMID: 33117392 DOI: 10.3389/fimmu.2020.582010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
210 Salamanna F, Veronesi F, Martini L, Landini MP, Fini M. Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic Review of the Current Data. Front Med (Lausanne) 2021;8:653516. [PMID: 34017846 DOI: 10.3389/fmed.2021.653516] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
211 Mansourabadi AH, Sadeghalvad M, Mohammadi-Motlagh HR, Rezaei N. The immune system as a target for therapy of SARS-CoV-2: A systematic review of the current immunotherapies for COVID-19. Life Sci 2020;258:118185. [PMID: 32750438 DOI: 10.1016/j.lfs.2020.118185] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 23.5] [Reference Citation Analysis]
212 Sherren PB, Ostermann M, Agarwal S, Meadows CIS, Ioannou N, Camporota L. COVID-19-related organ dysfunction and management strategies on the intensive care unit: a narrative review. Br J Anaesth 2020;125:912-25. [PMID: 32988604 DOI: 10.1016/j.bja.2020.08.050] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
213 Zhang XN, Wu LJ, Kong X, Zheng BY, Zhang Z, He ZW. Regulation of the expression of proinflammatory cytokines induced by SARS-CoV-2. World J Clin Cases 2021; 9(7): 1513-1523 [PMID: 33728295 DOI: 10.12998/wjcc.v9.i7.1513] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
214 Cortés Colorado JM, Cardona Ardila LF, Aguirre Vásquez N, Gómez Calderón KC, Lozano Álvarez SL, Carrillo Bayona JA. Organizing pneumonia associated with SARS-CoV-2 infection. Radiol Case Rep 2021;16:2634-9. [PMID: 34178186 DOI: 10.1016/j.radcr.2021.06.028] [Reference Citation Analysis]
215 Littera R, Campagna M, Deidda S, Angioni G, Cipri S, Melis M, Firinu D, Santus S, Lai A, Porcella R, Lai S, Rassu S, Scioscia R, Meloni F, Schirru D, Cordeddu W, Kowalik MA, Serra M, Ragatzu P, Carta MG, Del Giacco S, Restivo A, Deidda S, Orrù S, Palimodde A, Perra R, Orrù G, Conti M, Balestrieri C, Serra G, Onali S, Marongiu F, Perra A, Chessa L. Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience. Front Immunol 2020;11:605688. [PMID: 33343579 DOI: 10.3389/fimmu.2020.605688] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
216 Luo Z, Chen W, Xiang M, Wang H, Xiao W, Xu C, Li Y, Min J, Tu Q. The preventive effect of Xuebijing injection against cytokine storm for severe patients with COVID-19: A prospective randomized controlled trial. Eur J Integr Med 2021;42:101305. [PMID: 33552315 DOI: 10.1016/j.eujim.2021.101305] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
217 García-Pérez BE, González-Rojas JA, Salazar MI, Torres-Torres C, Castrejón-Jiménez NS. Taming the Autophagy as a Strategy for Treating COVID-19. Cells 2020;9:E2679. [PMID: 33322168 DOI: 10.3390/cells9122679] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
218 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
219 Jin A, Yan B, Hua W, Feng D, Xu B, Liang L, Guo C. Clinical characteristics of patients diagnosed with COVID-19 in Beijing. Biosaf Health 2020;2:104-11. [PMID: 32835210 DOI: 10.1016/j.bsheal.2020.05.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
220 Zeng Q, Li YZ, Dong SY, Chen ZT, Gao XY, Zhang H, Huang G, Xu Y. Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension. Front Immunol 2020;11:596684. [PMID: 33362779 DOI: 10.3389/fimmu.2020.596684] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
221 Delpino MV, Quarleri J. SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis. Front Cell Infect Microbiol 2020;10:340. [PMID: 32596170 DOI: 10.3389/fcimb.2020.00340] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
222 Pan F, Yang L, Liang B, Ye T, Li L, Li L, Liu D, Wang J, Hesketh RL, Zheng C. Chest CT Patterns from Diagnosis to 1 Year of Follow-up in COVID-19. Radiology 2021;:211199. [PMID: 34609153 DOI: 10.1148/radiol.2021211199] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 14.0] [Reference Citation Analysis]
223 Cui N, Zou X, Xu L. Preliminary CT findings of coronavirus disease 2019 (COVID-19). Clin Imaging. 2020;65:124-132. [PMID: 32464579 DOI: 10.1016/j.clinimag.2020.04.042] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
224 Augustine R, S A, Nayeem A, Salam SA, Augustine P, Dan P, Maureira P, Mraiche F, Gentile C, Hansbro PM, McClements L, Hasan A. Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin-angiotensin-aldosterone system (RAAS) dysregulation. Chem Biol Interact 2021;351:109738. [PMID: 34740598 DOI: 10.1016/j.cbi.2021.109738] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
225 Gaspar-Marques J, van Zeller M, Carreiro-Martins P, Chaves Loureiro C. Severe asthma in the era of COVID-19: A narrative review. Pulmonology 2021:S2531-0437(21)00089-1. [PMID: 34053902 DOI: 10.1016/j.pulmoe.2021.04.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
226 Davis AP, Boyer M, Lee JH, Kao SC. COVID-19: the use of immunotherapy in metastatic lung cancer. Immunotherapy 2020;12:545-8. [PMID: 32349579 DOI: 10.2217/imt-2020-0096] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
227 Lv D, Xu Y, Cheng H, Ke Y, Zhang X, Ying K. A novel cell-based assay for dynamically detecting neutrophil extracellular traps-induced lung epithelial injuries. Exp Cell Res 2020;394:112101. [PMID: 32474064 DOI: 10.1016/j.yexcr.2020.112101] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
228 Yang ZH, Wang B, Ma Q, Wang L, Lin YX, Yan HF, Fan ZX, Chen HJ, Ge Z, Zhu F, Wang HJ, Zhang BN, Sun HD, Feng LM. Potential Mechanisms of Action of Chinese Patent Medicines for COVID-19: A Review. Front Pharmacol 2021;12:668407. [PMID: 34335247 DOI: 10.3389/fphar.2021.668407] [Reference Citation Analysis]
229 Desquilles L, Cano L, Ghukasyan G, Mouchet N, Landreau C, Corlu A, Clément B, Turlin B, Désert R, Musso O. Well-differentiated liver cancers reveal the potential link between ACE2 dysfunction and metabolic breakdown. Sci Rep 2022;12:1859. [PMID: 35115564 DOI: 10.1038/s41598-021-03710-0] [Reference Citation Analysis]
230 Martinez-Jimenez MA, Loza-Gonzalez VM, Kolosovas-Machuca ES, Yanes-Lane ME, Ramirez-GarciaLuna AS, Ramirez-GarciaLuna JL. Diagnostic accuracy of infrared thermal imaging for detecting COVID-19 infection in minimally symptomatic patients. Eur J Clin Invest 2021;51:e13474. [PMID: 33336385 DOI: 10.1111/eci.13474] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
231 Stoeckle K, Johnston CD, Jannat-Khah DP, Williams SC, Ellman TM, Vogler MA, Gulick RM, Glesby MJ, Choi JJ. COVID-19 in Hospitalized Adults With HIV. Open Forum Infect Dis 2020;7:ofaa327. [PMID: 32864388 DOI: 10.1093/ofid/ofaa327] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
232 Horenstein AL, Faini AC, Malavasi F. CD38 in the age of COVID-19: a medical perspective. Physiological Reviews 2021;101:1457-86. [DOI: 10.1152/physrev.00046.2020] [78495111110.1152/physrev.00046.2020','', '1948-5182')">Reference Citation Analysis]
233 Zhang YY, Li BR, Ning BT. The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections. Front Immunol 2020;11:2033. [PMID: 32922406 DOI: 10.3389/fimmu.2020.02033] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 12.0] [Reference Citation Analysis]
234 Zhao S, Lin Y, Zhou C, Wang L, Chen X, Clifford SP, Akca O, Huang J, Chen X. Short-Term Outcomes of Patients With COVID-19 Undergoing Invasive Mechanical Ventilation: A Retrospective Observational Study From Wuhan, China. Front Med (Lausanne) 2020;7:571542. [PMID: 33117833 DOI: 10.3389/fmed.2020.571542] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
235 Serrano Fernández L, Ruiz Iturriaga LA, España Yandiola PP, Méndez Ocaña R, Pérez Fernández S, Tabernero Huget E, Uranga Echeverria A, Gonzalez Jimenez P, García Hontoria P, Torres Martí A, Menendez Villanueva R, Zalacain Jorge R. Bacteraemic pneumococcal pneumonia and SARS-CoV-2 pneumonia: differences and similarities. Int J Infect Dis 2021;115:39-47. [PMID: 34800689 DOI: 10.1016/j.ijid.2021.11.023] [Reference Citation Analysis]
236 Xu R, Feng Z, Wang FS. Mesenchymal stem cell treatment for COVID-19. EBioMedicine 2022;77:103920. [PMID: 35279630 DOI: 10.1016/j.ebiom.2022.103920] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
237 Aladro-gonzalvo AR. Short-term changes in time spent sitting during the COVID-19 pandemic. Gazz Med Ital - Arch Sci Med 2021;180. [DOI: 10.23736/s0393-3660.20.04459-9] [Reference Citation Analysis]
238 Xu F, Gao J, Bergmann S, Sims AC, Ashbrook DG, Baric RS, Cui Y, Jonsson CB, Li K, Williams RW, Schughart K, Lu L. Genetic Dissection of the Regulatory Mechanisms of Ace2 in the Infected Mouse Lung. Front Immunol 2020;11:607314. [PMID: 33488611 DOI: 10.3389/fimmu.2020.607314] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
239 Licata A, Minissale MG, Distefano M, Montalto G. Liver injury, SARS-COV-2 infection and COVID-19: What physicians should really know? GastroHep 2021;3:121-30. [PMID: 34149320 DOI: 10.1002/ygh2.455] [Reference Citation Analysis]
240 Wang Y, Wang P, Qin J. Microfluidic Organs-on-a-Chip for Modeling Human Infectious Diseases. Acc Chem Res 2021;54:3550-62. [PMID: 34459199 DOI: 10.1021/acs.accounts.1c00411] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
241 Li M, Chen S, Xiang X, Wang Q, Liu X. Effects of SARS-CoV-2 and its functional receptor ACE2 on the cardiovascular system. Herz 2020;45:659-62. [PMID: 33025029 DOI: 10.1007/s00059-020-04989-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
242 Han H, Ma Q, Li C, Liu R, Zhao L, Wang W, Zhang P, Liu X, Gao G, Liu F, Jiang Y, Cheng X, Zhu C, Xia Y. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infect. 2020;9:1123-1130. [PMID: 32475230 DOI: 10.1080/22221751.2020.1770129] [Cited by in Crossref: 255] [Cited by in F6Publishing: 238] [Article Influence: 127.5] [Reference Citation Analysis]
243 Hazeldine J, Lord JM. Immunesenescence: A Predisposing Risk Factor for the Development of COVID-19? Front Immunol 2020;11:573662. [PMID: 33123152 DOI: 10.3389/fimmu.2020.573662] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
244 Dou Q, Wei X, Zhou K, Yang S, Jia P. Cardiovascular Manifestations and Mechanisms in Patients with COVID-19. Trends Endocrinol Metab 2020;31:893-904. [PMID: 33172748 DOI: 10.1016/j.tem.2020.10.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
245 Sirayder U, Inal-Ince D, Kepenek-Varol B, Acik C. Long-Term Characteristics of Severe COVID-19: Respiratory Function, Functional Capacity, and Quality of Life. Int J Environ Res Public Health 2022;19:6304. [PMID: 35627841 DOI: 10.3390/ijerph19106304] [Reference Citation Analysis]
246 Piechotta V, Chai KL, Valk SJ, Doree C, Monsef I, Wood EM, Lamikanra A, Kimber C, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev 2020;7:CD013600. [PMID: 32648959 DOI: 10.1002/14651858.CD013600.pub2] [Cited by in Crossref: 41] [Cited by in F6Publishing: 51] [Article Influence: 20.5] [Reference Citation Analysis]
247 Li J, Zhao G, Tao Y, Zhai P, Chen H, He H, Cai T. Multi-task contrastive learning for automatic CT and X-ray diagnosis of COVID-19. Pattern Recognit 2021;114:107848. [PMID: 33518812 DOI: 10.1016/j.patcog.2021.107848] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
248 Taylor W, Abbasi QH, Dashtipour K, Ansari S, Shah SA, Khalid A, Imran MA. A Review of the State of the Art in Non-Contact Sensing for COVID-19. Sensors (Basel) 2020;20:E5665. [PMID: 33023039 DOI: 10.3390/s20195665] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
249 Zeng F, Huang Y, Guo Y, Yin M, Chen X, Xiao L, Deng G. Association of inflammatory markers with the severity of COVID-19: A meta-analysis. Int J Infect Dis 2020;96:467-74. [PMID: 32425643 DOI: 10.1016/j.ijid.2020.05.055] [Cited by in Crossref: 137] [Cited by in F6Publishing: 120] [Article Influence: 68.5] [Reference Citation Analysis]
250 Xu Z, Zhang C, Wang FS. COVID-19 in people with HIV. Lancet HIV 2020;7:e524-6. [PMID: 32473658 DOI: 10.1016/S2352-3018(20)30163-6] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
251 Elizalde González JJ. SARS-CoV-2 y COVID-19. Una revisión de la pandemia. Medicina Crítica 2020;33:53-67. [DOI: 10.35366/93281] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
252 Pranata R, Huang I, Lim MA, Yonas E, Vania R, Lukito AA, Nasution SA, Siswanto BB, Kuswardhani RAT. Elevated De Ritis Ratio Is Associated With Poor Prognosis in COVID-19: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2021;8:676581. [PMID: 35004709 DOI: 10.3389/fmed.2021.676581] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
253 Yuksel A, Karadogan D, Gurkan CG, Akyil FT, Toreyin ZN, Marim F, Arikan H, Eyuboglu TS, Emiralioglu N, Serifoglu I, Develi E, Celik S, Sertcelik UO, Gursoy TR, Elversli MF, Oncel A, Er B, Firincioglulari A, Gunaydin FE, Ozakinci H, Ozcelik N, Esendagli D, Aydin A, Kose N, Ercelik M, Gulhan PY, Yildiz E, Irmak I, Kara BY, Gurz S, Karakas FG, Akgun M. Unclear Issues Regarding COVID-19. Eurasian J Med 2020;52:191-6. [PMID: 32612430 DOI: 10.5152/eurasianjmed.2020.20092] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
254 Kamiya K, Komine M, Ohtsuki M. Biologics for Psoriasis during the COVID-19 Pandemic. J Clin Med 2021;10:1390. [PMID: 33808455 DOI: 10.3390/jcm10071390] [Reference Citation Analysis]
255 Celik I, Eryilmaz-Eren E, Kilinc-Toker A, Eren D, Yildiz M, Kanat A, Topaloglu US, Guzeldag S, Kara M, Ulu-Kilic A. Low-dose tocilizumab is associated with improved outcome and a low risk of secondary infection in severe COVID-19 pneumonia. Int J Clin Pract 2021;:e14997. [PMID: 34714574 DOI: 10.1111/ijcp.14997] [Reference Citation Analysis]
256 Agrafiotis AC, Rummens P, Lardinois I. Pneumothorax in otherwise healthy non-intubated patients suffering from COVID-19 pneumonia: a systematic review. J Thorac Dis 2021;13:4519-29. [PMID: 34422378 DOI: 10.21037/jtd-21-208] [Reference Citation Analysis]
257 Ghahramani S, Tabrizi R, Lankarani KB, Kashani SMA, Rezaei S, Zeidi N, Akbari M, Heydari ST, Akbari H, Nowrouzi-Sohrabi P, Ahmadizar F. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis. Eur J Med Res. 2020;25:30. [PMID: 32746929 DOI: 10.1186/s40001-020-00432-3] [Cited by in Crossref: 121] [Cited by in F6Publishing: 91] [Article Influence: 60.5] [Reference Citation Analysis]
258 Cheng WT, Ke YH, Yang GY, Sun H, Chen Y, Ying RY, Zeng XH, Shen D, Tang KJ, Xu K, Yu F. Analysis of clinical features of COVID-19 in cancer patients. Acta Oncol 2020;59:1393-6. [PMID: 32857662 DOI: 10.1080/0284186X.2020.1810313] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
259 Castelli V, Cimini A, Ferri C. Cytokine Storm in COVID-19: "When You Come Out of the Storm, You Won't Be the Same Person Who Walked in". Front Immunol. 2020;11:2132. [PMID: 32983172 DOI: 10.3389/fimmu.2020.02132] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 17.0] [Reference Citation Analysis]
260 Jin H, Yang S, Yang F, Zhang L, Weng H, Liu S, Fan F, Li H, Zheng X, Yang H, Zhang Y, Zhou J, Li J. Elevated resting heart rates are a risk factor for mortality among patients with coronavirus disease 2019 in Wuhan, China. Journal of Translational Internal Medicine 2021;9:285-93. [DOI: 10.2478/jtim-2021-0042] [Reference Citation Analysis]
261 Hassan SU, Donia A, Sial U, Zhang X, Bokhari H. Glycoprotein- and Lectin-Based Approaches for Detection of Pathogens. Pathogens 2020;9:E694. [PMID: 32847039 DOI: 10.3390/pathogens9090694] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
262 Mortaz E, Tabarsi P, Varahram M, Folkerts G, Adcock IM. The Immune Response and Immunopathology of COVID-19. Front Immunol 2020;11:2037. [PMID: 32983152 DOI: 10.3389/fimmu.2020.02037] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 15.5] [Reference Citation Analysis]
263 Centurión OA, Miño LM, Scavenius KE. Severe Acute Respiratory Syndrome Coronavirus 2: The Importance of Prompt Detection of Cardiovascular Involvement. TOCMJ 2020;14:38-41. [DOI: 10.2174/18741924020140100038] [Reference Citation Analysis]
264 Chaudhry F, Jageka C, Levy PD, Cerghet M, Lisak RP. Review of the COVID-19 Risk in Multiple Sclerosis. J Cell Immunol 2021;3:68-77. [PMID: 33959727 DOI: 10.33696/immunology.3.080] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
265 Tseng HT, Wu XC, Huang CY, Shih CM, Lin YW, Lin FY. The Impact of SARS-CoV-2 Infection, and Application of Immunosuppressive Agents in Kidney Transplant Recipients Suffering from COVID-19. Pharmaceuticals (Basel) 2021;14:1054. [PMID: 34681278 DOI: 10.3390/ph14101054] [Reference Citation Analysis]
266 Luo MH, Qian YQ, Huang DL, Luo JC, Su Y, Wang H, Yu SJ, Liu K, Tu GW, Luo Z. Tailoring glucocorticoids in patients with severe COVID-19: a narrative review. Ann Transl Med 2021;9:1261. [PMID: 34532398 DOI: 10.21037/atm-21-1783] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
267 Chen X, Guo H, Qiu L, Zhang C, Deng Q, Leng Q. Immunomodulatory and Antiviral Activity of Metformin and Its Potential Implications in Treating Coronavirus Disease 2019 and Lung Injury. Front Immunol 2020;11:2056. [PMID: 32973814 DOI: 10.3389/fimmu.2020.02056] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
268 Khan S, Shafiei MS, Longoria C, Schoggins JW, Savani RC, Zaki H. SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-κB pathway. Elife 2021;10:e68563. [PMID: 34866574 DOI: 10.7554/eLife.68563] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
269 Shu L, Liu Y, Li J, Wu X, Li Y, Huang H. Landscape Profiling Analysis of DPP4 in Malignancies: Therapeutic Implication for Tumor Patients With Coronavirus Disease 2019. Front Oncol 2021;11:624899. [PMID: 33614513 DOI: 10.3389/fonc.2021.624899] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
270 Fan N, Fan W, Li Z, Shi M, Liang Y. Imaging characteristics of initial chest computed tomography and clinical manifestations of patients with COVID-19 pneumonia. Jpn J Radiol 2020;38:533-8. [PMID: 32318916 DOI: 10.1007/s11604-020-00973-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
271 Corchuelo J, Ulloa FC. Oral manifestations in a patient with a history of asymptomatic COVID-19: Case report. Int J Infect Dis 2020;100:154-7. [PMID: 32882435 DOI: 10.1016/j.ijid.2020.08.071] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 12.0] [Reference Citation Analysis]
272 Ma X, Ng M, Xu S, Xu Z, Qiu H, Liu Y, Lyu J, You J, Zhao P, Wang S, Tang Y, Cui H, Yu C, Wang F, Shao F, Sun P, Tang Z. Development and validation of prognosis model of mortality risk in patients with COVID-19. Epidemiol Infect 2020;148:e168. [PMID: 32746957 DOI: 10.1017/S0950268820001727] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 7.5] [Reference Citation Analysis]
273 Chen S, Gao Z, Hu L, Zuo Y, Fu Y, Wei M, Zitello E, Huang G, Deng Y. Association of Septic Shock with Mortality in Hospitalized COVID-19 Patients in Wuhan, China. Adv Virol 2022;2022:3178283. [PMID: 35502304 DOI: 10.1155/2022/3178283] [Reference Citation Analysis]
274 Zhou X, Ye Q. Cellular Immune Response to COVID-19 and Potential Immune Modulators. Front Immunol 2021;12:646333. [PMID: 33995364 DOI: 10.3389/fimmu.2021.646333] [Reference Citation Analysis]
275 Mudatsir M, Fajar JK, Wulandari L, Soegiarto G, Ilmawan M, Purnamasari Y, Mahdi BA, Jayanto GD, Suhendra S, Setianingsih YA, Hamdani R, Suseno DA, Agustina K, Naim HY, Muchlas M, Alluza HHD, Rosida NA, Mayasari M, Mustofa M, Hartono A, Aditya R, Prastiwi F, Meku FX, Sitio M, Azmy A, Santoso AS, Nugroho RA, Gersom C, Rabaan AA, Masyeni S, Nainu F, Wagner AL, Dhama K, Harapan H. Predictors of COVID-19 severity: a systematic review and meta-analysis. F1000Res 2020;9:1107. [PMID: 33163160 DOI: 10.12688/f1000research.26186.2] [Cited by in Crossref: 32] [Cited by in F6Publishing: 12] [Article Influence: 16.0] [Reference Citation Analysis]
276 Calvet J, Gratacós J, Amengual MJ, Llop M, Navarro M, Moreno A, Berenguer-Llergo A, Serrano A, Orellana C, Cervantes M. CD4 and CD8 Lymphocyte Counts as Surrogate Early Markers for Progression in SARS-CoV-2 Pneumonia: A Prospective Study. Viruses 2020;12:E1277. [PMID: 33182268 DOI: 10.3390/v12111277] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
277 Guo L, Jin Z, Gan TJ, Wang E. Silent Hypoxemia in Patients with COVID-19 Pneumonia: A Review. Med Sci Monit 2021;27:e930776. [PMID: 34635632 DOI: 10.12659/MSM.930776] [Reference Citation Analysis]
278 Tampe D, Hakroush S, Bösherz MS, Franz J, Hofmann-Winkler H, Pöhlmann S, Kluge S, Moerer O, Stadelmann C, Ströbel P, Winkler MS, Tampe B. Urinary Levels of SARS-CoV-2 Nucleocapsid Protein Associate With Risk of AKI and COVID-19 Severity: A Single-Center Observational Study. Front Med (Lausanne) 2021;8:644715. [PMID: 34113632 DOI: 10.3389/fmed.2021.644715] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
279 Su H, Wu G, Zhan L, Xu F, Qian H, Li Y, Zhu X. Exploration of the Mechanism of Lianhua Qingwen in Treating Influenza Virus Pneumonia and New Coronavirus Pneumonia with the Concept of "Different Diseases with the Same Treatment" Based on Network Pharmacology. Evid Based Complement Alternat Med 2022;2022:5536266. [PMID: 35145559 DOI: 10.1155/2022/5536266] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
280 Kwiecień I, Rutkowska E, Kłos K, Więsik-Szewczyk E, Jahnz-Różyk K, Rzepecki P, Chciałowski A. Maturation of T and B Lymphocytes in the Assessment of the Immune Status in COVID-19 Patients. Cells 2020;9:E2615. [PMID: 33291439 DOI: 10.3390/cells9122615] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
281 Shafqat A, Shafqat S, Salameh SA, Kashir J, Alkattan K, Yaqinuddin A. Mechanistic Insights Into the Immune Pathophysiology of COVID-19; An In-Depth Review. Front Immunol 2022;13:835104. [DOI: 10.3389/fimmu.2022.835104] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
282 Okor I, Bob-manuel T, Price J, Sleem A, Amoran O, Kelly J, Ekerete MF, Bamgbose MO, Bolaji OA, Krim SR. COVID-19 Myocarditis: An Emerging Clinical Conundrum. Current Problems in Cardiology 2022. [DOI: 10.1016/j.cpcardiol.2022.101268] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
283 Ufuk F, Demirci M, Uğurlu E, Çetin N, Yiğit N, Sarı T. Evaluation of disease severity with quantitative chest CT in COVID-19 patients. Diagn Interv Radiol 2021;27:164-71. [PMID: 33044173 DOI: 10.5152/dir.2020.20281] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
284 Fratta Pasini AM, Stranieri C, Cominacini L, Mozzini C. Potential Role of Antioxidant and Anti-Inflammatory Therapies to Prevent Severe SARS-Cov-2 Complications. Antioxidants (Basel) 2021;10:272. [PMID: 33578849 DOI: 10.3390/antiox10020272] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
285 Zhou G, Chen S, Chen Z. Advances in COVID-19: the virus, the pathogenesis, and evidence-based control and therapeutic strategies. Front Med 2020;14:117-25. [PMID: 32318975 DOI: 10.1007/s11684-020-0773-x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 19.5] [Reference Citation Analysis]
286 Qi G, Wang H, Guo Y, Peng C, Zhang C, Chen T, He J, Jin Z. Clinical outcomes of COVID-19 patients with rheumatic diseases: a retrospective cohort study and synthesis analysis in Wuhan, China. Clin Rheumatol 2022. [PMID: 35171364 DOI: 10.1007/s10067-022-06086-2] [Reference Citation Analysis]
287 Lopes AJ, Litrento PF, Provenzano BC, Carneiro AS, Monnerat LB, da Cal MS, Ghetti ATA, Mafort TT. Small airway dysfunction on impulse oscillometry and pathological signs on lung ultrasound are frequent in post-COVID-19 patients with persistent respiratory symptoms. PLoS One 2021;16:e0260679. [PMID: 34843598 DOI: 10.1371/journal.pone.0260679] [Reference Citation Analysis]
288 Khodashahi R, Naderi H, Bojdy A, Khodashahi M. Effectiveness of Antiviral and Immunomodulatory Agents in the Treatment of COVID-19: A Systematic Review. CRMR 2021;16:165-83. [DOI: 10.2174/1573398x16999201202121247] [Reference Citation Analysis]
289 Perez-Nieto OR, Guerrero-Gutiérrez MA, Zamarron-Lopez EI, Deloya-Tomas E, Gasca Aldama JC, Ñamendys-Silva SA. Impact of Asynchronies in Acute Respiratory Distress Syndrome Due to Coronavirus Disease 2019. Crit Care Explor 2020;2:e0200. [PMID: 32903941 DOI: 10.1097/CCE.0000000000000200] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
290 Shabalin IG, Czub MP, Majorek KA, Brzezinski D, Grabowski M, Cooper DR, Panasiuk M, Chruszcz M, Minor W. Molecular determinants of vascular transport of dexamethasone in COVID-19 therapy. bioRxiv 2020:2020. [PMID: 32743572 DOI: 10.1101/2020.07.21.212704] [Reference Citation Analysis]
291 Esposito A, Palmisano A, Cao R, Rancoita P, Landoni G, Grippaldi D, Boccia E, Cosenza M, Messina A, La Marca S, Palumbo D, Di Serio C, Spessot M, Tresoldi M, Scarpellini P, Ciceri F, Zangrillo A, De Cobelli F. Quantitative assessment of lung involvement on chest CT at admission: Impact on hypoxia and outcome in COVID-19 patients. Clin Imaging 2021;77:194-201. [PMID: 33984670 DOI: 10.1016/j.clinimag.2021.04.033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
292 Fernández-Ruiz M, Aguado JM. Immunomodulatory Therapies for COVID-19 in Solid Organ Transplant Recipients. Curr Transplant Rep 2020;:1-11. [PMID: 33110739 DOI: 10.1007/s40472-020-00306-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
293 Hunziker P, Zenklusen U. Lean Ad hoc Extracorporeal Membrane Oxygenation Systems for COVID-19. ASAIO J 2021;67:12-7. [PMID: 32804773 DOI: 10.1097/MAT.0000000000001278] [Reference Citation Analysis]
294 Bratosiewicz-Wąsik J, Wąsik TJ. Does Virus-Receptor Interplay Influence Human Coronaviruses Infection Outcome? Med Sci Monit 2020;26:e928572. [PMID: 33311429 DOI: 10.12659/MSM.928572] [Reference Citation Analysis]
295 Batta Y, King C, Johnson J, Haddad N, Boueri M, Haddad G. Sequelae and Comorbidities of COVID-19 Manifestations on the Cardiac and the Vascular Systems. Front Physiol 2022;12:748972. [DOI: 10.3389/fphys.2021.748972] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
296 Li B, Jin X, Zhang T, Zhao Y, Tian F, Li Y, Yang J, Zhao F, Li B. Comparison of cardiovascular metabolic characteristics and impact on COVID-19 and MERS. Eur J Prev Cardiol 2020;27:1320-4. [PMID: 32423251 DOI: 10.1177/2047487320925218] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
297 Espinosa-solano M, Gonzalez-vergara D, Ferrer-galvan M, Asensio-cruz MI, Lomas JM, Roca-oporto C, Navarro-amuedo MD, Paniagua-garcia M, Sotomayor C, Espinosa N, Garcia-gutierrez M, Molina Gil-bermejo J, Aguilar-guisado M, Poyato M, Praena-segovia J, Palomo A, Borrero-rodriguez M, Cordero E, Caballero-eraso C, Jara-palomares L. Repeated Pulses of Methyl-Prednisolone in Adults Hospitalized With COVID-19 Pneumonia and Acute Respiratory Distress Syndrome: A Preliminary Before–After Study (CortiCOVID Study). Open Respiratory Archives 2021;3:100086. [DOI: 10.1016/j.opresp.2021.100086] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
298 Lee JS, Park S, Jeong HW, Ahn JY, Choi SJ, Lee H, Choi B, Nam SK, Sa M, Kwon JS, Jeong SJ, Lee HK, Park SH, Choi JY, Kim SH, Jung I, Shin EC. Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19. Sci Immunol. 2020;5. [PMID: 32651212 DOI: 10.1126/sciimmunol.abd1554] [Cited by in Crossref: 255] [Cited by in F6Publishing: 227] [Article Influence: 127.5] [Reference Citation Analysis]
299 Wang E, Mei W, Shang Y, Zhang C, Yang L, Ma Y, Chen Y, Huang J, Zhu T, Mi W. Chinese Association of Anesthesiologists Expert Consensus on the Use of Perioperative Ultrasound in Coronavirus Disease 2019 Patients. J Cardiothorac Vasc Anesth 2020;34:1727-32. [PMID: 32418832 DOI: 10.1053/j.jvca.2020.04.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
300 Chen L, Liu S, Tian J, Pan H, Liu Y, Hu J, Wang M, Hou X. Disease progression patterns and risk factors associated with mortality in deceased patients with COVID-19 in Hubei Province, China. Immun Inflamm Dis 2020;8:584-94. [PMID: 32857453 DOI: 10.1002/iid3.343] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
301 Shakaib B, Zohra T, Ikram A, Shakaib MB, Ali A, Bashir A, Salman M, Khan MA, Ansari J. A comprehensive review on clinical and mechanistic pathophysiological aspects of COVID-19 Malady: How far have we come? Virol J 2021;18:120. [PMID: 34098986 DOI: 10.1186/s12985-021-01578-0] [Reference Citation Analysis]
302 Dandekar R, Henderson SG, Jansen HM, McDonald J, Moka S, Nazarathy Y, Rackauckas C, Taylor PG, Vuorinen A. Safe Blues: The case for virtual safe virus spread in the long-term fight against epidemics. Patterns (N Y) 2021;2:100220. [PMID: 33748797 DOI: 10.1016/j.patter.2021.100220] [Reference Citation Analysis]
303 Liu X, Wang J, Xu X, Liao G, Chen Y, Hu CH. Patterns of IgG and IgM antibody response in COVID-19 patients. Emerg Microbes Infect. 2020;9:1269-1274. [PMID: 32515684 DOI: 10.1080/22221751.2020.1773324] [Cited by in Crossref: 76] [Cited by in F6Publishing: 71] [Article Influence: 38.0] [Reference Citation Analysis]
304 Thomas M, Abtin F, Roth A, Yim C, Pahwa A, Paige J, Ukpo O. Postmortem CT in decedents with SARS-CoV-2 infection. A single institution experience. Forensic Sciences Research. [DOI: 10.1080/20961790.2021.1977479] [Reference Citation Analysis]
305 Chadalavada P, Padbidri V, Garg R, Alomari M, Babar A, Kewan T, Ahuja KR, Contreras J, Al-Jaghbeer MJ, Sanaka MR. Transaminases are Potential Biomarkers of Disease Severity in COVID-19 Patients: A Single-Center Experience. Cureus 2020;12:e11555. [PMID: 33365223 DOI: 10.7759/cureus.11555] [Reference Citation Analysis]
306 Moshref Javadi M, Taghdisi Hosseinzadeh M, Soliemani N, Rommasi F. Evaluating the immunogenicity of gold nanoparticles conjugated RBD with Freund's adjuvant as a potential vaccine against SARS-CoV-2. Microb Pathog 2022;:105687. [PMID: 35917987 DOI: 10.1016/j.micpath.2022.105687] [Reference Citation Analysis]
307 Allegra A, Pioggia G, Tonacci A, Musolino C, Gangemi S. Cancer and SARS-CoV-2 Infection: Diagnostic and Therapeutic Challenges. Cancers (Basel) 2020;12:E1581. [PMID: 32549297 DOI: 10.3390/cancers12061581] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 8.5] [Reference Citation Analysis]
308 Wu Y, Wang T, Guo C, Zhang D, Ge X, Huang Z, Zhou X, Li Y, Peng Q, Li J. Plasminogen improves lung lesions and hypoxemia in patients with COVID-19. QJM 2020;113:539-45. [PMID: 32275753 DOI: 10.1093/qjmed/hcaa121] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 15.5] [Reference Citation Analysis]
309 Safavi F, Nath A. Silencing of immune activation with methotrexate in patients with COVID-19. J Neurol Sci 2020;415:116942. [PMID: 32471659 DOI: 10.1016/j.jns.2020.116942] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
310 Zhou S, Chen C, Hu Y, Lv W, Ai T, Xia L. Chest CT imaging features and severity scores as biomarkers for prognostic prediction in patients with COVID-19. Ann Transl Med. 2020;8:1449. [PMID: 33313194 DOI: 10.21037/atm-20-3421] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
311 Baroiu L, Dumitru C, Iancu A, Leșe AC, Drăgănescu M, Baroiu N, Anghel L. COVID-19 impact on the liver. World J Clin Cases 2021; 9(16): 3814-3825 [PMID: 34141738 DOI: 10.12998/wjcc.v9.i16.3814] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
312 Lv XT, Zhu YP, Cheng AG, Jin YX, Ding HB, Wang CY, Zhang SY, Chen GP, Chen QQ, Liu QC. High serum lactate dehydrogenase and dyspnea: Positive predictors of adverse outcome in critical COVID-19 patients in Yichang. World J Clin Cases 2020; 8(22): 5535-5546 [PMID: 33344544 DOI: 10.12998/wjcc.v8.i22.5535] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
313 Pashkov EA, Korchevaya ER, Faizuloev EB, Svitich OA, Pashkov EP, Nechaev DN, Zverev VV. Potential of application of the RNA interference phenomenon in the treatment of new coronavirus infection COVID-19. Vopr Virusol 2021;66:241-51. [PMID: 34545716 DOI: 10.36233/0507-4088-61] [Reference Citation Analysis]
314 Niedźwiedzka-Rystwej P, Majchrzak A, Kurkowska S, Małkowska P, Sierawska O, Hrynkiewicz R, Parczewski M. Immune Signature of COVID-19: In-Depth Reasons and Consequences of the Cytokine Storm. Int J Mol Sci 2022;23:4545. [PMID: 35562935 DOI: 10.3390/ijms23094545] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
315 Huang X, He C, Hua X, Kan A, Sun S, Wang J, Li S. Bioinformatic Analysis of Correlation between Immune Infiltration and COVID-19 in Cancer Patients. Int J Biol Sci 2020;16:2464-76. [PMID: 32760213 DOI: 10.7150/ijbs.48639] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
316 Ge C, He Y. In Silico Prediction of Molecular Targets of Astragaloside IV for Alleviation of COVID-19 Hyperinflammation by Systems Network Pharmacology and Bioinformatic Gene Expression Analysis. Front Pharmacol 2020;11:556984. [PMID: 33041797 DOI: 10.3389/fphar.2020.556984] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
317 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
318 Keikha R, Hashemi-Shahri SM, Jebali A. The relative expression of miR-31, miR-29, miR-126, and miR-17 and their mRNA targets in the serum of COVID-19 patients with different grades during hospitalization. Eur J Med Res 2021;26:75. [PMID: 34256840 DOI: 10.1186/s40001-021-00544-4] [Reference Citation Analysis]
319 Qu J, Sumali B, Lee H, Terai H, Ishii M, Fukunaga K, Mitsukura Y, Nishimura T. Finding of the factors affecting the severity of COVID-19 based on mathematical models. Sci Rep 2021;11:24224. [PMID: 34930966 DOI: 10.1038/s41598-021-03632-x] [Reference Citation Analysis]
320 Abdelhamid HN, Badr G. Nanobiotechnology as a platform for the diagnosis of COVID-19: a review. Nanotechnol Environ Eng 2021;6. [DOI: 10.1007/s41204-021-00109-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 13.0] [Reference Citation Analysis]
321 Mussa BM, Srivastava A, Verberne AJM. COVID-19 and Neurological Impairment: Hypothalamic Circuits and Beyond. Viruses 2021;13:498. [PMID: 33802995 DOI: 10.3390/v13030498] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
322 Ahmad R, Haque M. Surviving the Storm: Cytokine Biosignature in SARS-CoV-2 Severity Prediction. Vaccines (Basel) 2022;10:614. [PMID: 35455363 DOI: 10.3390/vaccines10040614] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
323 Falasca L, Nardacci R, Colombo D, Lalle E, Di Caro A, Nicastri E, Antinori A, Petrosillo N, Marchioni L, Biava G, D'Offizi G, Palmieri F, Goletti D, Zumla A, Ippolito G, Piacentini M, Del Nonno F. Postmortem Findings in Italian Patients With COVID-19: A Descriptive Full Autopsy Study of Cases With and Without Comorbidities.J Infect Dis. 2020;222:1807-1815. [PMID: 32914853 DOI: 10.1093/infdis/jiaa578] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 27.0] [Reference Citation Analysis]
324 Fox SE, Akmatbekov A, Harbert JL, Li G, Quincy Brown J, Vander Heide RS. Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans. Lancet Respir Med 2020;8:681-6. [PMID: 32473124 DOI: 10.1016/S2213-2600(20)30243-5] [Cited by in Crossref: 450] [Cited by in F6Publishing: 331] [Article Influence: 225.0] [Reference Citation Analysis]
325 Maskin LP, Bonelli I, Olarte GL, Palizas F Jr, Velo AE, Lurbet MF, Lovazzano P, Kotsias S, Attie S, Lopez Saubidet I, Baredes ND, Setten M, Rodriguez PO. High- Versus Low-Dose Dexamethasone for the Treatment of COVID-19-Related Acute Respiratory Distress Syndrome: A Multicenter, Randomized Open-Label Clinical Trial. J Intensive Care Med 2021;:8850666211066799. [PMID: 34898320 DOI: 10.1177/08850666211066799] [Reference Citation Analysis]
326 Pernazza A, Mancini M, Rullo E, Bassi M, De Giacomo T, Rocca CD, d'Amati G. Early histologic findings of pulmonary SARS-CoV-2 infection detected in a surgical specimen. Virchows Arch 2020;477:743-8. [PMID: 32356025 DOI: 10.1007/s00428-020-02829-1] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 18.5] [Reference Citation Analysis]
327 Montazersaheb S, Hosseiniyan Khatibi SM, Hejazi MS, Tarhriz V, Farjami A, Ghasemian Sorbeni F, Farahzadi R, Ghasemnejad T. COVID-19 infection: an overview on cytokine storm and related interventions. Virol J 2022;19:92. [PMID: 35619180 DOI: 10.1186/s12985-022-01814-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
328 Benahmed AG, Gasmi A, Anzar W, Arshad M, Bjørklund G. Improving safety in dental practices during the COVID-19 pandemic. Health Technol (Berl) 2022;:1-10. [PMID: 35036281 DOI: 10.1007/s12553-021-00627-6] [Reference Citation Analysis]
329 Geramizadeh B, Marzban M. Histopathologic Findings of Coronavirus in Lung: A Mini-Review. Clin Pathol 2020;13:2632010X20951823. [PMID: 33111059 DOI: 10.1177/2632010X20951823] [Reference Citation Analysis]
330 Mohamadi M, Goodarzi A, Aryannejad A, Fattahi N, Alizadeh-Khoei M, Miri S, Hekmat H, Payab M, Bodaghabadi M. Geriatric challenges in the new coronavirus disease-19 (COVID-19) pandemic: A systematic review. Med J Islam Repub Iran 2020;34:123. [PMID: 33437719 DOI: 10.34171/mjiri.34.123] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
331 Can A, Coskun H. The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expect. Stem Cells Transl Med 2020;9:1287-302. [PMID: 32779878 DOI: 10.1002/sctm.20-0164] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
332 Ranaldi GT, Villani ER, Franza L. Rationale for ozone-therapy as an adjuvant therapy in COVID-19: a narrative review. Med Gas Res 2020;10:134-8. [PMID: 33004712 DOI: 10.4103/2045-9912.289462] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
333 Yu J, Chai P, Ge S, Fan X. Recent Understandings Toward Coronavirus Disease 2019 (COVID-19): From Bench to Bedside. Front Cell Dev Biol 2020;8:476. [PMID: 32582719 DOI: 10.3389/fcell.2020.00476] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
334 Li C, Wang DW, Zhao C. Cardiovascular Involvement in Patients with 2019 Novel Coronavirus Disease. J Transl Int Med 2021;9:152-60. [PMID: 34900625 DOI: 10.2478/jtim-2021-0016] [Reference Citation Analysis]
335 [DOI: 10.1101/2020.10.12.20211193] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
336 Munster VJ, Feldmann F, Williamson BN, van Doremalen N, Pérez-Pérez L, Schulz J, Meade-White K, Okumura A, Callison J, Brumbaugh B, Avanzato VA, Rosenke R, Hanley PW, Saturday G, Scott D, Fischer ER, de Wit E. Respiratory disease and virus shedding in rhesus macaques inoculated with SARS-CoV-2. bioRxiv 2020:2020. [PMID: 32511299 DOI: 10.1101/2020.03.21.001628] [Cited by in Crossref: 58] [Cited by in F6Publishing: 16] [Article Influence: 29.0] [Reference Citation Analysis]
337 Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, Li Q, Jiang C, Zhou Y, Liu S, Ye C, Zhang P, Xing Y, Guo H, Tang W. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect. 2020;81:e16-e25. [PMID: 32335169 DOI: 10.1016/j.jinf.2020.04.021] [Cited by in Crossref: 714] [Cited by in F6Publishing: 659] [Article Influence: 357.0] [Reference Citation Analysis]
338 Bzeizi K, Abdulla M, Mohammed N, Alqamish J, Jamshidi N, Broering D. Effect of COVID-19 on liver abnormalities: a systematic review and meta-analysis. Sci Rep 2021;11:10599. [PMID: 34012016 DOI: 10.1038/s41598-021-89513-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
339 Açıksarı G, Koçak M, Çağ Y, Altunal LN, Atıcı A, Çelik FB, Bölen F, Açıksarı K, Çalışkan M. Prognostic Value of Inflammatory Biomarkers in Patients with Severe COVID-19: A Single-Center Retrospective Study. Biomark Insights 2021;16:11772719211027022. [PMID: 34248354 DOI: 10.1177/11772719211027022] [Reference Citation Analysis]
340 Alavi M, Asare-Addo K, Nokhodchi A. Lectin Protein as a Promising Component to Functionalize Micelles, Liposomes and Lipid NPs against Coronavirus. Biomedicines 2020;8:E580. [PMID: 33297444 DOI: 10.3390/biomedicines8120580] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
341 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
342 Suardi C, Cazzaniga E, Graci S, Dongo D, Palestini P. Link between Viral Infections, Immune System, Inflammation and Diet. Int J Environ Res Public Health 2021;18:2455. [PMID: 33801527 DOI: 10.3390/ijerph18052455] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
343 Çakmak Karaaslan Ö, Özilhan MO, Maden O, Tüfekçioğlu O. Prevalence of cardiac involvement in home-based recovered coronavirus disease 2019 (COVID-19) patients: a retrospective observational study. Ir J Med Sci 2021. [PMID: 34714493 DOI: 10.1007/s11845-021-02824-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
344 Taheri M, Rad LM, Hussen BM, Nicknafs F, Sayad A, Ghafouri-Fard S. Evaluation of expression of VDR-associated lncRNAs in COVID-19 patients. BMC Infect Dis 2021;21:588. [PMID: 34147082 DOI: 10.1186/s12879-021-06248-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
345 Yang Q, Liu Q, Xu H, Lu H, Liu S, Li H. Imaging of coronavirus disease 2019: A Chinese expert consensus statement. Eur J Radiol 2020;127:109008. [PMID: 32335426 DOI: 10.1016/j.ejrad.2020.109008] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 15.5] [Reference Citation Analysis]
346 Farahani M, Niknam Z, Mohammadi Amirabad L, Amiri-Dashatan N, Koushki M, Nemati M, Danesh Pouya F, Rezaei-Tavirani M, Rasmi Y, Tayebi L. Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets. Biomed Pharmacother 2022;145:112420. [PMID: 34801852 DOI: 10.1016/j.biopha.2021.112420] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 15.0] [Reference Citation Analysis]
347 Caterino M, Costanzo M, Fedele R, Cevenini A, Gelzo M, Di Minno A, Andolfo I, Capasso M, Russo R, Annunziata A, Calabrese C, Fiorentino G, D'Abbraccio M, Dell'Isola C, Fusco FM, Parrella R, Fabbrocini G, Gentile I, Castaldo G, Ruoppolo M. The Serum Metabolome of Moderate and Severe COVID-19 Patients Reflects Possible Liver Alterations Involving Carbon and Nitrogen Metabolism. Int J Mol Sci 2021;22:9548. [PMID: 34502454 DOI: 10.3390/ijms22179548] [Reference Citation Analysis]
348 Zhong WJ, Duan JX, Liu T, Yang HH, Guan XX, Zhang CY, Yang JT, Xiong JB, Zhou Y, Guan CX, Li Q. Activation of NLRP3 inflammasome up-regulates TREM-1 expression in murine macrophages via HMGB1 and IL-18. Int Immunopharmacol 2020;89:107045. [PMID: 33045564 DOI: 10.1016/j.intimp.2020.107045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
349 Udovicic I, Stanojevic I, Djordjevic D, Zeba S, Rondovic G, Abazovic T, Lazic S, Vojvodic D, To K, Abazovic D, Khan W, Surbatovic M. Immunomonitoring of Monocyte and Neutrophil Function in Critically Ill Patients: From Sepsis and/or Trauma to COVID-19. J Clin Med 2021;10:5815. [PMID: 34945111 DOI: 10.3390/jcm10245815] [Reference Citation Analysis]
350 Yang H, Lan Y, Yao X, Lin S, Xie B. The chest CT features of coronavirus disease 2019 (COVID-19) in China: a meta-analysis of 19 retrospective studies. Virol J 2020;17:159. [PMID: 33087181 DOI: 10.1186/s12985-020-01432-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
351 Pelaia C, Tinello C, Vatrella A, De Sarro G, Pelaia G. Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications. Ther Adv Respir Dis. 2020;14:1753466620933508. [PMID: 32539627 DOI: 10.1177/1753466620933508] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 14.0] [Reference Citation Analysis]
352 Alsaad KO, Arabi YM, Hajeer AH. Spectrum of histopathological findings in coronavirus disease-19, Middle East respiratory syndrome and severe acute respiratory syndrome. Ann Thorac Med 2020;15:52-3. [PMID: 32489438 DOI: 10.4103/atm.ATM_105_20] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
353 Ladani AP, Loganathan M, Danve A. Managing rheumatic diseases during COVID-19. Clin Rheumatol 2020;39:3245-54. [PMID: 32895747 DOI: 10.1007/s10067-020-05387-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
354 El-Hachem N, Eid E, Nemer G, Dbaibo G, Abbas O, Rubeiz N, Zeineldine S, Matar GM, Bikorimana JP, Shammaa R, Haibe-Kains B, Kurban M, Rafei M. Integrative Transcriptome Analyses Empower the Anti-COVID-19 Drug Arsenal. iScience 2020;23:101697. [PMID: 33103068 DOI: 10.1016/j.isci.2020.101697] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
355 Sarzani R, Giulietti F, Di Pentima C, Giordano P, Spannella F. Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury. Am J Physiol Lung Cell Mol Physiol 2020;319:L325-36. [PMID: 32639866 DOI: 10.1152/ajplung.00189.2020] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 13.5] [Reference Citation Analysis]
356 Gordy JT, Mazumdar K, Dutta NK. Accelerating Drug Development through Repurposed FDA-Approved Drugs for COVID-19: Speed Is Important, Not Haste. Antimicrob Agents Chemother 2020;64. [DOI: 10.1128/aac.00857-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
357 Nersisyan S, Shkurnikov M, Turchinovich A, Knyazev E, Tonevitsky A. Integrative analysis of miRNA and mRNA sequencing data reveals potential regulatory mechanisms of ACE2 and TMPRSS2. PLoS One 2020;15:e0235987. [PMID: 32726325 DOI: 10.1371/journal.pone.0235987] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 13.5] [Reference Citation Analysis]
358 An P, Gu W, Luo S, Zhang M, Wang Y, Li Q. Radiological changes on chest CT following COVID-19 infection. Ann Acad Med Singap 2021;50:346-8. [DOI: 10.47102/annals-acadmedsg.2020208] [Reference Citation Analysis]
359 Tahaghoghi-Hajghorbani S, Zafari P, Masoumi E, Rajabinejad M, Jafari-Shakib R, Hasani B, Rafiei A. The role of dysregulated immune responses in COVID-19 pathogenesis. Virus Res 2020;290:198197. [PMID: 33069815 DOI: 10.1016/j.virusres.2020.198197] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
360 Kong M, Yang H, Li X, Shen J, Xu X, Lv D. Evolution of chest CT manifestations of COVID-19: a longitudinal study. J Thorac Dis. 2020;12:4892-4907. [PMID: 33145063 DOI: 10.21037/jtd-20-1363] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
361 Xu J, Zhou Z, Chen K, Ding Y, Hua Y, Ren M, Shen Y. How to minimize the impact of COVID-19 on laparoendoscopic single-site surgery training? ANZ J Surg 2022. [PMID: 35594058 DOI: 10.1111/ans.17819] [Reference Citation Analysis]
362 Tan W, Aboulhosn J. The cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease. Int J Cardiol 2020;309:70-7. [PMID: 32248966 DOI: 10.1016/j.ijcard.2020.03.063] [Cited by in Crossref: 126] [Cited by in F6Publishing: 106] [Article Influence: 63.0] [Reference Citation Analysis]
363 Ong SWX, Tan WYT, Chan YH, Fong SW, Renia L, Ng LF, Leo YS, Lye DC, Young BE. Safety and potential efficacy of cyclooxygenase-2 inhibitors in coronavirus disease 2019. Clin Transl Immunology 2020;9:e1159. [PMID: 32728438 DOI: 10.1002/cti2.1159] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
364 Bhatia R, Ganti SS, Narang RK, Rawal RK. Strategies and Challenges to Develop Therapeutic Candidates against COVID-19 Pandemic. TOVJ 2020;14:16-21. [DOI: 10.2174/1874357902014010016] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
365 Zhou L, Yan W, Li S, Yang H, Zhang X, Lu W, Liu J, Wang Y. Cost-effectiveness of interventions for the prevention and control of COVID-19: Systematic review of 85 modelling studies. J Glob Health 2022;12:05022. [PMID: 35712857 DOI: 10.7189/jogh.12.05022] [Reference Citation Analysis]
366 Archie SR, Cucullo L. Cerebrovascular and Neurological Dysfunction under the Threat of COVID-19: Is There a Comorbid Role for Smoking and Vaping? Int J Mol Sci 2020;21:E3916. [PMID: 32486196 DOI: 10.3390/ijms21113916] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
367 Shang Y, Pan C, Yang X, Zhong M, Shang X, Wu Z, Yu Z, Zhang W, Zhong Q, Zheng X, Sang L, Jiang L, Zhang J, Xiong W, Liu J, Chen D. Management of critically ill patients with COVID-19 in ICU: statement from front-line intensive care experts in Wuhan, China. Ann Intensive Care 2020;10:73. [PMID: 32506258 DOI: 10.1186/s13613-020-00689-1] [Cited by in Crossref: 54] [Cited by in F6Publishing: 41] [Article Influence: 27.0] [Reference Citation Analysis]
368 Pandey K, Acharya A, Mohan M, Ng CL, Reid SP, Byrareddy SN. Animal models for SARS-CoV-2 research: A comprehensive literature review. Transbound Emerg Dis 2021;68:1868-85. [PMID: 33128861 DOI: 10.1111/tbed.13907] [Cited by in Crossref: 11] [Cited by in F6Publishing: 17] [Article Influence: 5.5] [Reference Citation Analysis]
369 Ghanei M. It is time to consider an anti-inflammatory therapy based on the pathophysiology of COVID-19 infection during the right time window? Arch Med Sci 2021;17:546-50. [PMID: 33747291 DOI: 10.5114/aoms/130647] [Reference Citation Analysis]
370 Moghadam VD, Shafiee H, Ghorbani M, Heidarifar R. Prone positioning in management of COVID-19 hospitalized patients. Braz J Anesthesiol 2020;70:188-90. [PMID: 32427179 DOI: 10.1016/j.bjane.2020.05.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
371 Dormoy V, Perotin JM, Gosset P, Maskos U, Polette M, Deslée G. Nicotinic receptors as SARS-CoV-2 spike co-receptors? Med Hypotheses 2022;158:110741. [PMID: 34924680 DOI: 10.1016/j.mehy.2021.110741] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
372 Oommen A, Cunningham S, Joshi L. Transcriptomic Analysis of Respiratory Tissue and Cell Line Models to Examine Glycosylation Machinery during SARS-CoV-2 Infection. Viruses 2021;13:82. [PMID: 33435561 DOI: 10.3390/v13010082] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
373 Sang S, Sun R, Coquet J, Carmichael H, Seto T, Hernandez-Boussard T. Learning From Past Respiratory Infections to Predict COVID-19 Outcomes: Retrospective Study. J Med Internet Res 2021;23:e23026. [PMID: 33534724 DOI: 10.2196/23026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
374 Rotondo JC, Martini F, Maritati M, Mazziotta C, Di Mauro G, Lanzillotti C, Barp N, Gallerani A, Tognon M, Contini C. SARS-CoV-2 Infection: New Molecular, Phylogenetic, and Pathogenetic Insights. Efficacy of Current Vaccines and the Potential Risk of Variants. Viruses 2021;13:1687. [PMID: 34578269 DOI: 10.3390/v13091687] [Cited by in Crossref: 6] [Article Influence: 6.0] [Reference Citation Analysis]
375 Konig MF, Powell M, Staedtke V, Bai RY, Thomas DL, Fischer N, Huq S, Khalafallah AM, Koenecke A, Xiong R, Mensh B, Papadopoulos N, Kinzler KW, Vogelstein B, Vogelstein JT, Athey S, Zhou S, Bettegowda C. Preventing cytokine storm syndrome in COVID-19 using α-1 adrenergic receptor antagonists. J Clin Invest 2020;130:3345-7. [PMID: 32352407 DOI: 10.1172/JCI139642] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 21.5] [Reference Citation Analysis]
376 Pang L, Liu Y, Shen M, Ye J, Chen R, Lan Z, Wu Z, Guo Y, Zhang P. Influence of aging on deterioration of patients with COVID-19. Aging (Albany NY) 2020;12:26248-62. [PMID: 33232272 DOI: 10.18632/aging.202136] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
377 Ni M, Tian FB, Xiang DD, Yu B. Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID-19. J Med Virol 2020;92:2600-6. [PMID: 32470153 DOI: 10.1002/jmv.26070] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
378 Yadav R, Srivastava DK, Bajpai PK, Kumar R. Neurological Involvement in COVID-19 Patients: A Narrative Review. J Neurosci Rural Pract 2020;11:526-9. [PMID: 33144786 DOI: 10.1055/s-0040-1716423] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
379 Wang Y, Zhao J, Yang L, Hu J, Yao Y. Value of the Neutrophil-Lymphocyte Ratio in Predicting COVID-19 Severity: A Meta-analysis. Dis Markers 2021;2021:2571912. [PMID: 34650648 DOI: 10.1155/2021/2571912] [Reference Citation Analysis]
380 El-Ghiaty MA, Shoieb SM, El-Kadi AOS. Cytochrome P450-mediated drug interactions in COVID-19 patients: Current findings and possible mechanisms. Med Hypotheses 2020;144:110033. [PMID: 32758877 DOI: 10.1016/j.mehy.2020.110033] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
381 Wang Y, Ru Y, Zhuo G, Sheng M, Wang S, Ma J, Zhou C, Sun X, Zeng Y, Zhang Y, Li H, Lu Z, Wu D, Wu M. Investigation of the Potential Mechanism Governing the Effect of the Shen Zhu San on COVID-19 by Network Pharmacology. Evid Based Complement Alternat Med 2020;2020:8468303. [PMID: 33224256 DOI: 10.1155/2020/8468303] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
382 Khaksarinejad R, Arabpour Z, RezaKhani L, Parvizpour F, Rasmi Y. Biomarker based biosensors: An opportunity for diagnosis of COVID-19. Rev Med Virol 2022;:e2356. [PMID: 35478470 DOI: 10.1002/rmv.2356] [Reference Citation Analysis]
383 Oroojalian F, Haghbin A, Baradaran B, Hemmat N, Shahbazi MA, Baghi HB, Mokhtarzadeh A, Hamblin MR. Novel insights into the treatment of SARS-CoV-2 infection: An overview of current clinical trials. Int J Biol Macromol 2020;165:18-43. [PMID: 32991900 DOI: 10.1016/j.ijbiomac.2020.09.204] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
384 Zhao P, Zou J, Zhou F, Zhu Y, Song Q, Yu D, Li X. Immune features of COVID-19 convalescent individuals revealed by a single-cell RNA sequencing. International Immunopharmacology 2022. [DOI: 10.1016/j.intimp.2022.108767] [Reference Citation Analysis]
385 Elahi S. Hematopoietic responses to SARS-CoV-2 infection. Cell Mol Life Sci 2022;79. [DOI: 10.1007/s00018-022-04220-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
386 Abootalebi S, Aertker BM, Andalibi MS, Asdaghi N, Aykac O, Azarpazhooh MR, Bahit MC, Barlinn K, Basri H, Shahripour RB, Bersano A, Biller J, Borhani-Haghighi A, Brown RD, Campbell BC, Cruz-Flores S, De Silva DA, Di Napoli M, Divani AA, Edgell RC, Fifi JT, Ghoreishi A, Hirano T, Hong KS, Hsu CY, Huang JF, Inoue M, Jagolino AL, Kapral M, Kee HF, Keser Z, Khatri R, Koga M, Krupinski J, Liebeskind DS, Liu L, Ma H, Maud A, McCullough LD, Meyer DM, Mifsud V, Morovatdar N, Nilanont Y, Oxley TJ, Özdemir AÖ, Pandian J, Pantoni L, Papamitsakis NIH, Parry-Jones A, Phan T, Rodriguez G, Romano JG, Sabaa-Ayoun Z, Saber H, Sasannezhad P, Saver JL, Scharf E, Shuaib A, Silver B, Singhal S, Smith CJ, Stranges S, Sylaja PN, Torbey M, Toyoda K, Tsivgoulis G, Wasay M, Yassi N, Yoshimoto T, Zamani B, Zand R. Call to Action: SARS-CoV-2 and CerebrovAscular DisordErs (CASCADE). J Stroke Cerebrovasc Dis 2020;29:104938. [PMID: 32807412 DOI: 10.1016/j.jstrokecerebrovasdis.2020.104938] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
387 Tokano M, Kawano M, Takagi R, Matsushita S. Istradefylline, an adenosine A2a receptor antagonist, ameliorates neutrophilic airway inflammation and psoriasis in mice. Clinical & Exp Neuroim 2021;12:268-75. [DOI: 10.1111/cen3.12658] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
388 Ni L, Chen L, Huang X, Han C, Xu J, Zhang H, Luan X, Zhao Y, Xu J, Yuan W, Chen H. Combating COVID-19 with integrated traditional Chinese and Western medicine in China. Acta Pharm Sin B 2020;10:1149-62. [PMID: 32834946 DOI: 10.1016/j.apsb.2020.06.009] [Cited by in Crossref: 56] [Cited by in F6Publishing: 45] [Article Influence: 28.0] [Reference Citation Analysis]
389 Kovalic AJ, Huang G, Thuluvath PJ, Satapathy SK. Elevated Liver Biochemistries in Hospitalized Chinese Patients With Severe COVID-19: Systematic Review and Meta-analysis. Hepatology 2021;73:1521-30. [PMID: 32692464 DOI: 10.1002/hep.31472] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
390 Hemmer CJ, Geerdes-Fenge HF, Reisinger EC. [COVID-19: epidemiology and clinical facts]. Radiologe 2020;60:893-8. [PMID: 32865603 DOI: 10.1007/s00117-020-00741-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
391 Mast AE, Wolberg AS, Gailani D, Garvin MR, Alvarez C, Miller JI, Aronow B, Jacobson D. SARS-CoV-2 suppresses anticoagulant and fibrinolytic gene expression in the lung. Elife 2021;10:e64330. [PMID: 33683204 DOI: 10.7554/eLife.64330] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
392 Tsuchiya A, Takeuchi S, Iwasawa T, Kumagai M, Sato T, Motegi S, Ishii Y, Koseki Y, Tomiyoshi K, Natsui K, Takeda N, Yoshida Y, Yamazaki F, Kojima Y, Watanabe Y, Kimura N, Tominaga K, Kamimura H, Takamura M, Terai S. Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases. Inflamm Regen. 2020;40:14. [PMID: 32582401 DOI: 10.1186/s41232-020-00121-y] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 17.5] [Reference Citation Analysis]
393 Boeckmans J, Rodrigues RM, Demuyser T, Piérard D, Vanhaecke T, Rogiers V. COVID-19 and drug-induced liver injury: a problem of plenty or a petty point? Arch Toxicol 2020;94:1367-9. [PMID: 32266419 DOI: 10.1007/s00204-020-02734-1] [Cited by in F6Publishing: 50] [Reference Citation Analysis]
394 Costantini C, van de Veerdonk FL, Romani L. Covid-19-Associated Pulmonary Aspergillosis: The Other Side of the Coin. Vaccines (Basel) 2020;8:E713. [PMID: 33271780 DOI: 10.3390/vaccines8040713] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
395 Sapino A, Facchetti F, Bonoldi E, Gianatti A, Barbareschi M; Società Italiana di Anatomia Patologica e Citologia - SIAPEC. The autopsy debate during the COVID-19 emergency: the Italian experience. Virchows Arch 2020;476:821-3. [PMID: 32350596 DOI: 10.1007/s00428-020-02828-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 15.0] [Reference Citation Analysis]
396 Tian S, Xiao SY. Pathology of 2019 Novel Coronavirus Pneumonia: A Dynamic Disease Process. J Thorac Oncol 2020;15:e67-8. [PMID: 32340678 DOI: 10.1016/j.jtho.2020.03.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
397 Wiśniewska H, Skonieczna-Żydecka K, Parczewski M, Niścigorska-Olsen J, Karpińska E, Hornung M, Jurczyk K, Witak-Jędra M, Laurans Ł, Maciejewska K, Socha Ł, Leonciuk A, Bander D, Karasińska-Cieślak M, Aksak-Wąs B, Wawrzynowicz-Syczewska M. Hepatotropic Properties of SARS-CoV-2-Preliminary Results of Cross-Sectional Observational Study from the First Wave COVID-19 Pandemic. J Clin Med 2021;10:672. [PMID: 33572429 DOI: 10.3390/jcm10040672] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
398 Cervantes O, Cruz Talavera I, Every E, Coler B, Li M, Li A, Li H, Adams Waldorf K. Role of hormones in the pregnancy and sex‐specific outcomes to infections with respiratory viruses*. Immunological Reviews. [DOI: 10.1111/imr.13078] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
399 Hosseini A, Hashemi V, Shomali N, Asghari F, Gharibi T, Akbari M, Gholizadeh S, Jafari A. Innate and adaptive immune responses against coronavirus. Biomed Pharmacother 2020;132:110859. [PMID: 33120236 DOI: 10.1016/j.biopha.2020.110859] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
400 Zhang R, Liu Y, Zhang B, Wu C, Zhou J, Zhang Y, Yang W, Li Z, Shi S. Coagulopathy is associated with multiple organ damage and prognosis of COVID-19. EXCLI J 2021;20:174-91. [PMID: 33564286 DOI: 10.17179/excli2020-2853] [Reference Citation Analysis]
401 Sardu C, Gambardella J, Morelli MB, Wang X, Marfella R, Santulli G. Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? J Clin Med. 2020;9. [PMID: 32403217 DOI: 10.3390/jcm9051417] [Cited by in Crossref: 185] [Cited by in F6Publishing: 191] [Article Influence: 92.5] [Reference Citation Analysis]
402 Menter T, Haslbauer JD, Nienhold R, Savic S, Hopfer H, Deigendesch N, Frank S, Turek D, Willi N, Pargger H, Bassetti S, Leuppi JD, Cathomas G, Tolnay M, Mertz KD, Tzankov A. Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction. Histopathology. 2020;77:198-209. [PMID: 32364264 DOI: 10.1111/his.14134] [Cited by in Crossref: 493] [Cited by in F6Publishing: 466] [Article Influence: 246.5] [Reference Citation Analysis]
403 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
404 Wang W, Su X, Ding Y, Fan W, Zhou W, Su J, Chen Z, Zhao H, Xu K, Ni Q, Xu X, Qiu Y, Teng L. Thyroid Function Abnormalities in COVID-19 Patients. Front Endocrinol (Lausanne) 2020;11:623792. [PMID: 33679608 DOI: 10.3389/fendo.2020.623792] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
405 Gubernatorova EO, Gorshkova EA, Polinova AI, Drutskaya MS. IL-6: Relevance for immunopathology of SARS-CoV-2.Cytokine Growth Factor Rev. 2020;53:13-24. [PMID: 32475759 DOI: 10.1016/j.cytogfr.2020.05.009] [Cited by in Crossref: 89] [Cited by in F6Publishing: 80] [Article Influence: 44.5] [Reference Citation Analysis]
406 Fernanda de Mello Costa M, Weiner AI, Vaughan AE. Basal-like Progenitor Cells: A Review of Dysplastic Alveolar Regeneration and Remodeling in Lung Repair. Stem Cell Reports 2020;15:1015-25. [PMID: 33065046 DOI: 10.1016/j.stemcr.2020.09.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
407 Campione E, Lanna C, Cosio T, Rosa L, Conte MP, Iacovelli F, Romeo A, Falconi M, Del Vecchio C, Franchin E, Lia MS, Minieri M, Chiaramonte C, Ciotti M, Nuccetelli M, Terrinoni A, Iannuzzi I, Coppeta L, Magrini A, Bernardini S, Sabatini S, Rosapepe F, Bartoletti PL, Moricca N, Di Lorenzo A, Andreoni M, Sarmati L, Miani A, Piscitelli P, Squillaci E, Valenti P, Bianchi L. Lactoferrin as Antiviral Treatment in COVID-19 Management: Preliminary Evidence. Int J Environ Res Public Health 2021;18:10985. [PMID: 34682731 DOI: 10.3390/ijerph182010985] [Reference Citation Analysis]
408 Corse T, Dayan L, Kersten S, Battaglia F, Terlecky SR, Han Z. Clinical Outcomes of COVID-19 Patients with Pre-existing, Compromised Immune Systems: A Review of Case Reports. Int J Med Sci 2020;17:2974-86. [PMID: 33173418 DOI: 10.7150/ijms.50537] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
409 Sheervalilou R, Shirvaliloo M, Dadashzadeh N, Shirvalilou S, Shahraki O, Pilehvar-Soltanahmadi Y, Ghaznavi H, Khoei S, Nazarlou Z. COVID-19 under spotlight: A close look at the origin, transmission, diagnosis, and treatment of the 2019-nCoV disease. J Cell Physiol. 2020;235:8873-8924. [PMID: 32452539 DOI: 10.1002/jcp.29735] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
410 Wang Y, Zheng J, Islam MS, Yang Y, Hu Y, Chen X. The role of CD4+FoxP3+ regulatory T cells in the immunopathogenesis of COVID-19: implications for treatment. Int J Biol Sci 2021;17:1507-20. [PMID: 33907514 DOI: 10.7150/ijbs.59534] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
411 Schmitt CA, Bergey CM, Jasinska AJ, Ramensky V, Burt F, Svardal H, Jorgensen MJ, Freimer NB, Grobler JP, Turner TR. ACE2 and TMPRSS2 variation in savanna monkeys (Chlorocebus spp.): Potential risk for zoonotic/anthroponotic transmission of SARS-CoV-2 and a potential model for functional studies. PLoS One 2020;15:e0235106. [PMID: 32574196 DOI: 10.1371/journal.pone.0235106] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
412 Qi X, Liu C, Jiang Z, Gu Y, Zhang G, Shao C, Yue H, Chen Z, Ma B, Liu D, Zhang L, Wang J, Xu D, Lei J, Li X, Huang H, Wang Y, Liu H, Yang J, Pan H, Liu W, Wang W, Li F, Zou S, Zhang H, Dong J. Multicenter analysis of clinical characteristics and outcomes in patients with COVID-19 who develop liver injury. J Hepatol. 2020;73:455-458. [PMID: 32305291 DOI: 10.1016/j.jhep.2020.04.010] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 21.5] [Reference Citation Analysis]
413 Raciti L, Calabrò RS. Neurological complications of COVID-19: from pathophysiology to rehabilitation. An overview. Acta Biomed 2021;92:e2021317. [PMID: 34487099 DOI: 10.23750/abm.v92i4.10620] [Reference Citation Analysis]
414 Jeyaraman M, Muthu S, Bapat A, Jain R, Sushmitha ES, Gulati A, Channaiah Anudeep T, Dilip SJ, Jha NK, Kumar D, Kesari KK, Ojha S, Dholpuria S, Gupta G, Dureja H, Chellappan DK, Singh SK, Dua K, Jha SK. Bracing NK cell based therapy to relegate pulmonary inflammation in COVID-19. Heliyon 2021;7:e07635. [PMID: 34312598 DOI: 10.1016/j.heliyon.2021.e07635] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
415 Chera JS, Kumar S, Vats A, Kushwaha P, Behera M, De S. PU.1 is involved in the transcriptional up-regulation of RNA and DNA sensing pathway genes in buffalo fibroblasts. Vet Immunol Immunopathol 2021;242:110349. [PMID: 34695651 DOI: 10.1016/j.vetimm.2021.110349] [Reference Citation Analysis]
416 Kundu A, Basu S, Shetti NP, Malik AK, Aminabhavi TM. The COVID-19 paradox: Impact on India and developed nations of the world. Sens Int 2020;1:100026. [PMID: 34766040 DOI: 10.1016/j.sintl.2020.100026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
417 Shu T, Ning W, Wu D, Xu J, Han Q, Huang M, Zou X, Yang Q, Yuan Y, Bie Y, Pan S, Mu J, Han Y, Yang X, Zhou H, Li R, Ren Y, Chen X, Yao S, Qiu Y, Zhang DY, Xue Y, Shang Y, Zhou X. Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19. Immunity 2020;53:1108-1122.e5. [PMID: 33128875 DOI: 10.1016/j.immuni.2020.10.008] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 23.0] [Reference Citation Analysis]
418 Shi L, Wang L, Xu R, Zhang C, Xie Y, Liu K, Li T, Hu W, Zhen C, Wang FS. Mesenchymal stem cell therapy for severe COVID-19. Signal Transduct Target Ther 2021;6:339. [PMID: 34497264 DOI: 10.1038/s41392-021-00754-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
419 Meng Y, Zhang Q, Wang K, Zhang X, Yang R, Bi K, Chen W, Diao H. RBM15-mediated N6-methyladenosine modification affects COVID-19 severity by regulating the expression of multitarget genes. Cell Death Dis 2021;12:732. [PMID: 34301919 DOI: 10.1038/s41419-021-04012-z] [Reference Citation Analysis]
420 Muyayalo KP, Huang DH, Zhao SJ, Xie T, Mor G, Liao AH. COVID-19 and Treg/Th17 imbalance: Potential relationship to pregnancy outcomes. Am J Reprod Immunol 2020;84:e13304. [PMID: 32662111 DOI: 10.1111/aji.13304] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
421 Moccia F, Gerbino A, Lionetti V, Miragoli M, Munaron LM, Pagliaro P, Pasqua T, Penna C, Rocca C, Samaja M, Angelone T. COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches. Geroscience 2020;42:1021-49. [PMID: 32430627 DOI: 10.1007/s11357-020-00198-w] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 25.0] [Reference Citation Analysis]
422 Yurina V. Coronavirus epitope prediction from highly conserved region of spike protein. Clin Exp Vaccine Res 2020;9:169-73. [PMID: 32864374 DOI: 10.7774/cevr.2020.9.2.169] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
423 Hu K, Guan WJ, Bi Y, Zhang W, Li L, Zhang B, Liu Q, Song Y, Li X, Duan Z, Zheng Q, Yang Z, Liang J, Han M, Ruan L, Wu C, Zhang Y, Jia ZH, Zhong NS. Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial. Phytomedicine 2021;85:153242. [PMID: 33867046 DOI: 10.1016/j.phymed.2020.153242] [Cited by in Crossref: 98] [Cited by in F6Publishing: 112] [Article Influence: 49.0] [Reference Citation Analysis]
424 Rojulpote C, Gonuguntla K, Patil S, Bhattaru A, Bravo PE. COVID-19 and the Heart. Colomb Med (Cali). 2020;51:e4320. [PMID: 33012891 DOI: 10.25100/cm.v51i2.4320] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
425 Goshen-Lago T, Szwarcwort-Cohen M, Benguigui M, Almog R, Turgeman I, Zaltzman N, Halberthal M, Shaked Y, Ben-Aharon I. The Potential Role of Immune Alteration in the Cancer-COVID19 Equation-A Prospective Longitudinal Study. Cancers (Basel) 2020;12:E2421. [PMID: 32859016 DOI: 10.3390/cancers12092421] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
426 Azkur AK, Akdis M, Azkur D, Sokolowska M, van de Veen W, Brüggen MC, O'Mahony L, Gao Y, Nadeau K, Akdis CA. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy 2020;75:1564-81. [PMID: 32396996 DOI: 10.1111/all.14364] [Cited by in Crossref: 521] [Cited by in F6Publishing: 410] [Article Influence: 260.5] [Reference Citation Analysis]
427 Saeed U, Shah SY, Ahmad J, Imran MA, Abbasi QH, Shah SA. Machine learning empowered COVID-19 patient monitoring using non-contact sensing: An extensive review. J Pharm Anal 2022. [PMID: 35003825 DOI: 10.1016/j.jpha.2021.12.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
428 Coperchini F, Chiovato L, Croce L, Magri F, Rotondi M. The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system. Cytokine Growth Factor Rev 2020;53:25-32. [PMID: 32446778 DOI: 10.1016/j.cytogfr.2020.05.003] [Cited by in Crossref: 486] [Cited by in F6Publishing: 421] [Article Influence: 243.0] [Reference Citation Analysis]
429 Friji H, Hamadi R, Ghazzai H, Besbes H, Massoud Y. A Generalized Mechanistic Model for Assessing and Forecasting the Spread of the COVID-19 Pandemic. IEEE Access 2021;9:13266-85. [PMID: 34976570 DOI: 10.1109/ACCESS.2021.3051929] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 10.0] [Reference Citation Analysis]
430 Atzori L, Ferreli C, Mateeva V, Vassileva S, Rongioletti F. Clinicopathologic features between different viral epidemic outbreaks involving the skin. Clin Dermatol 2021;39:405-17. [PMID: 34517998 DOI: 10.1016/j.clindermatol.2021.04.002] [Reference Citation Analysis]
431 Dikken JL, Maat APWM, Wolf JL, Endeman H, Hoek RAS, Bogers AJJC, Mahtab EAF. Organizing Pneumonia and Microvascular Fibrosis as Late Sequelae after a COVID-19 Infection. A Case Report. Surgeries 2021;2:190-8. [DOI: 10.3390/surgeries2020020] [Reference Citation Analysis]
432 Shah JZ, Kumar SA, Patel AA. Myocarditis and Pericarditis in Patients with COVID-19. Heart Views 2020;21:209-14. [PMID: 33688413 DOI: 10.4103/HEARTVIEWS.HEARTVIEWS_154_20] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
433 Naqvi AAT, Fatima K, Mohammad T, Fatima U, Singh IK, Singh A, Atif SM, Hariprasad G, Hasan GM, Hassan MI. Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach. Biochim Biophys Acta Mol Basis Dis 2020;1866:165878. [PMID: 32544429 DOI: 10.1016/j.bbadis.2020.165878] [Cited by in Crossref: 211] [Cited by in F6Publishing: 186] [Article Influence: 105.5] [Reference Citation Analysis]
434 Dong Y, Dai T, Liu J, Zhang L, Zhou F. Coronavirus in Continuous Flux: From SARS-CoV to SARS-CoV-2. Adv Sci (Weinh) 2020;7:2001474. [PMID: 32837848 DOI: 10.1002/advs.202001474] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
435 Gao J, Huang X, Gu H, Lou L, Xu Z. Predictive criteria of severe cases in COVID-19 patients of early stage: A retrospective observational study. J Clin Lab Anal 2020;34:e23562. [PMID: 32893398 DOI: 10.1002/jcla.23562] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
436 Wang M, Qin K, Zhai X. Combined Network Pharmacology, Molecular Docking, and Experimental Verification Approach to Investigate the Potential Mechanisms of Polydatin Against COVID-19. Natural Product Communications 2022;17:1934578X2210953. [DOI: 10.1177/1934578x221095352] [Reference Citation Analysis]
437 Birlutiu V, Birlutiu RM, Chicea L. Off-label tocilizumab and adjuvant iron chelator effectiveness in a group of severe COVID-19 pneumonia patients: A single center experience. Medicine (Baltimore) 2021;100:e25832. [PMID: 33950993 DOI: 10.1097/MD.0000000000025832] [Reference Citation Analysis]
438 Fauzi MA, Paiman N. COVID-19 pandemic in Southeast Asia: intervention and mitigation efforts. AEDS 2020;10:176-84. [DOI: 10.1108/aeds-04-2020-0064] [Cited by in Crossref: 13] [Article Influence: 6.5] [Reference Citation Analysis]
439 Eid RA, Attia AM, Hassan M, Shaker MA, Kamal MA. Demographic, clinical, and laboratory characteristics of patients with COVID-19 during the second and third waves of the pandemic in Egypt. J Infect Public Health 2021;14:1358-66. [PMID: 34511379 DOI: 10.1016/j.jiph.2021.08.009] [Reference Citation Analysis]
440 Liu SP, Zhang Q, Wang W, Zhang M, Liu C, Xiao X, Liu Z, Hu WM, Jin P. Hyperglycemia is a strong predictor of poor prognosis in COVID-19. Diabetes Res Clin Pract 2020;167:108338. [PMID: 32712122 DOI: 10.1016/j.diabres.2020.108338] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 10.5] [Reference Citation Analysis]
441 Coni P, Pichiri G, Lachowicz JI, Ravarino A, Ledda F, Fanni D, Gerosa C, Piras M, Coghe F, Gibo Y, Cau F, Castagnola M, Van Eyken P, Saba L, Piludu M, Faa G. Zinc as a Drug for Wilson's Disease, Non-Alcoholic Liver Disease and COVID-19-Related Liver Injury. Molecules 2021;26:6614. [PMID: 34771023 DOI: 10.3390/molecules26216614] [Reference Citation Analysis]
442 Su S, Shen J, Zhu L, Qiu Y, He JS, Tan JY, Iacucci M, Ng SC, Ghosh S, Mao R, Liang J. Involvement of digestive system in COVID-19: manifestations, pathology, management and challenges. Therap Adv Gastroenterol 2020;13:1756284820934626. [PMID: 32595762 DOI: 10.1177/1756284820934626] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 11.5] [Reference Citation Analysis]
443 Jiang H, Guo W, Shi Z, Jiang H, Zhang M, Wei L, Pan Y. Clinical imaging characteristics of inpatients with coronavirus disease-2019 in Heilongjiang Province, China: a retrospective study. Aging (Albany NY) 2020;12:13860-8. [PMID: 32688346 DOI: 10.18632/aging.103633] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
444 Kumar P, Erturk VS, Murillo-Arcila M. A new fractional mathematical modelling of COVID-19 with the availability of vaccine. Results Phys 2021;24:104213. [PMID: 33898210 DOI: 10.1016/j.rinp.2021.104213] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
445 Valdebenito S, Bessis S, Annane D, Lorin de la Grandmaison G, Cramer-Bordé E, Prideaux B, Eugenin EA, Bomsel M. COVID-19 Lung Pathogenesis in SARS-CoV-2 Autopsy Cases. Front Immunol 2021;12:735922. [PMID: 34671353 DOI: 10.3389/fimmu.2021.735922] [Reference Citation Analysis]
446 Libanda B. Public Institutional Structures for Disaster Preparedness in the Cereal Value Chain: A Zambian Case Study. GeoHazards 2021;2:352-65. [DOI: 10.3390/geohazards2040019] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
447 Nasonov EL. IMMUNOPATHOLOGY AND IMMUNOPHARMACOTHERAPY OF CORONAVIRUS DISEASE 2019 (COVID-19): FOCUS ON INTERLEUKIN 6. Naučno-praktičeskaâ revmatologiâ 2020;58:245-61. [DOI: 10.14412/1995-4484-2020-245-261] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
448 Lei F, Liu YM, Zhou F, Qin JJ, Zhang P, Zhu L, Zhang XJ, Cai J, Lin L, Ouyang S, Wang X, Yang C, Cheng X, Liu W, Li H, Xie J, Wu B, Luo H, Xiao F, Chen J, Tao L, Cheng G, She ZG, Zhou J, Wang H, Lin J, Luo P, Fu S, Zhou J, Ye P, Xiao B, Mao W, Liu L, Yan Y, Liu L, Chen G, Li H, Huang X, Zhang BH, Yuan Y. Longitudinal Association Between Markers of Liver Injury and Mortality in COVID-19 in China. Hepatology 2020;72:389-98. [PMID: 32359177 DOI: 10.1002/hep.31301] [Cited by in Crossref: 202] [Cited by in F6Publishing: 178] [Article Influence: 101.0] [Reference Citation Analysis]
449 Brojakowska A, Eskandari A, Bisserier M, Bander J, Garikipati VNS, Hadri L, Goukassian DA, Fish KM. Comorbidities, sequelae, blood biomarkers and their associated clinical outcomes in the Mount Sinai Health System COVID-19 patients. PLoS One 2021;16:e0253660. [PMID: 34228746 DOI: 10.1371/journal.pone.0253660] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
450 Zheng ZX. Stem cell therapy: A promising treatment for COVID-19. World J Clin Cases 2021; 9(36): 11148-11155 [DOI: 10.12998/wjcc.v9.i36.11148] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
451 Noce A, Santoro ML, Marrone G, D'Agostini C, Amelio I, Duggento A, Tesauro M, Di Daniele N. Serological determinants of COVID-19. Biol Direct 2020;15:21. [PMID: 33138856 DOI: 10.1186/s13062-020-00276-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
452 Shah T, McCarthy M, Nasir I, Archer H, Ragheb E, Kluger J, Kashyap N, Paredes C, Patel P, Lu J, Kandel P, Song C, Khan M, Ul Haq F, Ahmad R, Howes C, Cambi B, Lancaster G, Cleman M, Dela Cruz CS, Parise H, Lansky A. Design and rationale of the colchicine/statin for the prevention of COVID-19 complications (COLSTAT) trial. Contemp Clin Trials 2021;110:106547. [PMID: 34461322 DOI: 10.1016/j.cct.2021.106547] [Reference Citation Analysis]
453 Guo Z, Zhang Z, Prajapati M, Li Y. Lymphopenia Caused by Virus Infections and the Mechanisms Beyond. Viruses 2021;13:1876. [PMID: 34578457 DOI: 10.3390/v13091876] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
454 Sivandzadeh GR, Askari H, Safarpour AR, Ejtehadi F, Raeis-Abdollahi E, Vaez Lari A, Abazari MF, Tarkesh F, Bagheri Lankarani K. COVID-19 infection and liver injury: Clinical features, biomarkers, potential mechanisms, treatment, and management challenges. World J Clin Cases 2021; 9(22): 6178-6200 [PMID: 34434987 DOI: 10.12998/wjcc.v9.i22.6178] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
455 Ma L, Song K, Huang Y. Coronavirus Disease-2019 (COVID-19) and Cardiovascular Complications. J Cardiothorac Vasc Anesth 2021;35:1860-5. [PMID: 32451271 DOI: 10.1053/j.jvca.2020.04.041] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
456 Idalsoaga F, Ayares G, Arab JP, Díaz LA. COVID-19 and Indirect Liver Injury: A Narrative Synthesis of the Evidence. J Clin Transl Hepatol 2021;9:760-8. [PMID: 34722191 DOI: 10.14218/JCTH.2020.00140] [Reference Citation Analysis]
457 Gholizadeh P, Safari R, Marofi P, Zeinalzadeh E, Pagliano P, Ganbarov K, Esposito S, Khodadadi E, Yousefi M, Samadi Kafil H. Alteration of Liver Biomarkers in Patients with SARS-CoV-2 (COVID-19). J Inflamm Res 2020;13:285-92. [PMID: 32669866 DOI: 10.2147/JIR.S257078] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
458 Prata D, Rodrigues W, De Souza Bermejo PH, Moreira M, Camargo W, Lisboa M, Rossone Reis G, de Araujo HX. The relationship between (sub)tropical climates and the incidence of COVID-19. PeerJ 2021;9:e10655. [PMID: 33680577 DOI: 10.7717/peerj.10655] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
459 Oluwasanmi A, Aftab MU, Qin Z, Ngo ST, Doan TV, Nguyen SB, Nguyen SH, Selisteanu D. Transfer Learning and Semisupervised Adversarial Detection and Classification of COVID-19 in CT Images. Complexity 2021;2021:1-11. [DOI: 10.1155/2021/6680455] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 8.0] [Reference Citation Analysis]
460 Khan JR, Awan N, Islam MM, Muurlink O. Healthcare Capacity, Health Expenditure, and Civil Society as Predictors of COVID-19 Case Fatalities: A Global Analysis. Front Public Health 2020;8:347. [PMID: 32719765 DOI: 10.3389/fpubh.2020.00347] [Cited by in Crossref: 27] [Cited by in F6Publishing: 16] [Article Influence: 13.5] [Reference Citation Analysis]
461 Richard I, Robinson B, Dawson A, Aya A, Ali R. An Atypical Presentation of Fulminant Myocarditis Secondary to COVID-19 Infection. Cureus 2020;12:e9179. [PMID: 32802614 DOI: 10.7759/cureus.9179] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
462 Carsana L, Sonzogni A, Nasr A, Rossi RS, Pellegrinelli A, Zerbi P, Rech R, Colombo R, Antinori S, Corbellino M, Galli M, Catena E, Tosoni A, Gianatti A, Nebuloni M. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study. Lancet Infect Dis. 2020;20:1135-1140. [PMID: 32526193 DOI: 10.1016/s1473-3099(20)30434-5] [Cited by in Crossref: 459] [Cited by in F6Publishing: 364] [Article Influence: 229.5] [Reference Citation Analysis]
463 Bao L, Zhang C, Dong J, Zhao L, Li Y, Sun J. Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection. Front Microbiol 2020;11:1840. [PMID: 32849438 DOI: 10.3389/fmicb.2020.01840] [Cited by in Crossref: 74] [Cited by in F6Publishing: 58] [Article Influence: 37.0] [Reference Citation Analysis]
464 Migliorini F, Vaishya R, Eschweiler J, Oliva F, Hildebrand F, Maffulli N. Vitamins C and D and COVID-19 Susceptibility, Severity and Progression: An Evidence Based Systematic Review. Medicina (Kaunas) 2022;58:941. [PMID: 35888660 DOI: 10.3390/medicina58070941] [Reference Citation Analysis]
465 Kawakami R, Sakamoto A, Kawai K, Gianatti A, Pellegrini D, Nasr A, Kutys B, Guo L, Cornelissen A, Mori M, Sato Y, Pescetelli I, Brivio M, Romero M, Guagliumi G, Virmani R, Finn AV. Pathological Evidence for SARS-CoV-2 as a Cause of Myocarditis: JACC Review Topic of the Week. J Am Coll Cardiol 2021;77:314-25. [PMID: 33478655 DOI: 10.1016/j.jacc.2020.11.031] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 39.0] [Reference Citation Analysis]
466 Yan H, Lu J, Wang J, Chen L, Wang Y, Li L, Miao L, Zhang H. Prevention of Cyclophosphamide-Induced Immunosuppression in Mice With Traditional Chinese Medicine Xuanfei Baidu Decoction. Front Pharmacol 2021;12:730567. [PMID: 34737699 DOI: 10.3389/fphar.2021.730567] [Reference Citation Analysis]
467 Ho KS, Howell D, Rogers L, Narasimhan B, Verma H, Steiger D. The relationship between asthma, eosinophilia, and outcomes in coronavirus disease 2019 infection. Ann Allergy Asthma Immunol 2021;127:42-8. [PMID: 33647451 DOI: 10.1016/j.anai.2021.02.021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
468 Xie M, Chen Q. Insight into 2019 novel coronavirus - An updated interim review and lessons from SARS-CoV and MERS-CoV. Int J Infect Dis 2020;94:119-24. [PMID: 32247050 DOI: 10.1016/j.ijid.2020.03.071] [Cited by in Crossref: 206] [Cited by in F6Publishing: 153] [Article Influence: 103.0] [Reference Citation Analysis]
469 Greenland JR, Michelow MD, Wang L, London MJ. COVID-19 Infection: Implications for Perioperative and Critical Care Physicians. Anesthesiology 2020;132:1346-61. [PMID: 32195698 DOI: 10.1097/ALN.0000000000003303] [Cited by in Crossref: 99] [Cited by in F6Publishing: 63] [Article Influence: 49.5] [Reference Citation Analysis]
470 Syed A, Khan A, Gosai F, Asif A, Dhillon S. Gastrointestinal pathophysiology of SARS-CoV2 - a literature review. J Community Hosp Intern Med Perspect. 2020;10:523-528. [PMID: 33194122 DOI: 10.1080/20009666.2020.1811556] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
471 Rovito R, Augello M, Ben-Haim A, Bono V, d'Arminio Monforte A, Marchetti G. Hallmarks of Severe COVID-19 Pathogenesis: A Pas de Deux Between Viral and Host Factors. Front Immunol 2022;13:912336. [PMID: 35757770 DOI: 10.3389/fimmu.2022.912336] [Reference Citation Analysis]
472 Maulding ND, Seiler S, Pearson A, Kreusser N, Stuart JM. Dual RNA-Seq analysis of SARS-CoV-2 correlates specific human transcriptional response pathways directly to viral expression. Sci Rep 2022;12:1329. [PMID: 35079083 DOI: 10.1038/s41598-022-05342-4] [Reference Citation Analysis]
473 Li C, Jiang J, Wang F, Zhou N, Veronese G, Moslehi JJ, Ammirati E, Wang DW. Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients. J Mol Cell Cardiol 2020;147:74-87. [PMID: 32827510 DOI: 10.1016/j.yjmcc.2020.08.008] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 11.0] [Reference Citation Analysis]
474 Samad N, Dutta S, Sodunke TE, Fairuz A, Sapkota A, Miftah ZF, Jahan I, Sharma P, Abubakar AR, Rowaiye AB, Oli AN, Charan J, Islam S, Haque M. Fat-Soluble Vitamins and the Current Global Pandemic of COVID-19: Evidence-Based Efficacy from Literature Review. J Inflamm Res 2021;14:2091-110. [PMID: 34045883 DOI: 10.2147/JIR.S307333] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
475 Madhusudhan KS, Srivastava DN, Garg KV, Khandelwal N. Computed Tomography of the Chest in COVID-19: A Pictorial Review of Indian Patients. Ann Natl Acad Med Sci 2021;57:82-92. [DOI: 10.1055/s-0041-1728973] [Reference Citation Analysis]
476 Khodashahi R, Sedaghat A, Khodashahi M. Early Intravenous Immunoglobulin as an Effective Drug for the Treatment of COVID-19: A Case Series and Case Review. Arch Clin Infect Dis 2020;15. [DOI: 10.5812/archcid.103732] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
477 Valjarević A, Milić M, Valjarević D, Stanojević-ristić Z, Petrović L, Milanović M, Filipović D, Ristanović B, Basarin B, Lukić T. Modelling and mapping of the COVID-19 trajectory and pandemic paths at global scale: A geographer’s perspective. Open Geosciences 2020;12:1603-16. [DOI: 10.1515/geo-2020-0156] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
478 Chen Z. COVID-19: A revelation - A reply to Ian Mitroff. Technol Forecast Soc Change 2020;156:120072. [PMID: 32327853 DOI: 10.1016/j.techfore.2020.120072] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
479 Lonati C, Gatti S, Catania A. Activation of Melanocortin Receptors as a Potential Strategy to Reduce Local and Systemic Reactions Induced by Respiratory Viruses. Front Endocrinol (Lausanne) 2020;11:569241. [PMID: 33362713 DOI: 10.3389/fendo.2020.569241] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
480 Wenling Y, Junchao Q, Xiao Z, Ouyang S. Pregnancy and COVID-19: management and challenges. Rev Inst Med Trop Sao Paulo 2020;62:e62. [PMID: 32876296 DOI: 10.1590/s1678-9946202062062] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
481 Leija-Martínez JJ, Huang F, Del-Río-Navarro BE, Sanchéz-Muñoz F, Muñoz-Hernández O, Giacoman-Martínez A, Hall-Mondragon MS, Espinosa-Velazquez D. IL-17A and TNF-α as potential biomarkers for acute respiratory distress syndrome and mortality in patients with obesity and COVID-19. Med Hypotheses 2020;144:109935. [PMID: 32795834 DOI: 10.1016/j.mehy.2020.109935] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
482 Shen C, Li Q, Wei Y, Li Y, Li J, Tao J. Management of immune checkpoint therapy for patients with cancer in the face of COVID-19. J Immunother Cancer 2020;8:e001593. [PMID: 33303577 DOI: 10.1136/jitc-2020-001593] [Reference Citation Analysis]
483 Wang Q, Zhao H, Liu LG, Wang YB, Zhang T, Li MH, Xu YL, Gao GJ, Xiong HF, Fan Y, Cao Y, Ding R, Wang JJ, Cheng C, Xie W. Pattern of liver injury in adult patients with COVID-19: a retrospective analysis of 105 patients. Mil Med Res. 2020;7:28. [PMID: 32507110 DOI: 10.1186/s40779-020-00256-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 23] [Article Influence: 7.5] [Reference Citation Analysis]
484 Talebi-Taher M, Najafi MH, Behzad S. COVID-19 and RAAS inhibitors: is there a final conclusion? Iran J Microbiol 2021;13:728-36. [PMID: 35222849 DOI: 10.18502/ijm.v13i6.8071] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
485 [DOI: 10.1109/tiptekno50054.2020.9299289] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 5.5] [Reference Citation Analysis]
486 Esakandari H, Nabi-Afjadi M, Fakkari-Afjadi J, Farahmandian N, Miresmaeili SM, Bahreini E. A comprehensive review of COVID-19 characteristics. Biol Proced Online 2020;22:19. [PMID: 32774178 DOI: 10.1186/s12575-020-00128-2] [Cited by in Crossref: 74] [Cited by in F6Publishing: 63] [Article Influence: 37.0] [Reference Citation Analysis]
487 Niu R, Ye S, Li Y, Ma H, Xie X, Hu S, Huang X, Ou Y, Chen J. Chest CT features associated with the clinical characteristics of patients with COVID-19 pneumonia. Ann Med 2021;53:169-80. [PMID: 33426973 DOI: 10.1080/07853890.2020.1851044] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
488 Jin H, Hong C, Chen S, Zhou Y, Wang Y, Mao L, Li Y, He Q, Li M, Su Y, Wang D, Wang L, Hu B. Consensus for prevention and management of coronavirus disease 2019 (COVID-19) for neurologists. Stroke Vasc Neurol 2020;5:146-51. [PMID: 32385132 DOI: 10.1136/svn-2020-000382] [Cited by in Crossref: 72] [Cited by in F6Publishing: 56] [Article Influence: 36.0] [Reference Citation Analysis]
489 Aleem A, Mahadevaiah G, Shariff N, Kothadia JP. Hepatic manifestations of COVID-19 and effect of remdesivir on liver function in patients with COVID-19 illness. Proc (Bayl Univ Med Cent) 2021;34:473-7. [PMID: 34219928 DOI: 10.1080/08998280.2021.1885289] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
490 Wiggill TM, Mayne ES, Vaughan JL, Louw S. Overview of the Haematological Effects of COVID-19 Infection. Adv Exp Med Biol 2021;1321:163-72. [PMID: 33656722 DOI: 10.1007/978-3-030-59261-5_14] [Reference Citation Analysis]
491 Yang LV, Oppelt KA, Thomassen MJ, Marie MA, Nik Akhtar S, McCallen JD. Can GPR4 Be a Potential Therapeutic Target for COVID-19? Front Med (Lausanne) 2020;7:626796. [PMID: 33553219 DOI: 10.3389/fmed.2020.626796] [Reference Citation Analysis]
492 Mirza-Aghazadeh-Attari M, Zarrintan A, Nezami N, Mohammadi A, Zarrintan A, Mohebbi I, Pirnejad H, Khademvatani K, Ashkavand Z, Forughi P, Arasteh A, Attari JA. Predictors of coronavirus disease 19 (COVID-19) pneumonitis outcome based on computed tomography (CT) imaging obtained prior to hospitalization: a retrospective study. Emerg Radiol 2020;27:653-61. [PMID: 32770367 DOI: 10.1007/s10140-020-01833-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
493 Li CX, Noreen S, Zhang LX, Saeed M, Wu PF, Ijaz M, Dai DF, Maqbool I, Madni A, Akram F, Naveed M, Li JH. A critical analysis of SARS-CoV-2 (COVID-19) complexities, emerging variants, and therapeutic interventions and vaccination strategies. Biomed Pharmacother 2021;146:112550. [PMID: 34959116 DOI: 10.1016/j.biopha.2021.112550] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
494 Munk AJL, Schmidt NM, Alexander N, Henkel K, Hennig J. Covid-19-Beyond virology: Potentials for maintaining mental health during lockdown. PLoS One 2020;15:e0236688. [PMID: 32750072 DOI: 10.1371/journal.pone.0236688] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
495 Thakkar S, Arora S, Kumar A, Jaswaney R, Faisaluddin M, Ammad Ud Din M, Shariff M, Barssoum K, Patel HP, Nirav A, Jani C, Patel K, Savani S, DeSimone C, Mulpuru S, Deshmukh A. A Systematic Review of the Cardiovascular Manifestations and Outcomes in the Setting of Coronavirus-19 Disease. Clin Med Insights Cardiol 2020;14:1179546820977196. [PMID: 33312009 DOI: 10.1177/1179546820977196] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
496 Jia L, Chen Z, Zhang Y, Ma L, Wang L, Hu X, Liu H, Chen J, Liu D, Guan W. Suppression and Activation of Intracellular Immune Response in Initial Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Front Microbiol 2021;12:768740. [PMID: 34899651 DOI: 10.3389/fmicb.2021.768740] [Reference Citation Analysis]
497 Dong M, Zhang J, Ma X, Tan J, Chen L, Liu S, Xin Y, Zhuang L. ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19. Biomed Pharmacother 2020;131:110678. [PMID: 32861070 DOI: 10.1016/j.biopha.2020.110678] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 19.5] [Reference Citation Analysis]
498 Sang L, Guo X, Shi J, Hou S, Fan H, Lv Q. Characteristics and Developments in Mesenchymal Stem Cell Therapy for COVID-19: An Update. Stem Cells Int 2021;2021:5593584. [PMID: 34211556 DOI: 10.1155/2021/5593584] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
499 Gubbi S, Nazari MA, Taieb D, Klubo-Gwiezdzinska J, Pacak K. Catecholamine physiology and its implications in patients with COVID-19. Lancet Diabetes Endocrinol 2020;8:978-86. [PMID: 33128872 DOI: 10.1016/S2213-8587(20)30342-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 10.5] [Reference Citation Analysis]
500 Hu S, Jiang S, Qi X, Bai R, Ye XY, Xie T. Races of small molecule clinical trials for the treatment of COVID-19: An up-to-date comprehensive review. Drug Dev Res 2021. [PMID: 34762760 DOI: 10.1002/ddr.21895] [Reference Citation Analysis]
501 Váncsa S, Hegyi PJ, Zádori N, Szakó L, Vörhendi N, Ocskay K, Földi M, Dembrovszky F, Dömötör ZR, Jánosi K, Rakonczay Z Jr, Hartmann P, Horváth T, Erőss B, Kiss S, Szakács Z, Németh D, Hegyi P, Pár G. Pre-existing Liver Diseases and On-Admission Liver-Related Laboratory Tests in COVID-19: A Prognostic Accuracy Meta-Analysis With Systematic Review. Front Med (Lausanne) 2020;7:572115. [PMID: 33282888 DOI: 10.3389/fmed.2020.572115] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
502 Hashemian SMR, Pourhanifeh MH, Hamblin MR, Shahrzad MK, Mirzaei H. RdRp inhibitors and COVID-19: Is molnupiravir a good option? Biomed Pharmacother 2021;146:112517. [PMID: 34902743 DOI: 10.1016/j.biopha.2021.112517] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
503 Maisch B. [The ESC recommendations for COVID-19-no guideline, but a learning guidance]. Herz 2021;46:46-55. [PMID: 33315146 DOI: 10.1007/s00059-020-05006-x] [Reference Citation Analysis]
504 Chang YK, Hung CL, Timme S, Nosrat S, Chu CH. Exercise Behavior and Mood during the COVID-19 Pandemic in Taiwan: Lessons for the Future. Int J Environ Res Public Health 2020;17:E7092. [PMID: 32998207 DOI: 10.3390/ijerph17197092] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
505 Fu Y, Ma W, Wu J. Fostering Voluntary Compliance in the COVID-19 Pandemic: An Analytical Framework of Information Disclosure. The American Review of Public Administration 2020;50:685-91. [DOI: 10.1177/0275074020942102] [Cited by in Crossref: 7] [Article Influence: 3.5] [Reference Citation Analysis]
506 Trias-sabrià P, Dorca Duch E, Molina-molina M, Aso S, Díez-ferrer M, Marín Muñiz A, Bordas-martínez J, Sabater J, Luburich P, del Rio B, Solanich X, Dorca J, Santos S, Suárez-cuartin G. Radio-Histological Correlation of Lung Features in Severe COVID-19 Through CT-Scan and Lung Ultrasound Evaluation. Front Med 2022;9:820661. [DOI: 10.3389/fmed.2022.820661] [Reference Citation Analysis]
507 Jiang C, Yao X, Zhao Y, Wu J, Huang P, Pan C, Liu S, Pan C. Comparative review of respiratory diseases caused by coronaviruses and influenza A viruses during epidemic season. Microbes Infect. 2020;22:236-244. [PMID: 32405236 DOI: 10.1016/j.micinf.2020.05.005] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 15.0] [Reference Citation Analysis]
508 Filgueira TO, Castoldi A, Santos LER, de Amorim GJ, de Sousa Fernandes MS, Anastácio WLDN, Campos EZ, Santos TM, Souto FO. The Relevance of a Physical Active Lifestyle and Physical Fitness on Immune Defense: Mitigating Disease Burden, With Focus on COVID-19 Consequences. Front Immunol 2021;12:587146. [PMID: 33613573 DOI: 10.3389/fimmu.2021.587146] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
509 Maev IV, Shpektor AV, Vasilyeva EY, Manchurov VN, Andreev DN. [Novel coronavirus infection COVID-19: extrapulmonary manifestations]. Ter Arkh 2020;92:4-11. [PMID: 33346454 DOI: 10.26442/00403660.2020.08.000767] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
510 Reina J. [The SARS-CoV-2, a new pandemic zoonosis that threatens the world]. Vacunas 2020;21:17-22. [PMID: 32565763 DOI: 10.1016/j.vacun.2020.03.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 3.5] [Reference Citation Analysis]
511 Cho H, Jung YH, Cho HB, Kim HT, Kim KS. Positive control synthesis method for COVID-19 diagnosis by one-step real-time RT-PCR. Clin Chim Acta 2020;511:149-53. [PMID: 33058837 DOI: 10.1016/j.cca.2020.10.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
512 Xia S, Wu M, Chen S, Zhang T, Ye L, Liu J, Li H. Long Term Culture of Human Kidney Proximal Tubule Epithelial Cells Maintains Lineage Functions and Serves as an Ex vivo Model for Coronavirus Associated Kidney Injury. Virol Sin 2020;35:311-20. [PMID: 32602046 DOI: 10.1007/s12250-020-00253-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
513 Fleming N, Sacks LJ, Pham CT, Neoh SL, Ekinci EI. An overview of COVID-19 in people with diabetes: Pathophysiology and considerations in the inpatient setting. Diabet Med 2021;38:e14509. [PMID: 33377213 DOI: 10.1111/dme.14509] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
514 Hammoud H, Bendari A, Bendari T, Bougmiza I. Histopathological Findings in COVID-19 Cases: A Systematic Review. Cureus. [DOI: 10.7759/cureus.25573] [Reference Citation Analysis]
515 Rastogi A, Tewari P. Covid 19 and its cardiovascular effects. Ann Card Anaesth 2020;23:401-8. [PMID: 33109794 DOI: 10.4103/aca.aca_237_20] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
516 Abbasi BA, Saraf D, Sharma T, Sinha R, Singh S, Sood S, Gupta P, Gupta A, Mishra K, Kumari P, Rawal K. Identification of vaccine targets & design of vaccine against SARS-CoV-2 coronavirus using computational and deep learning-based approaches. PeerJ 2022;10:e13380. [DOI: 10.7717/peerj.13380] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
517 Abu-El-Rub E, Khasawneh RR, Almahasneh F, Altaany Z, Bataineh N, Zegallai H, Sekaran S. Mesenchymal stem cells and COVID-19: What they do and what they can do. World J Stem Cells 2021; 13(9): 1318-1337 [PMID: 34630865 DOI: 10.4252/wjsc.v13.i9.1318] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
518 Peiter GC, de Souza CBT, de Oliveira LM, Pagliarin LG, dos Anjos VNF, da Silva FAF, de Melo FF, Teixeira KN. COVID-19 liver and gastroenterology findings: An in silico analysis of SARS-CoV-2 interactions with liver molecules. World J Hepatol 2022; 14(6): 1131-1141 [DOI: 10.4254/wjh.v14.i6.1131] [Reference Citation Analysis]
519 Pascarella G, Strumia A, Piliego C, Bruno F, Del Buono R, Costa F, Scarlata S, Agrò FE. COVID-19 diagnosis and management: a comprehensive review. J Intern Med 2020;288:192-206. [PMID: 32348588 DOI: 10.1111/joim.13091] [Cited by in Crossref: 375] [Cited by in F6Publishing: 309] [Article Influence: 187.5] [Reference Citation Analysis]
520 Mendoza-Pinto C, García-Carrasco M, Realpozo PM, Méndez-Martínez S. [Therapeutic options for the management of severe Covid-19: A rheumatology perspective]. Reumatol Clin (Engl Ed) 2020. [PMID: 32426002 DOI: 10.1016/j.reuma.2020.05.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
521 Pequeno P, Mendel B, Rosa C, Bosholn M, Souza JL, Baccaro F, Barbosa R, Magnusson W. Air transportation, population density and temperature predict the spread of COVID-19 in Brazil. PeerJ 2020;8:e9322. [PMID: 32547889 DOI: 10.7717/peerj.9322] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 20.0] [Reference Citation Analysis]
522 Qu J, Chang LK, Tang X, Du Y, Yang X, Liu X, Han P, Xue Y. Clinical characteristics of COVID-19 and its comparison with influenza pneumonia. Acta Clin Belg 2020;75:348-56. [PMID: 32723027 DOI: 10.1080/17843286.2020.1798668] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
523 Myint PK, Carter B, Barlow-Pay F, Short R, Einarsson AG, Bruce E, McCarthy K, Verduri A, Collins J, Hesford J, Rickard F, Mitchell E, Holloway M, McGovern A, Vilches-Moraga A, Braude P, Pearce L, Stechman M, Price A, Quinn TJ, Clini E, Moug S, Hewitt J. Routine use of immunosuppressants is associated with mortality in hospitalised patients with COVID-19. Ther Adv Drug Saf 2021;12:2042098620985690. [PMID: 33680426 DOI: 10.1177/2042098620985690] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
524 Gbadamosi AQ, Oyedele L, Olawale O, Abioye S. Offsite Construction for Emergencies: A focus on Isolation Space Creation (ISC) measures for the COVID-19 pandemic. Prog Disaster Sci 2020;8:100130. [PMID: 34173448 DOI: 10.1016/j.pdisas.2020.100130] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
525 Mahalmani VM, Mahendru D, Semwal A, Kaur S, Kaur H, Sarma P, Prakash A, Medhi B. COVID-19 pandemic: A review based on current evidence. Indian J Pharmacol 2020;52:117-29. [PMID: 32565599 DOI: 10.4103/ijp.IJP_310_20] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
526 Norouzi M, Miar P, Norouzi S, Nikpour P. Nervous System Involvement in COVID-19: a Review of the Current Knowledge. Mol Neurobiol 2021;58:3561-74. [PMID: 33765290 DOI: 10.1007/s12035-021-02347-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
527 Wang S, Pan Y, Wang Q, Miao H, Brown AN, Rong L. Modeling the viral dynamics of SARS-CoV-2 infection. Math Biosci 2020;328:108438. [PMID: 32771304 DOI: 10.1016/j.mbs.2020.108438] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 15.0] [Reference Citation Analysis]
528 Poggiali E, Vercelli A, Iannicelli T, Tinelli V, Celoni L, Magnacavallo A. COVID-19, Chronic Obstructive Pulmonary Disease and Pneumothorax: A Frightening Triad. Eur J Case Rep Intern Med 2020;7:001742. [PMID: 32665932 DOI: 10.12890/2020_001742] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
529 Liu J, Cui M, Yang T, Yao P. Correlation between gastrointestinal symptoms and disease severity in patients with COVID-19: a systematic review and meta-analysis. BMJ Open Gastroenterol 2020;7:e000437. [PMID: 32665397 DOI: 10.1136/bmjgast-2020-000437] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
530 Dilogo IH, Aditianingsih D, Sugiarto A, Burhan E, Damayanti T, Sitompul PA, Mariana N, Antarianto RD, Liem IK, Kispa T, Mujadid F, Novialdi N, Luviah E, Kurniawati T, Lubis AMT, Rahmatika D. Umbilical cord mesenchymal stromal cells as critical COVID-19 adjuvant therapy: A randomized controlled trial. Stem Cells Transl Med 2021. [PMID: 34102020 DOI: 10.1002/sctm.21-0046] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
531 Botek M, Krejčí J, Valenta M, McKune A, Sládečková B, Konečný P, Klimešová I, Pastucha D. Molecular Hydrogen Positively Affects Physical and Respiratory Function in Acute Post-COVID-19 Patients: A New Perspective in Rehabilitation. Int J Environ Res Public Health 2022;19:1992. [PMID: 35206179 DOI: 10.3390/ijerph19041992] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
532 Bahrami A, Ferns GA. Genetic and pathogenic characterization of SARS-CoV-2: a review. Future Virology 2020;15:533-49. [DOI: 10.2217/fvl-2020-0129] [Cited by in Crossref: 7] [Article Influence: 3.5] [Reference Citation Analysis]
533 Guzik TJ, Mohiddin SA, Dimarco A, Patel V, Savvatis K, Marelli-Berg FM, Madhur MS, Tomaszewski M, Maffia P, D'Acquisto F, Nicklin SA, Marian AJ, Nosalski R, Murray EC, Guzik B, Berry C, Touyz RM, Kreutz R, Wang DW, Bhella D, Sagliocco O, Crea F, Thomson EC, McInnes IB. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res 2020;116:1666-87. [PMID: 32352535 DOI: 10.1093/cvr/cvaa106] [Cited by in Crossref: 487] [Cited by in F6Publishing: 433] [Article Influence: 243.5] [Reference Citation Analysis]
534 Jiang J, Wang YE, Palazzo AF, Shen Q. Roles of Nucleoporin RanBP2/Nup358 in Acute Necrotizing Encephalopathy Type 1 (ANE1) and Viral Infection. Int J Mol Sci 2022;23:3548. [PMID: 35408907 DOI: 10.3390/ijms23073548] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
535 Agrawal M, Saraf S, Saraf S, Murty US, Kurundkar SB, Roy D, Joshi P, Sable D, Choudhary YK, Kesharwani P, Alexander A. In-line treatments and clinical initiatives to fight against COVID-19 outbreak. Respir Med 2020;:106192. [PMID: 33199136 DOI: 10.1016/j.rmed.2020.106192] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
536 Orlov M, Wander PL, Morrell ED, Mikacenic C, Wurfel MM. A Case for Targeting Th17 Cells and IL-17A in SARS-CoV-2 Infections. J Immunol 2020;205:892-8. [PMID: 32651218 DOI: 10.4049/jimmunol.2000554] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 11.0] [Reference Citation Analysis]
537 Liu T, Feng M, Wen Z, He Y, Lin W, Zhang M. Comparison of the Characteristics of Cytokine Storm and Immune Response Induced by SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections. J Inflamm Res 2021;14:5475-87. [PMID: 34720596 DOI: 10.2147/JIR.S329697] [Reference Citation Analysis]
538 Fakhoury HMA, Kvietys PR, Shakir I, Shams H, Grant WB, Alkattan K. Lung-Centric Inflammation of COVID-19: Potential Modulation by Vitamin D. Nutrients 2021;13:2216. [PMID: 34203190 DOI: 10.3390/nu13072216] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
539 Altawalah H. Antibody Responses to Natural SARS-CoV-2 Infection or after COVID-19 Vaccination. Vaccines (Basel) 2021;9:910. [PMID: 34452035 DOI: 10.3390/vaccines9080910] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
540 Carnero Contentti E, Correa J. Immunosuppression during the COVID-19 pandemic in neuromyelitis optica spectrum disorders patients: A new challenge. Mult Scler Relat Disord 2020;41:102097. [PMID: 32278860 DOI: 10.1016/j.msard.2020.102097] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
541 Tiyo BT, Schmitz GJH, Ortega MM, da Silva LT, de Almeida A, Oshiro TM, Duarte AJDS. What Happens to the Immune System after Vaccination or Recovery from COVID-19? Life (Basel) 2021;11:1152. [PMID: 34833028 DOI: 10.3390/life11111152] [Reference Citation Analysis]
542 Yu D, Du Q, Yan S, Guo XG, He Y, Zhu G, Zhao K, Ouyang S. Liver injury in COVID-19: clinical features and treatment management. Virol J 2021;18:121. [PMID: 34108015 DOI: 10.1186/s12985-021-01593-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
543 Mawhinney JA, Wilcock C, Haboubi H, Roshanzamir S. Neurotropism of SARS-CoV-2: COVID-19 presenting with an acute manic episode. BMJ Case Rep 2020;13:e236123. [PMID: 32540882 DOI: 10.1136/bcr-2020-236123] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
544 Li Q, Li W, Jin Y, Xu W, Huang C, Li L, Huang Y, Fu Q, Chen L. Efficacy Evaluation of Early, Low-Dose, Short-Term Corticosteroids in Adults Hospitalized with Non-Severe COVID-19 Pneumonia: A Retrospective Cohort Study. Infect Dis Ther 2020;9:823-36. [PMID: 32880102 DOI: 10.1007/s40121-020-00332-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 10.5] [Reference Citation Analysis]
545 Yao C, Bora SA, Parimon T, Zaman T, Friedman OA, Palatinus JA, Surapaneni NS, Matusov YP, Cerro Chiang G, Kassar AG, Patel N, Green CER, Aziz AW, Suri H, Suda J, Lopez AA, Martins GA, Stripp BR, Gharib SA, Goodridge HS, Chen P. Cell-Type-Specific Immune Dysregulation in Severely Ill COVID-19 Patients. Cell Rep 2021;34:108590. [PMID: 33357411 DOI: 10.1016/j.celrep.2020.108590] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]
546 Sun H, Su X, Huang L, Mu D, Qu Y. Research Progress on the Cardiac Injury from ACE2 Targeting in SARS-CoV-2 Infection. Biomolecules 2021;11:196. [PMID: 33573324 DOI: 10.3390/biom11020196] [Reference Citation Analysis]
547 Harkin TJ, Rurak KM, Martins J, Eber C, Szporn AH, Beasley MB. Delayed diagnosis of COVID-19 in a 34-year-old man with atypical presentation. Lancet Respir Med 2020;8:644-6. [PMID: 32437648 DOI: 10.1016/S2213-2600(20)30232-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
548 van den Heuvel FMA, Vos JL, Koop Y, van Dijk APJ, Duijnhouwer AL, de Mast Q, van de Veerdonk FL, Bosch F, Kok B, Netea MG, Hoogerwerf J, Hoefsloot W, Tjwa ETTL, de Korte CL, van Kimmenade RRJ, Nijveldt R. Cardiac function in relation to myocardial injury in hospitalised patients with COVID-19. Neth Heart J 2020;28:410-7. [PMID: 32643071 DOI: 10.1007/s12471-020-01458-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
549 Venditto VJ, Haydar D, Abdel-Latif A, Gensel JC, Anstead MI, Pitts MG, Creameans J, Kopper TJ, Peng C, Feola DJ. Immunomodulatory Effects of Azithromycin Revisited: Potential Applications to COVID-19. Front Immunol 2021;12:574425. [PMID: 33643308 DOI: 10.3389/fimmu.2021.574425] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
550 Caputo ND, Strayer RJ, Levitan R. Early Self-Proning in Awake, Non-intubated Patients in the Emergency Department: A Single ED's Experience During the COVID-19 Pandemic. Acad Emerg Med 2020;27:375-8. [PMID: 32320506 DOI: 10.1111/acem.13994] [Cited by in Crossref: 232] [Cited by in F6Publishing: 189] [Article Influence: 116.0] [Reference Citation Analysis]
551 Wang Y, Chen L, Wang J, He X, Huang F, Chen J, Yang X. Electrocardiogram analysis of patients with different types of COVID-19. Ann Noninvasive Electrocardiol 2020;25:e12806. [PMID: 32951316 DOI: 10.1111/anec.12806] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
552 Schrijver B, Assmann JLJC, van Gammeren AJ, Vermeulen RCH, Portengen L, Heukels P, Langerak AW, Dik WA, van der Velden VHJ, Ermens TAAM. Extensive longitudinal immune profiling reveals sustained innate immune activation in COVID-19 patients with unfavorable outcome. Eur Cytokine Netw 2020;31:154-67. [PMID: 33648924 DOI: 10.1684/ecn.2020.0456] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
553 Choi JH, Park JH. Things You Should Know in the Performing Echocardiographic Examination in Patients with COVID-19. J Cardiovasc Imaging 2021;29:20-30. [PMID: 33511797 DOI: 10.4250/jcvi.2020.0128] [Reference Citation Analysis]
554 Şengül A, Mutlu P, Özdemir Ö, Satıcı C, Turan MO, Arslan S, Ogan N, Ekici Ünsal Z, Bozkuş F, Çapraz A, Demirkol MA, Mutlu LC, Yıldız Gülhan P, Alkılınç E, Fazlıoğlu N, Söyler Y, Kabalak PA, Özaydın D, Turan PA, Yıldırım F, Aydemir Y, Şen N, Mirici A. Characteristics of our hypoxemic COVID-19 pneumonia patients receiving corticosteroids and mortality-associated factors. Expert Rev Respir Med 2022. [PMID: 35839345 DOI: 10.1080/17476348.2022.2102480] [Reference Citation Analysis]
555 Tu C, Wang G, Geng Y, Guo N, Cui N, Liu J. Establishment of a Clinical Nomogram Model to Predict the Progression of COVID-19 to Severe Disease. Ther Clin Risk Manag 2021;17:553-61. [PMID: 34103920 DOI: 10.2147/TCRM.S308961] [Reference Citation Analysis]
556 Pérez-Gómez A, Vitallé J, Gasca-Capote C, Gutierrez-Valencia A, Trujillo-Rodriguez M, Serna-Gallego A, Muñoz-Muela E, Jiménez-Leon MLR, Rafii-El-Idrissi Benhnia M, Rivas-Jeremias I, Sotomayor C, Roca-Oporto C, Espinosa N, Infante-Domínguez C, Crespo-Rivas JC, Fernández-Villar A, Pérez-González A, López-Cortés LF, Poveda E, Ruiz-Mateos E; Virgen del Rocío Hospital COVID-19 Working Team. Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection. Cell Mol Immunol 2021. [PMID: 34290398 DOI: 10.1038/s41423-021-00728-2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
557 Boari GEM, Chiarini G, Bonetti S, Malerba P, Bianco G, Faustini C, Braglia-Orlandini F, Turini D, Guarinoni V, Saottini M, Viola S, Ferrari-Toninelli G, Pasini G, Mascadri C, Bonzi B, Desenzani P, Tusi C, Zanotti E, Nardin M, Rizzoni D. Prognostic factors and predictors of outcome in patients with COVID-19 and related pneumonia: a retrospective cohort study. Biosci Rep 2020;40:BSR20203455. [PMID: 33201172 DOI: 10.1042/BSR20203455] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
558 Zumla A, Wang FS, Ippolito G, Petrosillo N, Agrati C, Azhar EI, Chang C, El-Kafrawy SA, Osman M, Zitvogel L, Galle PR, Locatelli F, Gorman E, Cordon-Cardo C, O'Kane C, McAuley D, Maeurer M. Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy - Achieving global consensus and visibility for cellular host-directed therapies. Int J Infect Dis. 2020;96:431-439. [PMID: 32425638 DOI: 10.1016/j.ijid.2020.05.040] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
559 Wu Z, Liu X, Liu J, Zhu F, Liu Y, Liu Y, Peng H. Correlation between ground-glass opacity on pulmonary CT and the levels of inflammatory cytokines in patients with moderate-to-severe COVID-19 pneumonia. Int J Med Sci 2021;18:2394-400. [PMID: 33967617 DOI: 10.7150/ijms.56683] [Reference Citation Analysis]
560 Fabre JB, Grelot L, Vanbiervielt W, Mazerie J, Manca R, Martin V. Managing the combined consequences of COVID-19 infection and lock-down policies on athletes: narrative review and guidelines proposal for a safe return to sport. BMJ Open Sport Exerc Med 2020;6:e000849. [PMID: 33194223 DOI: 10.1136/bmjsem-2020-000849] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
561 An PJ, Zhu YZ, Yang LP. Biochemical indicators of coronavirus disease 2019 exacerbation and the clinical implications. Pharmacol Res 2020;159:104946. [PMID: 32450346 DOI: 10.1016/j.phrs.2020.104946] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
562 Shi L, Huang H, Lu X, Yan X, Jiang X, Xu R, Wang S, Zhang C, Yuan X, Xu Z, Huang L, Fu JL, Li Y, Zhang Y, Yao WQ, Liu T, Song J, Sun L, Yang F, Zhang X, Zhang B, Shi M, Meng F, Song Y, Yu Y, Wen J, Li Q, Mao Q, Maeurer M, Zumla A, Yao C, Xie WF, Wang FS. Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial. Signal Transduct Target Ther 2021;6:58. [PMID: 33568628 DOI: 10.1038/s41392-021-00488-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 28] [Article Influence: 20.0] [Reference Citation Analysis]
563 Biswas B, Chattopadhyay S, Hazra S, Hansda AK, Goswami R. COVID-19 pandemic: the delta variant, T-cell responses, and the efficacy of developing vaccines. Inflamm Res 2022. [PMID: 35292834 DOI: 10.1007/s00011-022-01555-5] [Reference Citation Analysis]
564 Caniglia JL, Asuthkar S, Tsung AJ, Guda MR, Velpula KK. Immunopathology of galectin-3: an increasingly promising target in COVID-19. F1000Res 2020;9:1078. [PMID: 33082935 DOI: 10.12688/f1000research.25979.2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
565 Xu Y, Liu S, Zhang Y, Zhi Y. Does hereditary angioedema make COVID-19 worse? World Allergy Organ J 2020;13:100454. [PMID: 32834893 DOI: 10.1016/j.waojou.2020.100454] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
566 Singh M, Bansal V, Feschotte C. A single-cell RNA expression map of human coronavirus entry factors. bioRxiv 2020:2020. [PMID: 32511375 DOI: 10.1101/2020.05.08.084806] [Cited by in Crossref: 17] [Cited by in F6Publishing: 2] [Article Influence: 8.5] [Reference Citation Analysis]
567 Shah VK, Firmal P, Alam A, Ganguly D, Chattopadhyay S. Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past. Front Immunol 2020;11:1949. [PMID: 32849654 DOI: 10.3389/fimmu.2020.01949] [Cited by in Crossref: 90] [Cited by in F6Publishing: 72] [Article Influence: 45.0] [Reference Citation Analysis]
568 Wang W, Chen J, Hu D, Pan P, Liang L, Wu W, Tang Y, Huang XR, Yu X, Wu J, Lan HY. SARS-CoV-2 N Protein Induces Acute Kidney Injury via Smad3-Dependent G1 Cell Cycle Arrest Mechanism. Adv Sci (Weinh) 2022;9:e2103248. [PMID: 34813685 DOI: 10.1002/advs.202103248] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
569 Abdelrahman Z, Li M, Wang X. Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses. Front Immunol 2020;11:552909. [PMID: 33013925 DOI: 10.3389/fimmu.2020.552909] [Cited by in Crossref: 59] [Cited by in F6Publishing: 48] [Article Influence: 29.5] [Reference Citation Analysis]
570 Eybpoosh S, Afshari M, Haghdoost AA, Afsar Kazerooni P, Gouya MM, Tayeri K. Severity and mortality of COVID-19 infection in HIV-infected individuals: Preliminary findings from Iran. Med J Islam Repub Iran 2021;35:33. [PMID: 34211935 DOI: 10.47176/mjiri.35.33] [Reference Citation Analysis]
571 Xiong L, Zang X, Feng G, Zhao F, Wang S, Zeng W, Yu K, Zhai Y. Clinical characteristics and peripheral immunocyte subsets alteration of 85 COVID-19 deaths. Aging (Albany NY) 2021;13:6289-97. [PMID: 33711813 DOI: 10.18632/aging.202819] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
572 Prete M, Favoino E, Catacchio G, Racanelli V, Perosa F. SARS-CoV-2 Inflammatory Syndrome. Clinical Features and Rationale for Immunological Treatment. Int J Mol Sci 2020;21:E3377. [PMID: 32397684 DOI: 10.3390/ijms21093377] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
573 Yang Z, Liu J, Zhou Y, Zhao X, Zhao Q. The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis. J Infect. 2020;81:e13-e20. [PMID: 32283144 DOI: 10.1016/j.jinf.2020.03.062] [Cited by in Crossref: 154] [Cited by in F6Publishing: 150] [Article Influence: 77.0] [Reference Citation Analysis]
574 Filograna L, Grassi S, Manenti G, Di Donna C, Tatulli D, Nardoni F, Masini V, Ausania F, Grassi VM, Floris R, Colosimo C, Arena V, Pascali VL, Oliva A. Postmortem CT pulmonary findings in SARS-CoV-2-positive cases: correlation with lung histopathological findings and autopsy results. Int J Legal Med. [DOI: 10.1007/s00414-022-02793-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
575 Körner RW, Majjouti M, Alcazar MAA, Mahabir E. Of Mice and Men: The Coronavirus MHV and Mouse Models as a Translational Approach to Understand SARS-CoV-2. Viruses 2020;12:E880. [PMID: 32806708 DOI: 10.3390/v12080880] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 10.5] [Reference Citation Analysis]
576 Rha MS, Kim AR, Shin EC. SARS-CoV-2-Specific T Cell Responses in Patients with COVID-19 and Unexposed Individuals. Immune Netw 2021;21:e2. [PMID: 33728095 DOI: 10.4110/in.2021.21.e2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
577 Shi Y, Wang G, Cai XP, Deng JW, Zheng L, Zhu HH, Zheng M, Yang B, Chen Z. An overview of COVID-19. J Zhejiang Univ Sci B 2020;21:343-60. [PMID: 32425000 DOI: 10.1631/jzus.B2000083] [Cited by in Crossref: 85] [Cited by in F6Publishing: 44] [Article Influence: 42.5] [Reference Citation Analysis]
578 Shao Z, Feng Y, Zhong L, Xie Q, Lei M, Liu Z, Wang C, Ji J, Liu H, Gu Z, Hu Z, Su L, Wu M, Liu Z. Clinical efficacy of intravenous immunoglobulin therapy in critical ill patients with COVID-19: a multicenter retrospective cohort study. Clin Transl Immunology 2020;9:e1192. [PMID: 33082954 DOI: 10.1002/cti2.1192] [Cited by in Crossref: 30] [Cited by in F6Publishing: 38] [Article Influence: 15.0] [Reference Citation Analysis]
579 Thimmulappa RK, Mudnakudu-Nagaraju KK, Shivamallu C, Subramaniam KJT, Radhakrishnan A, Bhojraj S, Kuppusamy G. Antiviral and immunomodulatory activity of curcumin: A case for prophylactic therapy for COVID-19. Heliyon 2021;7:e06350. [PMID: 33655086 DOI: 10.1016/j.heliyon.2021.e06350] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 14.0] [Reference Citation Analysis]
580 Burgoyne RA, Fisher AJ, Borthwick LA. The Role of Epithelial Damage in the Pulmonary Immune Response. Cells 2021;10:2763. [PMID: 34685744 DOI: 10.3390/cells10102763] [Reference Citation Analysis]
581 Wei F, Kong D, Li T, Li A, Tan Y, Fang J, Zhuang X, Lai C, Xu W, Dong H, Ma C, Hong K, Cui Y, Tang S, Yu F, Zheng C. Efficacy and safety of umbilical cord mesenchymal stem cells for the treatment of patients with COVID-19. Clinics (Sao Paulo) 2021;76:e2604. [PMID: 34008772 DOI: 10.6061/clinics/2021/e2604] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
582 Sarin SK. "Fast, faster, and fastest: science on the run during COVID-19 drama"-"do not forget the liver". Hepatol Int. 2020;14:454-455. [PMID: 32277386 DOI: 10.1007/s12072-020-10042-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
583 Garcia G Jr, Sharma A, Ramaiah A, Sen C, Purkayastha A, Kohn DB, Parcells MS, Beck S, Kim H, Bakowski MA, Kirkpatrick MG, Riva L, Wolff KC, Han B, Yuen C, Ulmert D, Purbey PK, Scumpia P, Beutler N, Rogers TF, Chatterjee AK, Gabriel G, Bartenschlager R, Gomperts B, Svendsen CN, Betz UAK, Damoiseaux RD, Arumugaswami V. Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication. Cell Rep 2021;35:108940. [PMID: 33784499 DOI: 10.1016/j.celrep.2021.108940] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
584 Cao J, Cai X, Chen M. Liver Injury in COVID-19: Caution and Management. Liver Cancer. 2020;9:625-626. [PMID: 33083285 DOI: 10.1159/000508696] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
585 Bellan M, Soddu D, Balbo PE, Baricich A, Zeppegno P, Avanzi GC, Baldon G, Bartolomei G, Battaglia M, Battistini S, Binda V, Borg M, Cantaluppi V, Castello LM, Clivati E, Cisari C, Costanzo M, Croce A, Cuneo D, De Benedittis C, De Vecchi S, Feggi A, Gai M, Gambaro E, Gattoni E, Gramaglia C, Grisafi L, Guerriero C, Hayden E, Jona A, Invernizzi M, Lorenzini L, Loreti L, Martelli M, Marzullo P, Matino E, Panero A, Parachini E, Patrucco F, Patti G, Pirovano A, Prosperini P, Quaglino R, Rigamonti C, Sainaghi PP, Vecchi C, Zecca E, Pirisi M. Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge. JAMA Netw Open 2021;4:e2036142. [PMID: 33502487 DOI: 10.1001/jamanetworkopen.2020.36142] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 49.0] [Reference Citation Analysis]
586 Xiang Y, Yang Q, Sun H, Qin X, Li X, Zhang Q. [Chest CT findings and their dynamic changes in patients with COVID-19]. Nan Fang Yi Ke Da Xue Xue Bao 2020;40:327-32. [PMID: 32376589 DOI: 10.12122/j.issn.1673-4254.2020.03.05] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
587 Chen M, Tu C, Tan C, Zheng X, Sun F, Liang Y, Shi H, Wu J, Huang Y, Wang Z, Wang K, Lin M, Wu W, Zhou H, Liu J, Huang J. Hypersensitivity in the lungs is responsible for acute respiratory failure in COVID-19 patients: Case series of patients who received high-dose/short-term methylprednisolone. Clin Transl Allergy 2021;11:e12056. [PMID: 34484687 DOI: 10.1002/clt2.12056] [Reference Citation Analysis]
588 Hong W, Chen Q, Qian S, Basharat Z, Zimmer V, Wang Y, Zippi M, Pan J. Critically Ill vs. Non-Critically Ill Patients With COVID-19 Pneumonia: Clinical Features, Laboratory Findings, and Prediction. Front Cell Infect Microbiol 2021;11:550456. [PMID: 34327146 DOI: 10.3389/fcimb.2021.550456] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
589 Chen C, Lin S, Shen C, Hsieh K, Cheng C. Biomarkers during COVID-19: Mechanisms of Change and Implications for Patient Outcomes. Diagnostics 2022;12:509. [DOI: 10.3390/diagnostics12020509] [Reference Citation Analysis]
590 Adamo S, Chevrier S, Cervia C, Zurbuchen Y, Raeber ME, Yang L, Sivapatham S, Jacobs A, Baechli E, Rudiger A, Stüssi-Helbling M, Huber LC, Schaer DJ, Bodenmiller B, Boyman O, Nilsson J. Profound dysregulation of T cell homeostasis and function in patients with severe COVID-19. Allergy 2021;76:2866-81. [PMID: 33884644 DOI: 10.1111/all.14866] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 24.0] [Reference Citation Analysis]
591 Pfeifer M, Hamer OW. [COVID-19 pneumonia]. Internist (Berl) 2020;61:793-803. [PMID: 32728817 DOI: 10.1007/s00108-020-00854-5] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
592 Pezel T, Lima JAC. The potential sudden shift in clinical research and epidemiology of cardiovascular diseases, caused by COVID-19. Arch Cardiovasc Dis 2020;113:378-80. [PMID: 32586675 DOI: 10.1016/j.acvd.2020.05.001] [Reference Citation Analysis]
593 Li X, Pan X, Li Y, An N, Xing Y, Yang F, Tian L, Sun J, Gao Y, Shang H, Xing Y. Cardiac injury associated with severe disease or ICU admission and death in hospitalized patients with COVID-19: a meta-analysis and systematic review. Crit Care. 2020;24:468. [PMID: 32723362 DOI: 10.1186/s13054-020-03183-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
594 Shirani K, Sheikhbahaei E, Torkpour Z, Ghadiri Nejad M, Kamyab Moghadas B, Ghasemi M, Akbari Aghdam H, Ehsani A, Saber-Samandari S, Khandan A. A Narrative Review of COVID-19: The New Pandemic Disease. Iran J Med Sci 2020;45:233-49. [PMID: 32801413 DOI: 10.30476/ijms.2020.85869.1549] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
595 Zou H, Li SQ. Pulmonary fibrosis in critically ill patients with novel coronavirus pneumonia during the convalescent stage and a proposal for early intervention. Acta Pharmacol Sin 2021;42:1376-8. [PMID: 33188277 DOI: 10.1038/s41401-020-00566-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
596 Kgatle MM, Lawal IO, Mashabela G, Boshomane TMG, Koatale PC, Mahasha PW, Ndlovu H, Vorster M, Rodrigues HG, Zeevaart JR, Gordon S, Moura-Alves P, Sathekge MM. COVID-19 Is a Multi-Organ Aggressor: Epigenetic and Clinical Marks. Front Immunol 2021;12:752380. [PMID: 34691068 DOI: 10.3389/fimmu.2021.752380] [Reference Citation Analysis]
597 Dai MY, Chen Z, Leng Y, Wu M, Liu Y, Zhou F, Ming C, Shao N, Liu M, Cai H. Patients With Lung Cancer Have High Susceptibility of COVID-19: A Retrospective Study in Wuhan, China. Cancer Control 2020;27:1073274820960467. [PMID: 32938231 DOI: 10.1177/1073274820960467] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
598 Yadav AK, Verma D, Kumar A, Kumar P, Solanki PR. The perspectives of biomarker-based electrochemical immunosensors, artificial intelligence and the Internet of Medical Things toward COVID-19 diagnosis and management. Mater Today Chem 2021;20:100443. [PMID: 33615086 DOI: 10.1016/j.mtchem.2021.100443] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
599 Feng C, Wang L, Chen X, Zhai Y, Zhu F, Chen H, Wang Y, Su X, Huang S, Tian L, Zhu W, Sun W, Zhang L, Han Q, Zhang J, Pan F, Chen L, Zhu Z, Xiao H, Liu Y, Liu G, Chen W, Li T. A novel artificial intelligence-assisted triage tool to aid in the diagnosis of suspected COVID-19 pneumonia cases in fever clinics. Ann Transl Med 2021;9:201. [PMID: 33708828 DOI: 10.21037/atm-20-3073] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
600 Papa A, Di Dato MT, Buonavolonta P, Saracco E, Salzano AM, Casale B. Clinical Management of Il-6 Driven Cytokine Storm Related to COVID-19 in a Patient with Recent Spinal Cord Stimulator Implants: A Case Report. Anesth Pain Med 2020;10:e104151. [PMID: 33134148 DOI: 10.5812/aapm.104151] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
601 Zhao J, Zhou H, Huang W, Zhou J, Qiu M, Deng Z, Chen L, Weng Y, Cai L, Gu Y, Zheng Q, Chen Q, Hou X, Wang L, Shen L, Yang Z. Cell morphological analysis of SARS-CoV-2 infection by transmission electron microscopy. J Thorac Dis 2020;12:4368-73. [PMID: 32944349 DOI: 10.21037/jtd-20-1368] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
602 He F, Luo Q, Lei M, Fan L, Shao X, Hu K, Qin S, Yu N, Cao J, Yang L. Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review. Clin Rheumatol 2020;39:2803-10. [PMID: 32725351 DOI: 10.1007/s10067-020-05230-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
603 Ni Y, Zeng H, Song X, Zheng J, Wu H, Liu C, Zhang Y. Potential metal-related strategies for prevention and treatment of COVID-19. Rare Met . [DOI: 10.1007/s12598-021-01894-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
604 Torres T, Puig L. Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic. Am J Clin Dermatol 2020;21:307-11. [PMID: 32277351 DOI: 10.1007/s40257-020-00514-2] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 22.0] [Reference Citation Analysis]
605 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
606 Long Q, Li J, Hu X, Bai Y, Zheng Y, Gao Z. Follow-Ups on Persistent Symptoms and Pulmonary Function Among Post-Acute COVID-19 Patients: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2021;8:702635. [PMID: 34540862 DOI: 10.3389/fmed.2021.702635] [Reference Citation Analysis]
607 Juul S, Nielsen EE, Feinberg J, Siddiqui F, Jørgensen CK, Barot E, Nielsen N, Bentzer P, Veroniki AA, Thabane L, Bu F, Klingenberg S, Gluud C, Jakobsen JC. Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project). PLoS Med 2020;17:e1003293. [PMID: 32941437 DOI: 10.1371/journal.pmed.1003293] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 15.0] [Reference Citation Analysis]
608 Shao MJ, Shang LX, Luo JY, Shi J, Zhao Y, Li XM, Yang YN. Myocardial injury is associated with higher mortality in patients with coronavirus disease 2019: a meta-analysis. J Geriatr Cardiol 2020;17:224-8. [PMID: 32362922 DOI: 10.11909/j.issn.1671-5411.2020.04.009] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
609 Miranda MNS, Pingarilho M, Pimentel V, Torneri A, Seabra SG, Libin PJK, Abecasis AB. A Tale of Three Recent Pandemics: Influenza, HIV and SARS-CoV-2. Front Microbiol 2022;13:889643. [PMID: 35722303 DOI: 10.3389/fmicb.2022.889643] [Reference Citation Analysis]
610 Jaiswal KB, Meenpal T. rPPG-FuseNet: Non-contact heart rate estimation from facial video via RGB/MSR signal fusion. Biomedical Signal Processing and Control 2022;78:104002. [DOI: 10.1016/j.bspc.2022.104002] [Reference Citation Analysis]
611 Norouzi M, Norouzi S, Ruggiero A, Khan MS, Myers S, Kavanagh K, Vemuri R. Type-2 Diabetes as a Risk Factor for Severe COVID-19 Infection. Microorganisms 2021;9:1211. [PMID: 34205044 DOI: 10.3390/microorganisms9061211] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
612 Otifi HM, Adiga BK. Endothelial Dysfunction in Covid-19. The American Journal of the Medical Sciences 2022. [DOI: 10.1016/j.amjms.2021.12.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
613 Bhat SA, Sher F, Kumar R, Karahmet E, Haq SAU, Zafar A, Lima EC. Environmental and health impacts of spraying COVID-19 disinfectants with associated challenges. Environ Sci Pollut Res Int 2021. [PMID: 34599438 DOI: 10.1007/s11356-021-16575-7] [Reference Citation Analysis]
614 Zhao Y, Qin L, Zhang P, Li K, Liang L, Sun J, Xu B, Dai Y, Li X, Zhang C, Peng Y, Feng Y, Li A, Hu Z, Xiang H, Ogg G, Ho LP, McMichael A, Jin R, Knight JC, Dong T, Zhang Y. Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease. JCI Insight. 2020;5. [PMID: 32501293 DOI: 10.1172/jci.insight.139834] [Cited by in Crossref: 89] [Cited by in F6Publishing: 91] [Article Influence: 44.5] [Reference Citation Analysis]
615 Raja RK, Nguyen-Tri P, Balasubramani G, Alagarsamy A, Hazir S, Ladhari S, Saidi A, Pugazhendhi A, Samy AA. SARS-CoV-2 and its new variants: a comprehensive review on nanotechnological application insights into potential approaches. Appl Nanosci 2021;:1-29. [PMID: 34131555 DOI: 10.1007/s13204-021-01900-w] [Reference Citation Analysis]
616 Ye R, Zhou X, Shao F, Xiong L, Hong J, Huang H, Tong W, Wang J, Chen S, Cui A, Peng C, Zhao Y, Chen L. Feasibility of a 5G-Based Robot-Assisted Remote Ultrasound System for Cardiopulmonary Assessment of Patients With Coronavirus Disease 2019. Chest 2021;159:270-81. [PMID: 32653568 DOI: 10.1016/j.chest.2020.06.068] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
617 Bordallo B, Bellas M, Cortez AF, Vieira M, Pinheiro M. Severe COVID-19: what have we learned with the immunopathogenesis? Adv Rheumatol 2020;60:50. [PMID: 32962761 DOI: 10.1186/s42358-020-00151-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
618 Ting C, Aspal M, Vaishampayan N, Huang SK, Riemondy KA, Wang F, Farver C, Zemans RL. Fatal COVID-19 and Non-COVID-19 Acute Respiratory Distress Syndrome Is Associated with Incomplete Alveolar Type 1 Epithelial Cell Differentiation from the Transitional State without Fibrosis. Am J Pathol 2022;192:454-67. [PMID: 34973949 DOI: 10.1016/j.ajpath.2021.11.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
619 Yang G, Feng F, Li X, Zhang T, Li X, Li B. Changes of lymphocyte subsets in patients with COVID-19 and clinical significance: a case-control observational study. Journal of Bio-X Research 2021;4:36-9. [DOI: 10.1097/jbr.0000000000000089] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
620 You M, Wang W, Li Y, Liu J, Xu X, Qiu Z. Automatic cough detection from realistic audio recordings using C-BiLSTM with boundary regression. Biomedical Signal Processing and Control 2022;72:103304. [DOI: 10.1016/j.bspc.2021.103304] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
621 Buchrieser J, Dufloo J, Hubert M, Monel B, Planas D, Rajah MM, Planchais C, Porrot F, Guivel-Benhassine F, Van der Werf S, Casartelli N, Mouquet H, Bruel T, Schwartz O. Syncytia formation by SARS-CoV-2-infected cells. EMBO J 2020;39:e106267. [PMID: 33051876 DOI: 10.15252/embj.2020106267] [Cited by in Crossref: 72] [Cited by in F6Publishing: 70] [Article Influence: 36.0] [Reference Citation Analysis]
622 Erdem HA, Korkma PE, Çağlayan D, Işıkgöz Taşbakan M, Yamazhan T, Taşbakan MS, Sayıner A, Gökengin D. Treatment of SARS-CoV-2 pneumonia with favipiravir: early results from the Ege University cohort, Turkey. Turk J Med Sci 2021;51:912-20. [PMID: 33237663 DOI: 10.3906/sag-2008-33] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
623 Wu Y, Li H, Guo X, Yoshida EM, Mendez-Sanchez N, Levi Sandri GB, Teschke R, Romeiro FG, Shukla A, Qi X. Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients: a systematic review and meta-analysis. Hepatol Int 2020;14:621-37. [PMID: 32710250 DOI: 10.1007/s12072-020-10074-6] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 27.5] [Reference Citation Analysis]
624 Fang S, Wang H, Lu L, Jia Y, Xia Z. Decreased complement C3 levels are associated with poor prognosis in patients with COVID-19: A retrospective cohort study. Int Immunopharmacol 2020;89:107070. [PMID: 33039965 DOI: 10.1016/j.intimp.2020.107070] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
625 Sandoval Y, Januzzi JL Jr, Jaffe AS. Cardiac Troponin for Assessment of Myocardial Injury in COVID-19: JACC Review Topic of the Week. J Am Coll Cardiol 2020;76:1244-58. [PMID: 32652195 DOI: 10.1016/j.jacc.2020.06.068] [Cited by in Crossref: 100] [Cited by in F6Publishing: 88] [Article Influence: 50.0] [Reference Citation Analysis]
626 Tung ML, Tan B, Cherian R, Chandra B. Anti-phospholipid syndrome and COVID-19 thrombosis: connecting the dots. Rheumatol Adv Pract 2021;5:rkaa081. [PMID: 33615129 DOI: 10.1093/rap/rkaa081] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
627 Chen J, Wang W, Tang Y, Huang XR, Yu X, Lan HY. Inflammatory stress in SARS-COV-2 associated Acute Kidney Injury. Int J Biol Sci 2021;17:1497-506. [PMID: 33907513 DOI: 10.7150/ijbs.58791] [Reference Citation Analysis]
628 De Rossi N, Scarpazza C, Filippini C, Cordioli C, Rasia S, Mancinelli CR, Rizzoni D, Romanelli G, Cossi S, Vettoretto N, Bove S, Manfredini S, Beindorf EA, Mosca C, Scipione V, Flamminio G, Albini EA, Giansiracusa P, Capra R; Montichiari COVID-19 Study Group. Early use of low dose tocilizumab in patients with COVID-19: A retrospective cohort study with a complete follow-up. EClinicalMedicine 2020;25:100459. [PMID: 32838235 DOI: 10.1016/j.eclinm.2020.100459] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 18.5] [Reference Citation Analysis]
629 Haddadin FI, Mahdawi TE, Hattar L, Beydoun H, Fram F, Homoud M. A case of complete heart block in a COVID-19 infected patient. J Cardiol Cases 2021;23:27-30. [PMID: 32904735 DOI: 10.1016/j.jccase.2020.08.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
630 Gupta AK, Leslie A, Hewitt JN, Kovoor JG, Ovenden CD, Edwards S, Chan JCY, Worthington MG. Cardiac surgery on patients with COVID-19: a systematic review and meta-analysis. ANZ J Surg 2022. [PMID: 35373439 DOI: 10.1111/ans.17667] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
631 Sridhar S, Nicholls J. Pathophysiology of infection with SARS-CoV-2-What is known and what remains a mystery. Respirology 2021;26:652-65. [PMID: 34041821 DOI: 10.1111/resp.14091] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
632 Mendoza-Pinto C, García-Carrasco M, Munguía Realpozo P, Méndez-Martínez S. Therapeutic options for the management of severe COVID-19: A rheumatology perspective. Reumatol Clin (Engl Ed) 2021;17:431-6. [PMID: 34625144 DOI: 10.1016/j.reumae.2020.05.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
633 Morand A, Roquelaure B, Colson P, Amrane S, Bosdure E, Raoult D, Lagier JC, Fabre A. Child with liver transplant recovers from COVID-19 infection. A case report. Arch Pediatr 2020;27:275-6. [PMID: 32402433 DOI: 10.1016/j.arcped.2020.05.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
634 Xu J, Liang Z, Jian W, Li J, Tang G, Mo X, Zhang D, Zheng J, Qian Y, Liu J, Li S. Changes of quantitative CT-based airway wall dimensions in patients with COVID-19 during early recovery. J Thorac Dis 2021;13:1517-30. [PMID: 33841944 DOI: 10.21037/jtd-20-2790] [Reference Citation Analysis]
635 Yang H, Lu S. COVID-19 and Tuberculosis. J Transl Int Med 2020;8:59-65. [PMID: 32983927 DOI: 10.2478/jtim-2020-0010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
636 Nikolich-Zugich J, Knox KS, Rios CT, Natt B, Bhattacharya D, Fain MJ. SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes. Geroscience. 2020;42:505-514. [PMID: 32274617 DOI: 10.1007/s11357-020-00186-0] [Cited by in Crossref: 196] [Cited by in F6Publishing: 181] [Article Influence: 98.0] [Reference Citation Analysis]
637 Ascierto PA, Fu B, Wei H. IL-6 modulation for COVID-19: the right patients at the right time? J Immunother Cancer 2021;9:e002285. [PMID: 33837054 DOI: 10.1136/jitc-2020-002285] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
638 Megiorni F, Pontecorvi P, Gerini G, Anastasiadou E, Marchese C, Ceccarelli S. Sex-Related Factors in Cardiovascular Complications Associated to COVID-19. Biomolecules 2022;12:21. [DOI: 10.3390/biom12010021] [Reference Citation Analysis]
639 Fan Z, Chen L, Li J, Cheng X, Yang J, Tian C, Zhang Y, Huang S, Liu Z, Cheng J. Clinical Features of COVID-19-Related Liver Functional Abnormality. Clin Gastroenterol Hepatol. 2020;18:1561-1566. [PMID: 32283325 DOI: 10.1016/j.cgh.2020.04.002]available] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
640 Paland N, Pechkovsky A, Aswad M, Hamza H, Popov T, Shahar E, Louria-Hayon I. The Immunopathology of COVID-19 and the Cannabis Paradigm. Front Immunol 2021;12:631233. [PMID: 33643316 DOI: 10.3389/fimmu.2021.631233] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
641 Chakraborty J, Maity A, Sarkar H. A systematic drug repurposing approach to identify promising inhibitors from FDA-approved drugs against Nsp4 protein of SARS-CoV-2. J Biomol Struct Dyn 2021;:1-10. [PMID: 34844509 DOI: 10.1080/07391102.2021.2009033] [Reference Citation Analysis]
642 Rajput R, Sharma J. SARS-CoV-2 in Pregnancy: Fitting Into the Existing Viral Repertoire. Front Glob Womens Health 2021;2:647836. [PMID: 34816202 DOI: 10.3389/fgwh.2021.647836] [Reference Citation Analysis]
643 Zhan Z, Yang X, Du H, Zhang C, Song Y, Ran X, Zhang A, Yang M. Early Improvement of Acute Respiratory Distress Syndrome in Patients With COVID-19 in the Intensive Care Unit: Retrospective Analysis. JMIR Public Health Surveill 2021;7:e24843. [PMID: 33630743 DOI: 10.2196/24843] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
644 Mitra R, Moore SA, Gillespie M, Faulkner G, Vanderloo LM, Chulak-Bozzer T, Rhodes RE, Brussoni M, Tremblay MS. Healthy movement behaviours in children and youth during the COVID-19 pandemic: Exploring the role of the neighbourhood environment. Health Place 2020;65:102418. [PMID: 32871499 DOI: 10.1016/j.healthplace.2020.102418] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 14.5] [Reference Citation Analysis]
645 Zanframundo G, Graziani A, Barbara C, Francesco P, Teresa MM, Cristian C, Pierluigi G, Ludovico D. Resolution of pulmonary artery thrombosis in patients with moderate COVID-19 disease. J Community Hosp Intern Med Perspect 2021;11:470-2. [PMID: 34211650 DOI: 10.1080/20009666.2021.1921908] [Reference Citation Analysis]
646 Reddy KR. SARS-CoV-2 and the Liver: Considerations in Hepatitis B and Hepatitis C Infections. Clin Liver Dis (Hoboken) 2020;15:191-4. [PMID: 32489654 DOI: 10.1002/cld.970] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
647 Khedmat L, Mohaghegh P, Veysizadeh M, Hosseinkhani A, Fayazi S, Mirzadeh M. Pregnant women and infants against the infection risk of COVID-19: a review of prenatal and postnatal symptoms, clinical diagnosis, adverse maternal and neonatal outcomes, and available treatments. Arch Gynecol Obstet. [DOI: 10.1007/s00404-021-06325-y] [Reference Citation Analysis]
648 Ancochea J, Soriano JB. COPD in Spain at the Start of a New Decade. Arch Bronconeumol (Engl Ed) 2021;57:1-2. [PMID: 32204954 DOI: 10.1016/j.arbres.2020.01.025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
649 John AE, Joseph C, Jenkins G, Tatler AL. COVID-19 and pulmonary fibrosis: A potential role for lung epithelial cells and fibroblasts. Immunol Rev 2021;302:228-40. [PMID: 34028807 DOI: 10.1111/imr.12977] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
650 Lamers MM, van der Vaart J, Knoops K, Riesebosch S, Breugem TI, Mykytyn AZ, Beumer J, Schipper D, Bezstarosti K, Koopman CD, Groen N, Ravelli RBG, Duimel HQ, Demmers JAA, Verjans GMGM, Koopmans MPG, Muraro MJ, Peters PJ, Clevers H, Haagmans BL. An organoid-derived bronchioalveolar model for SARS-CoV-2 infection of human alveolar type II-like cells. EMBO J 2021;40:e105912. [PMID: 33283287 DOI: 10.15252/embj.2020105912] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 22.0] [Reference Citation Analysis]
651 Arora P, Sidarovich A, Krüger N, Kempf A, Nehlmeier I, Graichen L, Moldenhauer AS, Winkler MS, Schulz S, Jäck HM, Stankov MV, Behrens GMN, Pöhlmann S, Hoffmann M. B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination. Cell Rep 2021;37:109825. [PMID: 34614392 DOI: 10.1016/j.celrep.2021.109825] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
652 Bonny V, Maillard A, Mousseaux C, Plaçais L, Richier Q. [COVID-19: Pathogenesis of a multi-faceted disease]. Rev Med Interne 2020;41:375-89. [PMID: 32507520 DOI: 10.1016/j.revmed.2020.05.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
653 Zhong M, Sun A, Xiao T, Yao G, Sang L, Zheng X, Zhang J, Jin X, Xu L, Yang W, Wang P, Hu K, Zhang D, Ge J. A Randomized, Single-Blind, Group Sequential, Active-Controlled Study to Evaluate the Clinical Efficacy and Safety of α-Lipoic Acid for Critically Ill Patients With Coronavirus Disease 2019 (COVID-19). Front Med 2022;8:566609. [DOI: 10.3389/fmed.2021.566609] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
654 Filograna L, Manenti G, Ampanozi G, Calcagni A, Ryan CP, Floris R, Thali MJ. Potentials of post-mortem CT investigations during SARS-COV-2 pandemic: a narrative review. Radiol med. [DOI: 10.1007/s11547-022-01457-w] [Reference Citation Analysis]
655 Junaid K, Ejaz H, Abdalla AE, Abosalif KOA, Ullah MI, Yasmeen H, Younas S, Hamam SSM, Rehman A. Effective Immune Functions of Micronutrients against SARS-CoV-2. Nutrients 2020;12:E2992. [PMID: 33003648 DOI: 10.3390/nu12102992] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
656 Shalash AO, Hussein WM, Skwarczynski M, Toth I. Key Considerations for the Development of Safe and Effective SARS-CoV-2 Subunit Vaccine: A Peptide-Based Vaccine Alternative. Adv Sci (Weinh) 2021;8:e2100985. [PMID: 34176237 DOI: 10.1002/advs.202100985] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
657 Xu Y, Yang X, Bian H, Xia M. Metabolic dysfunction associated fatty liver disease and coronavirus disease 2019: clinical relationship and current management. Lipids Health Dis 2021;20:126. [PMID: 34602072 DOI: 10.1186/s12944-021-01564-z] [Reference Citation Analysis]
658 Nasiri R, Akbarpour S, Zali AR, Khodakarami N, Boochani MH, Noory AR, Soori H. Spatio-temporal analysis of COVID-19 incidence rate using GIS: a case study-Tehran metropolitan, Iran. GeoJournal 2021;:1-15. [PMID: 33994652 DOI: 10.1007/s10708-021-10438-x] [Reference Citation Analysis]
659 Zhan Q, Wang W, Ding X. Examination of Potential of Thermopile-Based Contactless Respiratory Gating. Sensors (Basel) 2021;21:5525. [PMID: 34450966 DOI: 10.3390/s21165525] [Reference Citation Analysis]
660 Sultan S, Lim JK, Altayar O, Davitkov P, Feuerstein JD, Siddique SM, Falck-Ytter Y, El-Serag HB; AGA Institute. Electronic address: ewilson@gastro.org. AGA Rapid Recommendations for Gastrointestinal Procedures During the COVID-19 Pandemic. Gastroenterology 2020;159:739-758.e4. [PMID: 32247018 DOI: 10.1053/j.gastro.2020.03.072] [Cited by in Crossref: 161] [Cited by in F6Publishing: 126] [Article Influence: 80.5] [Reference Citation Analysis]
661 Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, Wang T, Zhang X, Chen H, Yu H, Zhang M, Wu S, Song J, Chen T, Han M, Li S, Luo X, Zhao J, Ning Q. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130:2620-2629. [PMID: 32217835 DOI: 10.1172/jci137244] [Cited by in Crossref: 1925] [Cited by in F6Publishing: 1406] [Article Influence: 962.5] [Reference Citation Analysis]
662 Chen H, Zhang L, Zhang W, Liu L, Dai Z, Chen M, Zhang D. Blood Purification in Severe and Critical COVID-19 Patients: A Case Series of 5 Patients. Front Public Health 2021;9:741125. [PMID: 34869156 DOI: 10.3389/fpubh.2021.741125] [Reference Citation Analysis]
663 Zhou T, Su TT, Mudianto T, Wang J. Immune asynchrony in COVID-19 pathogenesis and potential immunotherapies. J Exp Med 2020;217:e20200674. [PMID: 32910820 DOI: 10.1084/jem.20200674] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 13.5] [Reference Citation Analysis]
664 Ciuca IM. COVID-19 in Children: An Ample Review. Risk Manag Healthc Policy 2020;13:661-9. [PMID: 32636686 DOI: 10.2147/RMHP.S257180] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 9.5] [Reference Citation Analysis]
665 Kumar A, Sharma A, Tirpude NV, Sharma S, Padwad YS, Kumar S. Pharmaco-immunomodulatory interventions for averting cytokine storm-linked disease severity in SARS-CoV-2 infection. Inflammopharmacol. [DOI: 10.1007/s10787-021-00903-x] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
666 Samson M, Nicolas B, Guilhem A, Greigert H, Ciudad M, Cladiere C, Straub C, Blot M, Piroth L, Rogier T, Devilliers H, Manckoundia P, Ghesquiere T, Francois S, Lakomy D, Audia S, Bonnotte B. T-cell immune response predicts the risk of critical SARS-Cov2 infection in hospitalized COVID-19 patients. European Journal of Internal Medicine 2022. [DOI: 10.1016/j.ejim.2022.06.001] [Reference Citation Analysis]
667 Lanzoni G, Linetsky E, Correa D, Alvarez RA, Marttos A, Hirani K, Cayetano SM, Castro JG, Paidas MJ, Efantis Potter J, Xu X, Glassberg M, Tan J, Patel AN, Goldstein B, Kenyon NS, Baidal D, Alejandro R, Vianna R, Ruiz P, Caplan AI, Ricordi C. Umbilical Cord-derived Mesenchymal Stem Cells for COVID-19 Patients with Acute Respiratory Distress Syndrome (ARDS). CellR4 Repair Replace Regen Reprogram 2020;8:e2839. [PMID: 34164564 DOI: 10.32113/cellr4_20204_2839] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
668 Bakhshwin D, Alotaibi M, Ali AS, Althomali A, Alsuwat A, Alhamyani A, Alwathnani A, Alsaggaf S, Alrafiah A. Mortality Predictors Among COVID-19 Elderly in Taif, Saudi Arabia. Infect Drug Resist 2022;15:3213-23. [PMID: 35754783 DOI: 10.2147/IDR.S364279] [Reference Citation Analysis]
669 Zhang Y, Chen X, Jia L, Zhang Y. Potential mechanism of SARS-CoV-2-associated central and peripheral nervous system impairment. Acta Neurol Scand 2022. [PMID: 35699161 DOI: 10.1111/ane.13657] [Reference Citation Analysis]
670 Tahvildari A, Arbabi M, Farsi Y, Jamshidi P, Hasanzadeh S, Calcagno TM, Nasiri MJ, Mirsaeidi M. Clinical Features, Diagnosis, and Treatment of COVID-19 in Hospitalized Patients: A Systematic Review of Case Reports and Case Series. Front Med (Lausanne) 2020;7:231. [PMID: 32574328 DOI: 10.3389/fmed.2020.00231] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 11.0] [Reference Citation Analysis]
671 Yu WL, Toh HS, Liao CT, Chang WT. Cardiovascular Complications of COVID-19 and Associated Concerns: A Review. Acta Cardiol Sin 2021;37:9-17. [PMID: 33488023 DOI: 10.6515/ACS.202101_37(1).20200913A] [Reference Citation Analysis]
672 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
673 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
674 Zheng HY, He XY, Li W, Song TZ, Han JB, Yang X, Liu FL, Luo RH, Tian RR, Feng XL, Ma YH, Liu C, Li MH, Zheng YT. Pro-inflammatory microenvironment and systemic accumulation of CXCR3+ cell exacerbate lung pathology of old rhesus macaques infected with SARS-CoV-2. Signal Transduct Target Ther 2021;6:328. [PMID: 34471088 DOI: 10.1038/s41392-021-00734-w] [Reference Citation Analysis]
675 Fancellu A, Sanna V, Scognamillo F, Feo CF, Vidili G, Nigri G, Porcu A. Surgical treatment of hepatocellular carcinoma in the era of COVID-19 pandemic: A comprehensive review of current recommendations. World J Clin Cases 2021; 9(15): 3517-3530 [PMID: 34046452 DOI: 10.12998/wjcc.v9.i15.3517] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
676 Peddapalli A, Gehani M, Kalle AM, Peddapalli SR, Peter AE, Sharad S. Demystifying Excess Immune Response in COVID-19 to Reposition an Orphan Drug for Down-Regulation of NF-κB: A Systematic Review. Viruses 2021;13:378. [PMID: 33673529 DOI: 10.3390/v13030378] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
677 Gupta A, Marzook H, Ahmad F. Comorbidities and clinical complications associated with SARS-CoV-2 infection: an overview. Clin Exp Med 2022. [PMID: 35362771 DOI: 10.1007/s10238-022-00821-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
678 Abiri R, Abdul-Hamid H, Sytar O, Abiri R, Bezerra de Almeida E Jr, Sharma SK, Bulgakov VP, Arroo RRJ, Malik S. A Brief Overview of Potential Treatments for Viral Diseases Using Natural Plant Compounds: The Case of SARS-Cov. Molecules 2021;26:3868. [PMID: 34202844 DOI: 10.3390/molecules26133868] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
679 Sarker MT, Hasan AQF, Rafi MO, Hossain MJ, El-mageed HRA, Elsapagh RM, Capasso R, Emran TB. A Comprehensive Overview of the Newly Emerged COVID-19 Pandemic: Features, Origin, Genomics, Epidemiology, Treatment, and Prevention. Biologics 2021;1:357-83. [DOI: 10.3390/biologics1030021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
680 Zhou M, Xu J, Liao T, Yin Z, Yang F, Wang K, Wang Z, Yang D, Wang S, Peng Y, Peng S, Wu F, Chen L, Jin Y. Comparison of Residual Pulmonary Abnormalities 3 Months After Discharge in Patients Who Recovered From COVID-19 of Different Severity. Front Med (Lausanne) 2021;8:682087. [PMID: 34249973 DOI: 10.3389/fmed.2021.682087] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
681 Ebisudani T, Sugimoto S, Haga K, Mitsuishi A, Takai-Todaka R, Fujii M, Toshimitsu K, Hamamoto J, Sugihara K, Hishida T, Asamura H, Fukunaga K, Yasuda H, Katayama K, Sato T. Direct derivation of human alveolospheres for SARS-CoV-2 infection modeling and drug screening. Cell Rep 2021;35:109218. [PMID: 34038715 DOI: 10.1016/j.celrep.2021.109218] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
682 Du RH, Liu LM, Yin W, Wang W, Guan LL, Yuan ML, Li YL, Hu Y, Li XY, Sun B, Peng P, Shi HZ. Hospitalization and Critical Care of 109 Decedents with COVID-19 Pneumonia in Wuhan, China. Ann Am Thorac Soc. 2020;17:839-846. [PMID: 32255382 DOI: 10.1513/annalsats.202003-225oc] [Cited by in Crossref: 101] [Cited by in F6Publishing: 78] [Article Influence: 50.5] [Reference Citation Analysis]
683 Romanelli A, Mascolo S. Immunosuppression drug-related and clinical manifestation of Coronavirus disease 2019: A therapeutical hypothesis. Am J Transplant 2020;20:1947-8. [PMID: 32243698 DOI: 10.1111/ajt.15905] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 27.0] [Reference Citation Analysis]
684 van Eeden C, Khan L, Osman MS, Cohen Tervaert JW. Natural Killer Cell Dysfunction and Its Role in COVID-19. Int J Mol Sci 2020;21:E6351. [PMID: 32883007 DOI: 10.3390/ijms21176351] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 16.0] [Reference Citation Analysis]
685 Huang YF, Bai C, He F, Xie Y, Zhou H. Review on the potential action mechanisms of Chinese medicines in treating Coronavirus Disease 2019 (COVID-19). Pharmacol Res 2020;158:104939. [PMID: 32445956 DOI: 10.1016/j.phrs.2020.104939] [Cited by in Crossref: 69] [Cited by in F6Publishing: 57] [Article Influence: 34.5] [Reference Citation Analysis]
686 Georgakopoulou VE, Garmpis N, Damaskos C, Valsami S, Dimitroulis D, Diamantis E, Farmaki P, Papageorgiou CV, Makrodimitri S, Gravvanis N, Velonias S, Sklapani P, Trakas N, Antoniou EA, Kontzoglou K, Nikolidakis L, Damaskou Z, Syllaios A, Marinos G, Vogiatzi G, Korrou GE, Kyriakos G, Quiles-Sanchez LV, Patsouras A, Lamprinos D, Stelianidi A, Savvanis S, Garmpi A. The Impact of Peripheral Eosinophil Counts and Eosinophil to Lymphocyte Ratio (ELR) in the Clinical Course of COVID-19 Patients: A Retrospective Study. In Vivo 2021;35:641-8. [PMID: 33402521 DOI: 10.21873/invivo.12303] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
687 Ok F, Erdogan O, Durmus E, Carkci S, Canik A. Predictive values of blood urea nitrogen/creatinine ratio and other routine blood parameters on disease severity and survival of COVID-19 patients. J Med Virol 2021;93:786-93. [PMID: 32662893 DOI: 10.1002/jmv.26300] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 12.0] [Reference Citation Analysis]
688 Pang QL, He WC, Li JX, Huang L. Symptomatic and optimal supportive care of critical COVID-19: A case report and literature review. World J Clin Cases 2020; 8(23): 6181-6189 [PMID: 33344621 DOI: 10.12998/wjcc.v8.i23.6181] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
689 Pomara C, Li Volti G, Cappello F. The Post-Lockdown Era: What Is Next in Italy? Front Pharmacol 2020;11:1074. [PMID: 32760280 DOI: 10.3389/fphar.2020.01074] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
690 Lu Y, Liu F, Tong G, Qiu F, Song P, Wang X, Zou X, Wan D, Cui M, Xu Y, Zheng Z, Hong P. Clinical evidence of an interferon-glucocorticoid therapeutic synergy in COVID-19. Signal Transduct Target Ther 2021;6:107. [PMID: 33658482 DOI: 10.1038/s41392-021-00496-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
691 Chen L, Hu W, Guo X, Zhao P, Tang J, Gu Y, Huang N, Wang C, Cui A, Zhang D, Hu L, Feng Y, Hu S, Chen M, Duru F, Xiong C. Association of coagulation dysfunction with cardiac injury among hospitalized patients with COVID-19. Sci Rep 2021;11:4432. [PMID: 33627696 DOI: 10.1038/s41598-021-83822-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
692 Schmelter F, Föh B, Mallagaray A, Rahmöller J, Ehlers M, Lehrian S, von Kopylow V, Künsting I, Lixenfeld AS, Martin E, Ragab M, Meyer-Saraei R, Kreutzmann F, Eitel I, Taube S, Käding N, Jantzen E, Graf T, Sina C, Günther UL. Metabolic and Lipidomic Markers Differentiate COVID-19 From Non-Hospitalized and Other Intensive Care Patients. Front Mol Biosci 2021;8:737039. [PMID: 34938772 DOI: 10.3389/fmolb.2021.737039] [Reference Citation Analysis]
693 Nagoor Meeran MF, Javed H, Sharma C, Goyal SN, Kumar S, Jha NK, Ojha S. Can Echinacea be a potential candidate to target immunity, inflammation, and infection - The trinity of coronavirus disease 2019. Heliyon 2021;7:e05990. [PMID: 33585706 DOI: 10.1016/j.heliyon.2021.e05990] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
694 Zhu Z, Lian X, Su X, Wu W, Marraro GA, Zeng Y. From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses. Respir Res 2020;21:224. [PMID: 32854739 DOI: 10.1186/s12931-020-01479-w] [Cited by in Crossref: 172] [Cited by in F6Publishing: 1] [Article Influence: 86.0] [Reference Citation Analysis]
695 Cau R, Pacielli A, Fatemeh H, Vaudano P, Arru C, Crivelli P, Stranieri G, Suri JS, Mannelli L, Conti M, Mahammedi A, Kalra M, Saba L. Complications in COVID-19 patients: Characteristics of pulmonary embolism. Clin Imaging 2021;77:244-9. [PMID: 34029929 DOI: 10.1016/j.clinimag.2021.05.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
696 Roedl K, Jarczak D, Drolz A, Wichmann D, Boenisch O, de Heer G, Burdelski C, Frings D, Sensen B, Nierhaus A, Lütgehetmann M, Kluge S, Fuhrmann V. Severe liver dysfunction complicating course of COVID-19 in the critically ill: multifactorial cause or direct viral effect? Ann Intensive Care 2021;11:44. [PMID: 33721137 DOI: 10.1186/s13613-021-00835-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
697 Manfredi A, Luppi F, Cassone G, Vacchi C, Salvarani C, Sebastiani M. Pathogenesis and treatment of idiopathic and rheumatoid arthritis-related interstitial pneumonia. The possible lesson from COVID-19 pneumonia. Expert Rev Clin Immunol 2020;16:751-70. [PMID: 32722946 DOI: 10.1080/1744666X.2020.1803064] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
698 Taghizadieh A, Mikaeili H, Ahmadi M, Valizadeh H. Acute kidney injury in pregnant women following SARS-CoV-2 infection: A case report from Iran. Respir Med Case Rep 2020;30:101090. [PMID: 32405454 DOI: 10.1016/j.rmcr.2020.101090] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
699 Cho JY, Kim SS, Lee YS, Song DS, Lee JH, Kim JH. Management of liver diseases during the pandemic of coronavirus disease-19. Clin Mol Hepatol 2020;26:243-50. [PMID: 32570302 DOI: 10.3350/cmh.2020.0111] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
700 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
701 Begum H, Abbas K, Alam AF, Song H, Chowdhury MT, Abdul Ghani AB. Impact of the COVID-19 pandemic on the environment and socioeconomic viability: a sustainable production chain alternative. FS 2022;ahead-of-print. [DOI: 10.1108/fs-02-2021-0053] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
702 Silva-Sobrinho RA, Zilly A, Silva RMMD, Arcoverde MAM, Deschutter EJ, Palha PF, Bernardi AS. Coping with COVID-19 in an international border region: health and economy. Rev Lat Am Enfermagem 2021;29:e3398. [PMID: 33439950 DOI: 10.1590/1518-8345.4659.3398] [Reference Citation Analysis]
703 Durhan G, Ardalı Düzgün S, Başaran Demirkazık F, Irmak İ, İdilman İ, Gülsün Akpınar M, Akpınar E, Öcal S, Telli G, Topeli A, Arıyürek OM. Visual and software-based quantitative chest CT assessment of COVID-19: correlation with clinical findings. Diagn Interv Radiol 2020;26:557-64. [PMID: 32876569 DOI: 10.5152/dir.2020.20407] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
704 Singh V, Singh MK. Acute Kidney Injury in COVID-19: a Brief Review. Indian J Surg 2021;:1-5. [PMID: 33935396 DOI: 10.1007/s12262-020-02697-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
705 Liekkinen J, de Santos Moreno B, Paananen RO, Vattulainen I, Monticelli L, Bernardino de la Serna J, Javanainen M. Understanding the Functional Properties of Lipid Heterogeneity in Pulmonary Surfactant Monolayers at the Atomistic Level. Front Cell Dev Biol 2020;8:581016. [PMID: 33304898 DOI: 10.3389/fcell.2020.581016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
706 Tatar E, Karatas M, Bozaci I, Ari A, Acar T, Simsek C, Yildirim AM, Yildirim O, Uslu A. Intravenous Immunoglobulin and Favipiravir treatment for A Kidney Transplant Patient with Severe Covid-19 Pneumonia. Transfus Apher Sci 2020;59:102904. [PMID: 32807652 DOI: 10.1016/j.transci.2020.102904] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
707 Sui Y, Bekele Y, Berzofsky JA. Potential SARS-CoV-2 Immune Correlates of Protection in Infection and Vaccine Immunization. Pathogens. 2021;10. [PMID: 33573221 DOI: 10.3390/pathogens10020138] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 15.0] [Reference Citation Analysis]
708 Medzikovic L, Cunningham CM, Li M, Amjedi M, Hong J, Ruffenach G, Eghbali M. Sex differences underlying preexisting cardiovascular disease and cardiovascular injury in COVID-19. J Mol Cell Cardiol 2020;148:25-33. [PMID: 32835666 DOI: 10.1016/j.yjmcc.2020.08.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
709 Cheah IK, Halliwell B. Could Ergothioneine Aid in the Treatment of Coronavirus Patients? Antioxidants (Basel) 2020;9:E595. [PMID: 32646061 DOI: 10.3390/antiox9070595] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
710 Brzoska J, von Eick H, Hündgen M. Interferons in the Therapy of Severe Coronavirus Infections: A Critical Analysis and Recollection of a Forgotten Therapeutic Regimen with Interferon Beta. Drug Res (Stuttg) 2020;70:291-7. [PMID: 32443163 DOI: 10.1055/a-1170-4395] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
711 Al-Rohaimi AH, Al Otaibi F. Novel SARS-CoV-2 outbreak and COVID19 disease; a systemic review on the global pandemic. Genes Dis 2020;7:491-501. [PMID: 33335956 DOI: 10.1016/j.gendis.2020.06.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
712 Majid S, Khan MS, Rashid S, Niyaz A, Farooq R, Bhat SA, Wani HA, Qureshi W. COVID-19: Diagnostics, Therapeutic Advances, and Vaccine Development. Curr Clin Microbiol Rep 2021;:1-15. [PMID: 33614398 DOI: 10.1007/s40588-021-00157-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
713 Silveira FM, Mello ALR, da Silva Fonseca L, dos Santos Ferreira L, Kirschnick LB, Martins MD, Schuch LF, de Arruda JAA, Soares CD, de Oliveira Sales A, Bologna-molina R, Santos-silva AR, Vasconcelos ACU. Morphological and tissue-based molecular characterization of oral lesions in patients with COVID-19: A living systematic review. Archives of Oral Biology 2022. [DOI: 10.1016/j.archoralbio.2022.105374] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
714 Lei C, Su B, Dong H, Bellavia A, Di Fenza R, Safaee Fakhr B, Gianni S, Grassi LG, Kacmarek R, Araujo Morais CC, Pinciroli R, Vassena E, Berra L. Protocol of a randomized controlled trial testing inhaled Nitric Oxide in mechanically ventilated patients with severe acute respiratory syndrome in COVID-19 (SARS-CoV-2). medRxiv 2020:2020. [PMID: 32511534 DOI: 10.1101/2020.03.09.20033530] [Cited by in Crossref: 12] [Article Influence: 6.0] [Reference Citation Analysis]
715 Frohman EM, Villemarette-Pittman NR, Melamed E, Cruz RA, Longmuir R, Varkey TC, Steinman L, Zamvil SS, Frohman TC. Part I. SARS-CoV-2 triggered 'PANIC' attack in severe COVID-19. J Neurol Sci 2020;415:116936. [PMID: 32532449 DOI: 10.1016/j.jns.2020.116936] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
716 Ren P, Zhu C, He Y, Jiang H, Chen J. Analysis of the dynamic relationship between immune profiles and the clinical features of patients with COVID-19. Ann Transl Med 2021;9:1118. [PMID: 34430559 DOI: 10.21037/atm-21-812] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
717 Ducastel M, Chenevier-Gobeaux C, Ballaa Y, Meritet JF, Brack M, Chapuis N, Pene F, Carlier N, Szwebel TA, Roche N, Terrier B, Borderie D. Oxidative Stress and Inflammatory Biomarkers for the Prediction of Severity and ICU Admission in Unselected Patients Hospitalized with COVID-19. Int J Mol Sci 2021;22:7462. [PMID: 34299080 DOI: 10.3390/ijms22147462] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
718 Ranard LS, Fried JA, Abdalla M, Anstey DE, Givens RC, Kumaraiah D, Kodali SK, Takeda K, Karmpaliotis D, Rabbani LE, Sayer G, Kirtane AJ, Leon MB, Schwartz A, Uriel N, Masoumi A. Approach to Acute Cardiovascular Complications in COVID-19 Infection. Circ Heart Fail 2020;13:e007220. [PMID: 32500721 DOI: 10.1161/CIRCHEARTFAILURE.120.007220] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 13.5] [Reference Citation Analysis]
719 Wu Y, Wang T, Guo C, Zhang D, Ge X, Huang Z, Zhou X, Li Y, Peng Q, Li J. Plasminogen Improves Lung Lesions and Hypoxemia in Patients with COVID-19. SSRN Journal. [DOI: 10.2139/ssrn.3552628] [Cited by in Crossref: 3] [Reference Citation Analysis]
720 Al-Zaqri N, Pooventhiran T, Alharthi FA, Bhattacharyya U, Thomas R. Structural investigations, quantum mechanical studies on proton and metal affinity and biological activity predictions of selpercatinib. J Mol Liq 2021;325:114765. [PMID: 33746318 DOI: 10.1016/j.molliq.2020.114765] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
721 Hosseini NF, Dalirfardouei R, Aliramaei MR, Najafi R. Stem cells or their exosomes: which is preferred in COVID-19 treatment? Biotechnol Lett. [DOI: 10.1007/s10529-021-03209-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
722 Passaro A, Peters S, Mok TSK, Attili I, Mitsudomi T, de Marinis F. Testing for COVID-19 in lung cancer patients. Ann Oncol 2020;31:832-4. [PMID: 32278879 DOI: 10.1016/j.annonc.2020.04.002] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 18.5] [Reference Citation Analysis]
723 Jiang F, Yang WL, Wang JW, Zhu Z, Luo C, Arendt-Nielsen L, Song XJ. Pain during and after coronavirus disease 2019: Chinese perspectives. Pain Rep 2021;6:e931. [PMID: 33997586 DOI: 10.1097/PR9.0000000000000931] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
724 Luo J, Zhu X, Jian J, Chen X, Yin K. Cardiovascular disease in patients with COVID-19: evidence from cardiovascular pathology to treatment. Acta Biochim Biophys Sin (Shanghai) 2021;53:273-82. [PMID: 33428706 DOI: 10.1093/abbs/gmaa176] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
725 Costanzo M, Caterino M, Fedele R, Cevenini A, Pontillo M, Barra L, Ruoppolo M. COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19. Int J Mol Sci 2022;23:2414. [PMID: 35269564 DOI: 10.3390/ijms23052414] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
726 Lai W, Li S, Du Z, Ma X, Lu J, Gao WD, Abbott GW, Hu Z, Kang Y. Severe Patients With ARDS With COVID-19 Treated With Extracorporeal Membrane Oxygenation in China: A Retrospective Study. Front Med (Lausanne) 2021;8:699227. [PMID: 34746170 DOI: 10.3389/fmed.2021.699227] [Reference Citation Analysis]
727 Jiang L, Yang Y, Gandhewar J. Bilateral corneal endothelial failure following COVID-19 pneumonia. BMJ Case Rep 2021;14:e242702. [PMID: 34544701 DOI: 10.1136/bcr-2021-242702] [Reference Citation Analysis]
728